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ABSTRACT 
 
 
Since the large-scale metaproteome was first reported in 2005, 
metaproteomics has advanced at a tremendous rate both in its quantitative and 
qualitative metrics.  Furthermore metaproteomics is now being applied as a 
general tool in microbial ecology in a large variety of environmental studies.  
Though metaproteomics is becoming a useful and even a standard tool for the 
microbial ecologist, standardized bioinformatics pipelines are not readily 
available.  Therefore, we developed quantitative and functional analysis pipeline 
for metaproteomics (QFAM) to help analyze large and complicated 
metaproteomics data in a robust and timely fashion with outputs designed to be 
simple and clearly understood by the microbial ecologist.   
QFAM starts by running peptide-spectrum searches against resultant 
MS/MS datasets with mixed metagenome/appropriate protein FASTA database.  
Its primary search algorithm is MyriMatch/IDPicker.  MyriMatch/IDPicker uses 
multi-CPUs effectively, has an accurate scoring-system, correctly use the high 
MS accuracy data, and finally has a robust method for protein determination.  
These are required features for metaproteomics requiring large protein database 
and complicated peptide-structure. 
QFAM has quantitative (QAM) and functional (FAM) analysis to provide 
dependable protein signatures and confident information for understanding the 
characteristics of the metaproteome.  QAM employs a ’selfea’ R package, which 
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provides probability models as well as Cohen’s effect sizes.  Our benchmark data 
test and Monte Carlo simulation results show that selfea can reduce false 
positives efficiently while losing few true positives; one of the key goals of 
proteomics and/or metaproteomics experiments.   
FAM has two modules: BioSystems and COG analysis.  The BioSystems 
module is most appropriate for well-annotated model organisms, such as 
humans, whereas the COG module is useful for less-annotated microorganisms 
and metagenome sequences.  Both modules provide an enrichment test using 
Fisher’s exact-test and a significance test using selfea.  With two statistics, FAM 
generates differentially enriched functional terms that are insightful for discerning 
biological information held behind the metaproteome data.   
Two application studies in chapter 4 and 5 show how QFAM can be 
employed for metaproteomics data analysis.  QFAM is distinguished from other 
proteomics pipelines by multiprocessing as well as quantitative and functional 
analysis.  
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CHAPTER I 
INTRODUCTION 
 
Metaproteomics 
 
Metaproteomics in proteomics 
The goal of proteomics is to obtain an all-inclusive quantitative collection 
of proteins in a cell, a multicellular organism, an extracellular environment and/or 
a community of multiple organisms.  This comprehensive analysis is 
accomplished through protein extraction, identification and comparative analysis 
via liquid chromatography mass spectrometry (LC-MS), one-dimensional or two-
dimensional gel electrophoresis-mass spectrometry (1D-GeLC-MS/2DE-MS), 
affinity purifications-mass spectrometry (AP-MS) and protein- or antibody-based 
microarray [1].  The goals of proteomics research are various and extensive, 
such as protein quantification on a large scale, finding drug targets, exploring 
clinical protein markers, structural characterization of protein complexes, imaging 
protein traffic in multicellular system and discovery of significant proteins from 
disease states such as neurodegenerative [2], coronary artery [3] and Lyme 
disease [1,4,5] (Fig. 1). 
Proteomics has rapidly grown in technology, scope, and application over 
the last 20 years from the first simple proteomics experiments, which attempted 
to separate all of the proteins from E. coli on a 2d-PAGE system followed by the 
extremely laborious cutting out of spots one by one.   
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Figure 1 Applications of proteomics.  Proteomics is applied to a diverse set of 
life science fields including basic scientific research, clinical protein marker 
discovery, and drug discovery.  This figure was adapted from a book, ‘Molecular 
Biologist's Guide to Proteomics’ [5]. 
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These spots are identified by either MALDI-TOF peptide mass finger 
printing and/or direct infusion nano-spray followed by tandem mass spectrometry 
(MS/MS) [6,7].  Today in numerous laboratories around the world, proteomics is 
a massive endeavor with sometimes 10-20 high throughput 2d-LC-MS/MS 
instruments (i.e., hybrid Velos Orbitraps, QExactives or Fusion MS systems) 
running 24/7 in “discovery mode” with another 10 or so 1d-LC-MS/MS 
instruments (i.e., high resolution triple quadruple instruments) running in very 
accurate targeted quantitation mode.  These labs attempt to use the power of 
MS-based proteomics to rapidly define protein biomarkers, novel protein 
therapeutics and many other novel human heath applications.  Furthermore, 
high-throughput proteomics laboratories are now expanding into metabolomics 
and lipidomics, for a holistic “omics” approach to understanding disease, human 
health, drug mechanism and a host of other biological applications.  Clearly it can 
be stated that mass spectrometry is the fastest growing analytical application in 
the biological sciences today. 
Metaproteomics (also called Community Proteomics, Environmental 
Proteomics, or Community Proteogenomics) can be defined as “the study of all 
proteins recovered directly from environmental sources and is an extension of 
MS-based proteomics [8].  Wilmes primarily used and defined metaproteomics as 
“the large-scale characterization of the entire protein complement of 
environmental microbiota at a given point in time” [9,10].  Per Wilmes definition, 
metaproteomics involves studying the protein complement of microbial 
communities that consist of multiple species.  To date metaproteomics studies 
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have covered a diverse set of environmental samples including acid mine 
drainage biofilms [11], wastewaters [12], ocean sampling [13], soil systems [14], 
permafrost [15] and the human microbiome [16] (Table 1).  Since the first large-
scale metaproteome data was generated in 2005 [11], metaproteomics has 
rapidly advanced in terms of scale, depth, speed and quality.  For example, 
Lichtman et al. [17] in 2013 identified 234 proteins human and microbial proteins, 
but with today's technology and improvements in metaproteomics, now over 56k 
proteins have been identified in fecal material, as described in our diet proteome 
study in Chapter 5. 
Shotgun metaproteomics 
Metaproteomics studies are generally based on bottom up approach, also 
known as shotgun proteomics [10,18,19].  The bottom-up method aims to identify 
and quantify peptides that are generally 7-20 amino acids in length, which are 
obtained from digesting proteins with sequencing grade trypsin although 
sometimes other proteolysis enzymes are used.  The peptides are then injected 
onto a high performance liquid chromatography (HPLC) coupled with data 
dependent tandem mass spectrometer (LC-MS/MS) [18-20].  The top-down 
method directly investigates intact proteins either via LC-MS and/or LC-MS/MS 
analyses [20-22].  The bottom-up or shotgun proteomics methodologies tend to 
dominate MS-based proteomics in general and metaproteomics as well.  
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Table 1 Overview of metaproteomics studies.  This table was adapted from 
VerBerkmoes et al [21]. 
Microbiome Number of 
peptides/ 
proteins 
identified 
Protein/peptide 
separation 
method 
MS platform Peptide 
identification 
method 
Ocean 184/NA 2D-PAGE, 2D 
nano-LC 
LCQ, MS/MS Spectral 
matching, de 
novo 
Acid mine 
drainage 
6,188/2,033 
(2p) 
6,931/5,090 
(1p) 
2D nano-LC LTQ MS/MS Spectral 
matching 
Lake and soil NA/513 (1p) 2D nano-LC Q-ToF, 
MS/MS 
Spectral 
matching 
Estuary 7/3 (2p) 2D-PAGE + 
LC 
Q-ToF, 
MS/MS 
De novo 
Ocean 3/1 (2p) 1D-PAGE MALDI-ToF, 
MS 
Spectral 
matching 
Riftia symbionts NA/220 (2p) 2D-PAGE, 1D-
PAGE + 2D 
nano-LC 
MALDI-ToF 
MS, Q-ToF 
MS/MS 
Spectral 
matching 
Infant 
gastrointestinal 
tract 
11/1 (1p) 2D-PAGE MALDI-ToF 
MS 
De novo 
Acid mine 
drainage 
8,137/3,234 
(2p) 
2D nano-LC LTQ MS/MS Spectral 
matching 
Waste water 
treatment 
reactor 
NA/109 (2p) 2D-PAGE MALDI-ToF, 
MS/MS 
Spectral 
matching, de 
novo 
Contaminated 
soil/groundwater 
NA/59(1p) 1D+2D-PAGE 
+ LC 
MS/MS Spectral 
matching 
Sludge NA/46 (2p) 2D-PAGE MALDI-ToF 
MS, Q-ToF 
MS/MS 
Spectral 
matching 
Sludge 4,472/2,378 
(2p) 
2D nano-LC LTQ MS/MS, 
Orbitrap, 
MS/MS 
Spectral 
matching 
Sludge EPS 50/10 (1p) 1D-PAGE + 
LC 
4000Qtrap, 
MS/MS 
Spectral 
matching 
Ocean 6,533/1,042 
(1p-2p) 
2D nano-LC LTQ MS/MS Spectral 
matching 
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Table 1 continued. 
Microbiome Number of 
peptides/ 
proteins 
identified 
Protein/peptide 
separation 
method 
MS platform Peptide 
identification 
method 
Acid mine 
drainage 
NA/2,752 (2p) 2D nano-LC Orbitrap, 
MS/MS 
Spectral 
matching 
Gut NA/2,214 (2p) 2D nano-LC Orbitrap, 
MS/MS 
Spectral 
matching 
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Its advantages include large-scale data acquisition, improved ability to handle 
high-complexity samples, higher overall sensitivity, higher overall dynamic range, 
more accurate quantitation and better front-end separation of peptides vs. intact 
proteins via HPLC [20].   
These advantages are all required features to profile highly complicated 
metaproteomes.  Therefore, bottom-up proteomics is currently the most common 
methodology found in metaproteomics studies [21].  Although bottom-up 
approach is mainly used in metaproteomics studies, the top-down approach has 
its unique advantages.  Top-down approach provides a holistic view of intact 
proteins and can assist post-translational modification (PTM) identification.  
Integration of bottom-up and top-down approaches was successfully applied in 
studies of microbial isolates Shewanella oneidensis and Rhodopseudomonas 
palustris [23,24].   
The typical shotgun metaproteomics consists of five crucial steps: sample 
collection, protein extraction, protein digestion, LC-MS/MS analysis and 
bioinformatics analysis (Fig. 2).  It’s essential that each of these steps are 
optimized, biases minimized and carried out with great care and attention to all 
details as the entire experimental protocol can fail based on a single mistake in 
any step in any of the four critical steps.  
Sample collection is the first step in metaproteomics studies.  Piehowski et 
al showed that the biggest variation observed in proteomics experiments can be 
generated from sample collection [25].   
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Figure 2 Overview of typical shotgun metaproteomics steps.  Microbial 
ecologist carefully collects a sample containing the desired microbial community 
with great care to obtain a true in situ representation.  Proteins are then extracted 
from the microbial community with an un-biased methodology, with goal of 
obtaining a true representation of the protein abundances. Then, the collected 
proteins are proteolytical digested by an enzyme, typically trypsin.  The resultant 
peptides are desalted, concentrated, filtered and analyzed via 2D-LC-MS/MS.  
Finally, the resultant MS/MS spectra are identified and analyzed by many 
bioinformatics tools to obtain protein identification and quantification.  This 
illustration was adapted from Tanca et al [10] and http://www.planetorbitrap.com. 
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Also, careful and appropriate sample collection and archiving are important 
issues in microbial ecology [26,27].  Biomolecules, such as DNA, RNA, and 
proteins should be protected from chemical and physical shock.  Importantly, 
during the collection of the microbial community, great care should be taken so 
as to obtain a true in-situ snapshot of the proteome as it is in the natural 
environment; not as it is after extensive sample handling. Therefore, every 
environmental sample is generally stored in deep freezer at -80°C immediately 
after collection until protein extraction.   
The second step major goal is the un-biased extraction of the proteome 
followed by complete protein denaturation and di-sulfide bond breakage.  This 
prepares the proteome for enzymatic digestion via trypsin and/or other proteolytic 
enzymes.  There are various methods of protein extraction by combining various 
detergents (e.g., sodium dodecyl sulfate (SDS), CHAPS or Triton X-100), 
organic/inorganic compounds (e.g., phenol, NaOH), chaotropic agents (e.g., urea 
or guanidine hydrochloride), reducing agents (e.g., dithiothreitol (DTT), 
tributylphosphine) and thermal treatments (e.g., boiling) and/or sonication/bead-
beating/French press and etc.  Detergents like SDS are used for cell lysis and 
chaotropic agents can denature proteins.  Reducing agents are employed to 
break disulfide bonds and further denature proteins.  Rapid and controlled 
thermal treatment can inactivate native enzymatic activity and prevent unwanted 
nonspecific proteome degradation [28].  Because there is no gold standard for 
metaproteome extraction, it is important to consider the characteristics of the 
given community and target proteins to maximize extraction yield.  Very often 
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metaproteomics experts will try different methodologies on the environmental 
sample of interest until one obtains an optimal method.  Because environmentally 
derived samples are often biomass limited due to difficulties and cost of sample 
acquisition, protein extraction is more challenging than proteomics studies of 
laboratory-grown microbes [29].  This is even more pronounced in the sub-field of 
soil metaproteomics, where the presences of humic acids, excess plant material 
and other abundant small molecules can make an efficient extraction of the 
microbial metaproteome difficult.  Indeed, my PhD advisor, Dr. Nathan 
VerBerkmoes, has called the complex high organic soil metaproteome the most 
difficult analytical challenge on the planet to date. 
After proteins are extracted from a sample, the next step is protein 
digestion.  Before proteins are digested, chemical compounds, added for protein 
extraction, should be removed or diluted as not to disturb the following enzymatic 
digestion.  This cleaning step is traditionally fulfilled by protein precipitation using 
trichloroacetic acid (TCA), followed by excess washing with chilled acetone or 
ammonium acetate/methanol to the protein extract solution [10].  However, these 
classical methods may lose certain types of proteins.  Another alternative 
approach recently employed is filter-aided sample preparation (FASP), 
developed in 2009 by Mann et al [30] and modified by the VerBerkmoes lab for 
metaproteomics applications. This methodology has been successfully applied in 
many metaproteome studies [31-34] and it can combine sample cleanup and 
protein digestion on a centrifuge filter.  This FASP methodology showed improve 
  11 
performance over several competing methods, especially for low abundance 
proteins [31]. 
Protein digestion is an important step in shotgun metaproteomics because 
all the proteins in a bottom up approach are assembled from the digested 
peptides.  Trypsin is widely used for proteolysis in metaproteomics because it is 
highly specific and generates a positively charged N-terminus and C-terminus, 
which aids in obtaining high quality MS and MS/MS spectra [35].  Because MS-
based metaproteomics are usually run in positive ion mode, the positively 
charged ends are ideal for obtaining high quality MS and MS/MS spectra.  
Trypsin specifically targets carboxyl side of arginine and lysine of proteins in a 
weakly basic environment (Table 2).  Nevertheless, trypsin has difficulty digesting 
tightly folded proteins that may not be denatured by the denaturing reagents and 
an inadequate distribution of trypsin cleavage sites may generate too many short 
peptides for proper analysis [36].  Furthermore, membrane proteins tent to be 
resistant to trypsin due to their limited number of lysine and arginine residues 
[36].  According to Wu et al, trypsin generates predominantly small peptides 
shorter than 20 amino acid length (Fig. 3) [37].  The small size of these peptides, 
which average between 7~20 residues [36], can facilitate MS detection, but 
cause a number of redundant peptides that are derived from more than two 
proteins.  This is termed the uniqueness problem in metaproteomics and limits 
the analysis. 
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Table 2 Common proteases use in metaproteomics.  This table is adapted 
from the website: http://www.proteinsandproteomics.org/content/free/tables 
_1/table11.pdf. 
 
Protease Class Cleavage site 
Chymotrypsin Serin protease After F, T, or Y 
Endoproteinage Arg-C Serin protease After R 
Endoproteinage Asp-N Metalloprotease Before D and cysteic acid 
Endoproteinage Glu-C Serin protease After E, or after D or E 
Endoproteinage Lys-C Serin protease After K 
Pepsin Acid protease Broad specificity 
Trypsin Serin protease After K or R 
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Figure 3 in silico digestions of the human HeLa cell proteome with assorted 
proteases.   A) The number of peptides predicted without mis-cleavage and 
B) cleavage assuming two mis-cleavages.  This figure is adapted from Wu et 
al [37]. 
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Redundant non-unique peptides, often generated by trypsin digestion, are 
the biggest hurdle to accurately identifying proteins from the peptides identified 
by LC-MS/MS.  This problem is exaggerated in metaproteomics due to the 
increase in database size and the fact that very often microbes carry very 
homologous proteins with very similar sequences.  For example EF-TU, 
ribosomal, GroEL/GroES, other chaperones and glycolsis/TCA/oxidative 
phosphylation pathway proteins can be highly conserved across a wide range of 
microbes in a given environmental sample.   
Because redundant peptides can be found in more than two proteins, we 
cannot be sure where those peptides originate.  Hence, these are termed as non-
unique. Non-unique peptides limit the confidence of protein identification and 
quantification.  In other words, we cannot know from which proteins these 
redundant peptides arose from and which protein they should be assigned to.  To 
reduce the number of the problematic peptides, middle down proteomics is new 
method that attempts to use alternative proteases, which produce longer 
peptides [37-39].  Wu et al introduced the OmpT enzyme as replacement for 
trypsin to produce lengthy peptides longer than 3 kDa (Fig. 3) [37].  Peptide 
redundancy is generally dependent on the average length of produced peptides.  
While this methodology has not been widely used in metaproteomics, we feel 
that this is the next step in metaproteomics and would improve protein 
identification and quantification by limiting the “non-unique” problem, which has 
plagued metaproteomics studies. 
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In addition to a decrease in redundant peptides, longer peptides have less 
probability of false positive identification (Fig. 4) [40].  Figure 4 shows that the P-
score Bayesian probability model in MaxQuant [40] changes based on peptide 
length.  P-score distribution of false positive identifications shown in red gets 
smaller and narrower than true positive distribution shown in blue as the peptide 
length (L) gets longer.  Metaproteomics studies using the middle down approach 
have not been published, but we believe this could be a potential path forward for 
solving the “non-unique” peptide problem. 
LC-MS/MS analysis 
The digested peptides are separated by their chemical and physical 
characteristics through high-performance liquid chromatography (HPLC), ionized 
by electrospray ionization and measured on an MS instrument.  For most bottom-
up proteomics and metaproteomics experiments the mass spectrometer is 
operated in data-dependent mode.  This means that at any given point in time 
during the LC-MS/MS analysis, 50-100 peptides enter the mass spectrometer.  
Modern mass spectrometers have very high duty cycle (i.e., the speed going 
from one scan type to the next).  In the data-dependent mode the peptides mass 
(i.e., m/z) are accurately measured by the mass spectrometer in the full scan 
mode.  For example an Orbitrap mass spectrometer provides mass accuracies at 
~1-10 p.p.m or generally the third decimal place of the peptide mass.    
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Figure 4 These panels display distribution of P-scores, which is the peptide 
identification score of MaxQuant.  Blue color shows peptide identifications 
from a forward database search and red colors are from the reverse database, 
intended to be a false positive peptide database.  L is the peptide length.  This 
illustration was adapted from Cox et al [40].  
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Next the mass spectrometer picks the top 10-20 observed ions from the previous 
full scan, isolates them one by one and fragments them via energy deposition 
also termed MS/MS, CID, CAD, or now often called HCD.  Peptide sequence 
information is obtained at this step.  The intact peptides are isolated and 
fragmented down the peptide backbone thus providing sequence information.  
The accurate mass from the full scan coupled with the sequence information 
from the MS/MS scan are the two key points of information needed to confidently 
identify peptides via database searching (described below).  The instrument 
cycles between full scans and data-dependent MS/MS scans during the entire 
LC-MS/MS analyses.  
The key technology for this entire process is the simple but brilliant 
electrospray ionization (ESI) invited by John Fenn in 1984.  This revolutionary 
technique allowed for the soft ionization of large biomolecules into the gas phase 
directly from a flowing liquid stream simply by the application of high voltage to a 
metal needle.  The peptides are ionized by Coulomb explosion at Rayleigh limit 
[41,42].  ESI has revolutionized large molecule measurements using MS 
instrumentation.  ESI does not require any chemical reagents besides water, 
methanol, and a small amount of organic acid.  It is sensitive up to atto-mole 
levels and can easily ionize proteins up to 100,000 Da and much higher MW can 
be achieved with special instrumentation.  ESI enables the analyses of all major 
biomolecules (i.e., DNA/RNA, proteins, lipids, sugars, and small metabolites) via 
mass spectrometry.   
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Because microbial communities usually have more proteins than single 
isolated microorganisms, high quality peptide separation is essential to achieve 
high quality metaproteomic analyses.  If a massive number of peptide ions are 
ionized into the MS instrument at the same time, some of ions may not be 
appropriately measured or missed entirely due to the limitations of the MS scan 
speeds and MS dynamic range.  Peptide separation should be designed by first 
considering the ability of MS instrument available to the metaproteomics 
researcher.  Besides the scan speed, good peptides separation can reduce the 
density of the peptides entering the MS at any given time.  In other words, similar 
m/z peptides can be pulled apart by the LC separation.  Close m/z ions within the 
isolation window, which is generally 1-3 m/z units, are often sequenced together 
during MS/MS phase of the experiment.  This is undesirable to say the least.  
This co-isolation and resultant MS/MS sequencing makes peptide identification 
difficult.  To obtain better dynamic range, enhanced peptide identification and 
more confident protein quantification, the level of LC separation should be 
increased as much as possible.  In order to obtain the maximum proteome depth 
and protein quantitation, the LC-MS/MS was run for 24 hours with 2-dimensions 
of liquid chromatography separation, strong cation exchanged (SCX) coupled 
with (reverse-phase) RP separation for the human fecal proteome study (Chapter 
4) and influence of diet on the metaproteome (Chapter 5), we have termed this 
approach “deep and wide metaproteomics”.  This means that the goal of this 
proteome experiment is to measure deep into the proteome of each microbial 
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species with wide coverage across all the microbial species present in the 
community.   
High resolving power is an important virtue of the MS instrument for 
unambiguous protein identification in metaproteomics.  The higher the mass 
accuracy, the more exact peptide identification.  Low-resolution MS (LRMS) is 
less expensive and relatively easy to maintain, but cannot provide exact mass 
measurements.  The high-resolution MS (HRMS) can determine several decimal 
places of mass accuracy.  This high precision of HRMS can narrow down 
candidate peptides to only a few possibilities (Fig. 5).  HRMS can give more 
exact p.p.m. mass accuracy  than LRMS.  P.P.M is calculated by (((exact mass – 
accurate mass) / exact mass) x 106).  Lower p.p.m. means small mass error.  
Smaller p.p.m. (i.e., mass difference between observed and expected mass) can 
reduce false matches by removing similar weighted false peptide candidates.  
For metaproteomics experiments high mass accuracy for the full scan MS is 
absolutely essential.  High resolution for the MS/MS spectra provides even better 
results.  Because the potential metaproteome of a complex community is much 
more complicated than a single species proteome, it requires HRMS to narrow 
down candidate peptides.  Due to the need for high mass accuracy, the Orbitrap 
MS is widely used in metaproteomics studies because they offer higher 
resolution/accurate mass analyses in a stable instrument platform.  
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Figure 5 The effect of increasing mass accuracy for unambiguous 
identification of compounds.  P.P.M. is a parts per million (((exact mass – 
accurate mass) / exact mass) x 106).  Lower p.p.m. means small mass error.  If 
mass accuracy is low (i.e., p.p.m. is high), the number of candidate compounds 
increases linearly.  As the slope gets steeper, the molecular weight gets larger.  
This illustration is adapted from Quenzer et al [43]. 
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The Orbitrap MS is easy to use and maintain, produces high quality data, has 
excellent dynamic range and sensitivity and enables tandem in space and time 
MS/MS measurements.   
Even though high mass accuracy can provide better resolution for peptide 
identification, it is not enough to identify peptides, especially from highly complex 
metaproteomics samples.  Tandem mass spectrometry or MS/MS is required for 
exact peptide identification and sequencing.  In the MS/MS step, target ions from 
the survey full-scan mass spectrum (MS1) are selected, isolated, fragmented and 
the mass analyzed.  This MS/MS peak selection can be modified for different 
acquisition approaches, data dependent acquisition (DDA), and data 
independent acquisition (DIA) (Fig. 6). 
  In DDA approach, a fixed number of peaks from the MS1 scan are 
selected, isolated, and subjected to MS/MS analysis  (Fig. 6). DDA is powerful 
and versatile, but it limits the number of peptides sampled for fragmentation 
regardless of dynamic range and peak capacity of the MS system [44].  In a 
complex protein mixture, up to 84% of peptides are not sampled for MS/MS, 
while at most 30% of peptides are analyzed by MS/MS [45] via the DDA 
approach.  DIA is an alternative approach to DDA.  DIA collects holistic MS/MS 
spectra of all the peaks systematically and independently of the precursor ions 
(Fig. 6).   
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Figure 6 Data dependent acquisition (DDA) and data independent 
acquisition (DIA).  DDA targets MS/MS scans with narrow isolation windows 
centered on specific precursor ions in a survey MS1 scan.  DIA acquired MS/MS 
scans with wide isolation windows acquiring many peptide precursors.  Peptide 
precursor VLENTEIGDSIFDK++ is present in a single MS/MS spectrum in a DDA 
analysis, while it can be extracted from all retention times in DIA.  This image 
was adapted from Egertson et al [46]. 
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For example, DIA collects MS/MS data either without precursor ion selection [47], 
ion mobility–collision-induced dissociation–time-of-flight mass spectrometry [48], 
wide isolation windows [49], narrow isolation windows combined with many 
injections [50] or multiplexing strategies [44].  Even though DIA theoretically may 
acquire more peptide information than DDA, its data complexity is much higher 
than DDA because the MS/MS spectrum of DIA has fragment peaks arising from 
a wide number of peptides.  Thus data de-convolution and peptide identification 
for the DIA experiment is difficult to say the least. 
Traditional protein reference database search, widely used for DDA data, 
is not effective for DIA data due to the presence of multi-peptides in the MS/MS 
data.  There are several tools for DIA data analysis, such as Skyline [51], 
OpenSWATH [52] and UDMSE [53], but DIA still has a long way to go in spite of 
its rapid development to be accepted by the proteomics community and 
employed as routinely as the DDA method [54].  Currently there are no 
metaproteomics publications using DIA because it makes intricate 
metaproteomics data even more complicated.  However, DIA might enhance the 
depth of metaproteome experiments if the bioinformatics can de-convolute the 
highly complex MS/MS data.   
Quantification of proteins is a major goal for metaproteomics.  The number 
of proteins identified gets smaller and smaller following each experimental step 
as proteins are lost during the experimental procedures (Fig. 7).  
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Figure 7 Relative amount of proteins in original sample, that are identified 
and quantified by metaproteomic analysis.  Proteins are lost during protein 
extraction, digestion, and LC-MS/MS steps.  Low-abundant proteins are difficult 
to identify due to limited dynamic range.  Specific types of proteins can be 
missed by the protein extraction method.  Only a fraction of the original proteins 
is reliably quantified.  This illustration was adapted from Bantscheff et al [55]. 
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There are two major methodologies for protein quantification in proteomics. 
These are termed label-free quantification and labeled quantification.  Labeling 
methods can be categorized into metabolic labeling (SILAC [56] and isotopes), 
chemical labeling (ICAT [57,58], iTRAQ [58] and TMT[59]) and finally spiked 
isotopically labeled proteins.   
The label free methodology uses intrinsic data obtained during the LC-
MS/MS analyses of the sample such as counting spectra identified to each 
identified peptide.  This is termed peptide-spectrum match (PSM) (Fig. 8).   The 
label free methods are the simplest to employ and cheapest but provide limited 
quantitation accuracy. 
 Of the labeling methods, metabolic labeling is by far the most accurate 
(Table 3), but often cannot be employed in metaproteomics experiments due to 
difficulties in labeling an environmental sample with heavy nitrogen or carbon.  
Chemical labeling methods target specific residues for ICAT or the N-terminus for 
iTRAQ and TMT.  These methods have medium accuracy and quantitative 
coverage (Table 3).  These approaches can be used in metaproteomics as long 
as one is sure the environmental sample does not contain contaminants, which 
could interfere with the labeling process.  For example, chemical labeling cannot 
be used in soil samples due to the presences of humic acids, which will adsorb 
the entire label.  The spiked protein method compares the fixed amount of spiked 
heavy labeled internal standard proteins with environmental derived proteins.  
This method has low coverage and medium accuracy, but is rarely used due to 
cost restraints (Table 3).   
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Figure 8. Common quantitative mass spectrometry workflows.  Boxes in 
blue and yellow indicate experiments to be compared.  Solid line means that 
labeled sample is mixed.  Dashed line indicates points were experimental 
variation during quantification errors can occur.  This illustration was adapted 
from Bantscheff et al [55]. 
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Table 3 Accuracy and quantitative coverage of various labeling methods in 
proteomics.  “Accuracy” means how a labeling method can reflect exact 
difference between experimental groups.  “Quantitative proteome coverage” is 
how many proteins are quantitatively measured and identified by a labeling 
method.  “Linear dynamic range” is the number of digits for measurement of a 
labeling method.  This table was adapted from Bantscheff et al [55]. 
 Accuracy 
(process) 
Quantitative 
proteome 
coverage 
Linear 
dynamic 
range 
Metabolic protein labeling +++ ++ 1-2 logs 
Chemical protein labeling (MS) +++ ++ 1-2 logs 
Chemical peptide labeling (MS) ++ ++ 2 logs 
Chemical peptide labeling (MS/MS) ++ ++ 2 logs 
Enzymatic labeling (MS) ++ ++ 1-2 logs 
Spiked peptides ++ + 2 logs 
Label free (ion intensity) + +++ 2-3 logs 
Label free (spectrum counting) + +++ 2-3 logs 
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Label-free quantification has excellent coverage, but low accuracy.  It is easily 
employed in metaproteomics and the one most widely used (Table 3).  Overall, 
Label-free quantification is the most commonly used in metaproteomics though 
extensive isotopic labeling of an environmental sample has recently been 
demonstrated [60-63].   
Bioinformatics for metaproteomics 
 
Peptide-spectrum search and identification 
 Bioinformatics analysis is conducted to identify peptides from MS/MS 
spectra to reconstruct and quantify proteins.  Bioinformatics analysis is the most 
challenging in all the steps of metaproteomics.  The difficulty of computational 
analysis is due to the intricate data structure of the metaproteome and the lack of 
prior information about the microbial communities as well as limited or low quality 
reference metagenome databases.  
The species co-habiting a natural community may not be fully known, 
which means that we cannot construct a protein database collected from 
reference databases (DB), such as RefSeq [64], UniProt [65] or IMG [66].  Even 
though metagenome sequencing can replace or enhance an isolated reference 
DB, the metagenome databases are often not complete, contain unclosed 
genomes, and many have sequencing errors and/or partial protein sequences.   
There are two ways to construct protein sequence DB for metaproteomics.  
First, the protein DB is constructed by a collection of reference isolated microbial 
genome DB.  Specific microbes can be expected to be in environmental samples 
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based on previous studies or based on assumptions.  For example, we collected 
gut-isolated microorganisms for the human fecal protein study in Chapter 4 and 
the diet proteome study in Chapter 5.  The NIH funded Human Microbiome 
Project (HMP) has comprehensive gene and protein databases from microbes 
isolated from the gastrointestinal tract.  We obtained referenced proteins from a 
subset of isolates from the HMP DB that we used to construct our protein DB.   
Next, metagenome sequencing provides deep genome information for the 
community of interest.  Thus, metagenome sequence can complement proteins 
that were not anticipated to be in the samples.  Also, metagenome sequencing 
can predict potential coding sequences from unknown organism in the 
environment of interest.  However, metagenome sequences are often partial and 
incomplete.  Mixing the reference DB sequences and the metagenome 
sequences is the best method for construction of a comprehensive potential 
protein DB for metaproteomics. 
Because protein identification of the MS/MS spectrum via the database 
search method is based on having the correct peptide and thus the correct 
protein in the composite metagenome/isolate database, deficiencies in this 
composite database can severely hamper peptide and subsequent protein 
identification and quantification.  If the appropriate reference protein DB is 
unavailable or has limitations, de novo sequencing could theoretically be an 
alternative way for identification of the MS/MS spectra.  However, de novo 
sequencing based on MS/MS searches in metaproteomics has been found to be 
extremely time consuming with limited effectiveness.  Cantarel et al [67] 
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compared the number of peptides identified by DB search using SEQUEST [68], 
and de novo sequencing using PEAKS [69] and PepNovo [70].  Interestingly, this 
study showed that de novo sequencing could find almost 9,000 peptides that 
were not detected by the DB search.  At the same time, however, de novo 
sequencing missed more than 10,000 proteins identified by SEQUEST.  
Therefore, some PSM search pipeline, such as Proteome DiscovererTM (Thermo 
Fisher Scientific Inc.), combines DB searches and de novo sequencing to 
maximize metaproteome coverage. 
One of the advantages of de novo sequencing is that it does not require 
any prior database information.  The MS/MS spectrum is a collection of ions 
derived from the fragmentation of a precursor parent peptide ion but the 
observable fragmented ions will vary depending on the fragmentation method.  
Collision induced dissociation (CID) and higher-energy collision dissociation 
(HCD) produce b and y ions, while electron-transfer dissociation (ETD) generates 
c and z ions.  For example, when the MS/MS peptides are fragmented by CID 
and HCD, de novo peptide sequencing starts from the b and y ions that differ by 
the molecular mass of the amino acid residues.  By comparing ion mass, 
sequence order is determined (Fig. 9).  However, de novo sequencing from the 
MS/MS spectrum is generally not successful for the following reasons: 1. Low ion 
intensity causes incomplete detection of the sequence ions; 2. Many peptide 
sequences do not provide the full complement of potential y and b ions upon 
fragmentation; 3. Unusual amino acid and uncommon covalent modifications can 
prevent correct amino acid assignment [71].   
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Figure 9 Example of de novo sequencing from MS/MS spectrum.  This 
tandem mass spectrum of the [M+2H]+2 ion m/z 955.03 in LC/ESI/MS analyses 
of tryptic peptides from a 70 kDa iPLA2 digest.  This illustration was borrowed 
from http://msr.dom.wustl.edu/ms-peptide-mapping/. 
  
  32 
De novo sequencing is the ideal way to identify MS/MS, but is dependent on 
charge state of precursor ions and fragmentation efficiency, which limits its 
usefulness.  
 De novo sequencing is often used to support and improve DB-based 
MS/MS searches (DB search).  In contrast to de novo sequencing in 
metagenomics, peptide de novo sequencing cannot be confirmed by overlapping 
sequences. Thus building the identified peptides into proteins is a serious 
bioinformatics challenge.   Therefore, de novo sequencing methodologies are 
currently only used to support DB searches in metaproteomics. 
The most widely used method for MS/MS identification in proteomic and 
metaproteomic studies is the DB search method.  The MS/MS search engines, 
such as SEQUEST[68], MASCOT[72], X!Tandem[73], OMSSA[74], 
MyriMatch[75] and MS-GF+[76], use an assembled protein DB for peptide 
identification and subsequently build the peptides into proteins (i.e., assembly).  
These search methods compare the 100,000s of MS/MS spectra from the LC-
MS/MS analyses to the theoretical computational derived peptides MS/MS 
spectra generated from the protein DB based on the enzymatic digestion method 
used.  The major difference in these algorithms is their use of different scoring 
systems  (Fig. 10).  The first step for all search engines generate is to generate 
all the possible peptides from protein DB based on the experimental proteolytic 
enzyme used.  Then, candidate peptides are selected from the peptide library 
using the mass of the precursor ion.   
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Figure 10 Schematic diagram of the DB search for MS/MS spectrum 
analysis.  First, search engines are used to generate all the possible peptides 
from the protein DB while figuring in the number of allowed miss-cleavage based 
on the digestion enzyme.  Then, candidate peptides are selected from the 
peptide library using the mass of the precursor ion.  The next step is the 
calculation of scores, probability, correlation coefficient or similarity, between 
candidate peptides and MS/MS spectrum.  Through calculation of the score 
matrix top hits are determined.  With top hits, FDR is calculated based on decoy 
identification and final hits are selected. 
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The next step is to calculate the scores, probability, and correlation coefficient 
between the candidate peptides and the MS/MS spectrum.  It is at this step 
where the different algorithms show their biggest differences between the 
different analysis programs. 
Since SEQUEST was developed in 1994, many algorithms for MS/MS 
identification have been developed, such as MASCOT in 1999, X!Tandem in 
2004, OMSSA in 2004, MyriMatch in 2007 and MS-GF+ in 2014.  SEQUEST is 
the gold standard DB search engine and was commercialized and is included in 
the Thermo software package Proteome DiscovererTM 2.0.  SEQUEST calculates 
cross-correlation coefficient (XCorr), similarity score between theoretically 
generated peaks and query MS/MS spectrum, and DeltaCn, which is the 
difference of XCorr from the next candidate following an initial screen using the 
Sp score.  MASCOT is the other gold standard search engine and it is based on 
MOWSE algorithm, is the first probability-based scoring for mass finger printing, 
and provides a probability of observed matches between the queried MS/MS 
spectra and the peptide library.  Even though MASCOT and SEQUEST were 
released more than 15 years ago, these are still the most widely used DB search 
engines in proteomics.  However, the basic design of the scoring system in 
SEQUEST and MASCOT is for traditional CID and low-resolution MS [76]. 
 Because SEQUEST and MASCOT are old and commercialized, there 
have been numerous attempts to develop more accurate, faster, and free search 
engines. X!Tandem, OMSSA, MyriMatch and MS-GF+ were developed to fill this 
need.  OMSSA has a probability-based scoring system like MASCOT but 
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employs a Poisson distribution.  OMSSA is faster and much cheaper due to its 
open source algorithm.  X!Tandem is another engine that has a probability-based 
score (i.e., hyperscore) that is a combination of hypergeometric distribution and 
dot product.  X!Tandem collects common MS/MS peaks between theoretical 
peaks and actual query peaks which are filtered by their expected intensities, 
then generates a dot product matrix.  This dot product result is modified by 
multiplying by N factorial for the assigned b and y ions.  The factorial modification 
is determined based on the hypergeometric distribution.  X!Tandem calculates an 
E-value by extrapolating the linear regression line of the log histogram (i.e., the 
number of results) and measuring the difference between the top hit from the 
following hit.  This E-value plays a similar role to DeltaCn of SEQUEST.  
MyriMatch uses multivariate hypergeometric distribution (MVH) to calculate 
probability of matches between query and DB by chance. 
 MS-GF+ has a different approach from the other DB search engines (Fig. 
11).  Most DB search engines compare one spectrum to all the candidate 
peptides filtered from the library according to their preliminary score, such as Sp 
of SEQUEST and the noise filter of X!Tandem.  However, MS-GF+ generates a 
peptide dictionary of all possible de novo sequences from an MS/MS spectrum 
and searches for their presence in the peptide library [77].  MS-GF+ compares 
the log likelihood ratio of vectors of peptides and its spectra and calculates E-
value to find the best hit.  While traditional DB searches compare every spectrum 
against every peptide in the library, which increases the run time depending on 
the size of the library,, MS-GF+ execution time is not dependent on DB size.   
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Figure 11 DB search of MS-GF+.  MS GF+ is an updated version of the 
Spectral Dictionary [77].  Red line is a traditional DB search comparing spectra 
against the peptide library generated from the protein DB.  Blue line is the de 
novo based DB search constructing all the possible de novo sequences from a 
MS/MS spectrum.  This illustration was adapted from Kim et al [77]. 
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This is a very important advantage for metaproteomics analysis because these 
experiments generally have a much larger protein DB than single species 
proteomics experiments.  Because MS-GF+ is based on de novo sequencing and 
is independent of DB size, it can provide more sequences that are not found in 
the reference DB.  This is important in the proteomics analysis because the 
traditional search algorithms will miss peptides from unknown species in a 
microbial community because they are not in the predicted protein DB,  
 In addition to different scoring metrics, every DB search engine has a pre-
processing step prior to computing the scoring matrix.  This filtering step is to 
remove noise peaks and to collect valid b and y ions, but can also introduce 
problems.  If the filtering threshold is too low, noisy matches will hinder true 
matches; if it is too high, true fragment ions may be lost.  These different pre-
processing methods used by the different DB search engines can result in 
different peptide identifications. 
 Besides the accuracy of peptide identification, the speed of the MS/MS 
search is critical issue because the metaproteome databases tend to be very 
large.  MS-GF+ has an advantage on this issue because its search speed is not 
slowed by the protein DB size.  However, because the MS/MS search is parallel, 
which means it can be easily divided into small pieces, other MS search engines 
can make up for its need for searching all of the databases by simultaneously 
running the search on a cluster server or supercomputer.   For example, one LC-
MS/MS run consists of many of MS/MS spectra, so if we have 1,000,000 CPUs 
in a supercomputer, we can search a million MS/MS spectra at the same time. 
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This means that a million spectra can be processed at the same time it takes for 
one spectrum search.  There are several ways to parallelize the MS/MS peak 
search engines, such as X!!Tandem [78], wrapper for MS [79]  and MyriMatch 
[75].  In contrast to the other programs, MyriMatch does not require additional 
installed parameters to work effectively in a parallel environment.  It can utilize 
available cores with a simple option when executed.  MASCOT and SEQUEST 
also has a platform for a multi-core environment, but these commercial products 
are very expensive to put onto large Linux clusters.  Due to the very large protein 
DB size and the large number of MS/MS spectra along with potential PTMs, the 
analyses of metaproteomics datasets can near impossible on a single CPU 
Windows environment.  Thus a parallel computing environment is recommended 
for bioinformatics analysis of metaproteomics. 
 The target-decoy search strategy has revolutionized peptide and protein 
identification.  Before this methodology was introduced proteomics datasets were 
plagued with high false positive rates putting the whole field of proteomics in a 
questionable light.  Elias et al. suggested generating decoy databases. These 
databases have the same characteristics to the protein DB, but contain a 
competing target DB, and a decoy DB during the MS/MS search [80].  The decoy 
DB is generally engineered by reversing or random mixing of protein sequences 
of target DB (i.e., the original protein DB).  By reversing sequences, decoy 
proteins have same characteristics as the target DB in terms of digested peptides 
length and monoisotopic mass (Fig. 12).  
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Figure 12 Target-decoy DB comparison.  The number of trypsin-derived 
peptides plotted against the calculated monoisotopic mass of A) the target DB 
and B) a decoy DB from in silico tryptic digestion of IPI human protein DB.  C) 
The number of trypsin-derived peptides using the target (red line) and decoy 
(green line) DB.  The inset is a plot of the percentage of proteins that were 
identified in both target and decoy DB searches versus peptide length. This 
illustration was adapted from Elias et al [80].   
  
A) 
B) 
C) 
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Because the decoy sequences are not in the sample, if a protein is identified 
during a search, it is considered a false positive.  The number of false positives 
from decoy hits can then be used to calculate the false discovery rate (FDR) 
using the following formula: 
𝐹𝐷𝑅 = 2×𝐷𝑒𝑐𝑜𝑦  ℎ𝑖𝑡𝑠  (𝐹𝑃)𝐷𝑒𝑐𝑜𝑦  ℎ𝑖𝑡𝑠  (𝐹𝑃)+ 𝑇𝑎𝑟𝑔𝑒𝑡  𝑡ℎ𝑖𝑠  (𝑇𝑃) 
Generally, a < 5% FDR threshold is considered a publishable proteomics 
dataset.  The FDR formula is different for different analysis.  Software packages 
such as Peptide Protein Prophet, MASCOT, and Percolator have their own 
modified FDR formulas.  After the decoy search a FDR calculation is necessary.  
However, the arbitrarily generated decoy can not cover all the possible false 
positives, so there are concerns about using FDR as the gold standard method 
for MS/MS search assessment [81].  
 Applying FDR to metaproteomics is tricky because of the large number of 
non-unique peptide sequences and the amount of unknown genomic sequence 
in the samples.  With unique peptides, FDR is often overestimated (e.g., 6-8% in 
Wilkins et al [82]) because of the large reduction in real peptides that are 
redundantly matched.  With all the unique and non-unique peptides the rate is 
decreased to 0.6-0.9% [82] which is probably an underestimation due to the 
addition of many redundant peptides.  An adjustment of the FDR is required 
when evaluating the metaproteome considering its complex characteristics. 
As more and more peptide-spectrum matches (PSM) are published by 
proteomics laboratories world wide, a new method for searching MS/MS spectra 
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is becoming more popular.  The Spectral Library Method has a greatly reduced 
DB search time.  This is achieved by not using redundant searches of the same 
post-translational modifications (PTM) and peptides, especially from abundant 
common proteins found in all samples.  The National Institute for Standards and 
Technology (NIST) and the Global Proteome Machine (GPM) provides spectral 
libraries for proteomics studies.  X!Hunter [83], Spec2Spec [84] and Pepitome 
[85] use PSM searches against spectral libraries that do not need to generate 
theoretical MS/MS spectrum.  However, a spectral library search is not an 
appropriate method for metaproteomics because the spectral library requires 
samples that have been analyzed by a large number of labs with a high number 
of replicates such as serum/plasma studies.  
Post-process of PSM search results 
After a PSM search, post-processing is required to validate the PSMs and 
assemble the appropriate proteins.  Assessing the MS/MS identification is always 
important.  The threshold scoring metrics that gives reliable peptide identification 
is ambiguous.  Since the development of the first MS/MS search engines in 
1994, different evaluation methods for peptide identification have been 
evaluated.  DTASelect [86], developed in 2002 and widely used for protein 
assembly of SEQUEST results, suggests the following guideline for a SEQUEST 
search: > 1.8 XCorr for +1 charged ion, > 2.5 XCorr for +2 charged ion, > 3.5 
XCorr for +3 charged ion and > 0.08 DeltCN for every charged ions.  By 
providing filters, and simple protein assembly, DTASelect is widely used for 
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assembling SEQUEST search outputs.  Protein Prophet [87], also developed in 
2002 and incorporated into the trans proteomics pipeline (TPP), calculates 
probability based on a mixture-model EM method using a Bayesian approach for  
MS/MS identification.  Protein Prophet gives statistical guidelines for assessing 
the correct and incorrect peptide assignments.  It also estimates and the 
likelihood of proteins corresponding to those peptides in a sample.  To maximize 
peptide identification, Scaffold [88] employs various search engines and 
integrates its results from Protein Prophet.  Scaffold obtains MS/MS search 
results from SEQUEST, MASCOT, OMSSA, X!Tandem and etc.  Then, it 
evaluates peptide identifications of each engine using Protein Prophet.  These 
results are aggregated and re-evaluated by Protein Prophet.  By aggregating 
multiple evaluation methods, Scaffold provides a platform-independent result with 
maximized peptide and thus protein identifications. 
Protein assembly is a challenging step after peptide identification of the 
MS/MS.  Generally, assembly is more difficult than disassembly because some 
parts dissociate from a protein.  This may or may not have arisen from that 
specific protein.  Redundant peptides, found in two or more proteins, makes 
protein reconstruction and quantification difficult.  Metaproteomes generally have 
more shared peptides due to orthologous and paralogous proteins from multiple 
species.  Orthologous and paralogous proteins have similar protein sequences, 
so they generate shared or redundant peptides. 
Meyer-Arendt et al. demonstrated that the human protein database has 
89,486 entries in the international protein index (IPI) DB v3.75.  This would have 
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almost 2 million shared peptides with the 4 million trypsin-derived peptides 
(length > 7 amino acids allowing up to 2 miss-cleavages) [89].  Moreover, a 
metaproteome has a number of microbial species, which means there will be a 
greater chance for overlapping peptides than Meyer-Arendt’s human database 
only example.  Therefore, metaproteomics datasets have many shared peptides 
making ambiguous protein identifications common and problematic. 
How ambiguous protein identifications are dealt with has a direct impact 
on the final protein identification and quantification.  If an identified peptide A can 
be generated from protein 1, 2 and 3 in the protein DB, several interpretations 
are possible.  For example, peptide A may be derived only from 1, from 1 and 3 
together or from 1, 2, and 3 at the same time.  The ource of peptide A is 
uncertain due to lack of information, but different final protein identifications are 
possible based on how the ambiguous protein identifications are handled.  Using 
DTASelect, would identify all possible proteins, such as protein 1, 2 and 3 of 
above example.  However, IDPicker [90], developed in 2007 and linked to 
MyriMatch, reports a minimal protein list.  Protein assembly of IDPicker is based 
on a bipartite graph and greedy algorithm (Fig. 13).  First, IDPicker connects 
peptides and proteins in a bipartite graph (Fig. 13A).  Next, indistinguishable 
peptides and proteins are collapsed (Fig. 13B).  The collapsed bipartite graph is 
deconvoluted into separate protein clusters with connected peptides (Fig. 13C).  
Proteins that have uniquely matched peptides or supported by more than two 
different peptide groups are identified and added to the minimal protein list (Fig. 
13D).  IsoformResolver [89] accesses shared peptides differently.   
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Figure 13 Overview of bipartite graph model and analysis procedure of 
protein assembly in IDPicker.  Pro: protein, pep: peptide.  This figure was 
adapted from Zhang et al [90].  
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It uses a peptide-centric approach.  This approach is similar to the 
algorithm of MS-GF+ used for generating all possible de novo sequences.  
IsoformResolver constructs unique peptide libraries from the protein DB and 
assigns proteins to the corresponding peptides.  IsoformResolver is keeps 
shared peptides as unique entries. However, it cannot provide any insight on how 
to interpret the problematic peptides.  Percolator [91] employs semi-supervised 
machine learning to discriminate correct from incorrect PSMs, and calculates an 
accurate FDR and posterior error probabilities. 
Protein quantification varies based on the handling of ambiguous protein 
identifications.  Since shotgun metaproteomics explores peptides, not proteins, 
the quantitative measurement of peptides should be transferred to the 
corresponding proteins.  Processing of unique peptides, matched solely to one 
protein, makes it easy to assign the matched protein.  However, assigning 
shared peptides to candidate proteins is ambiguous due to the uncertainty of its 
origin.  DTASelect redundantly assigns SC of overlapping peptides to every 
candidate protein. This leads DTASelect to amplify the expression level 
according to the numbers of ambiguous peptides in the DB search results.  
IDPicker employs a greedy algorithm following a winner takes all approach.  After 
protein and peptide groups are separated, IDPicker prioritize proteins by whether 
a unique peptide is linked or not and the number of SC from linked unique 
peptides.  Greedy algorithm iteratively chooses proteins by order of priority and 
gives all the shared peptides to the winner.  IDPicker generates parsimonious 
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protein identification and amplifies their expression level by casting all the 
available votes.   
In label-free shotgun proteomics, SC of redundant peptides are 
sometimes distributed to the corresponding proteins (i.e., spectral balancing) 
[92,93].  Spectral balancing considers only proteins that have more than one 
unique peptide (i.e., unique proteins).  SC of a redundant peptide is divided into 
unique proteins by calculating the ratio of their unique peptide SC.  Divided SC of 
a shared peptide for its member unique protein is calculated as described below: 
𝐷𝑖𝑣𝑖𝑑𝑒𝑑  𝑆𝐶 = 𝑢𝑆𝐶𝑢𝑆𝐶!!!!! ×𝑠𝑆𝐶 
Where uSC is SC of a unique peptide, sSC is SC of the shared peptide and n is 
the number of unique proteins linked to the shared peptide.  This spectral 
balancing can be connected to the normalized spectral abundance factor (NSAF) 
if desired [92-94]. 
If we have more than two MS runs, technical replicates and/or biological 
replicates, as well as different biological or ecological samples, we need to 
normalize the total number of spectra to quantitatively compare across samples 
and LC-MS/MS runs.  There are systematic errors including instrumental error 
and human error even though MS runs were carried out by the same 
experimenter using the same instrument for the same sample.  The goal of 
normalization is to adjust and minimize these errors.  Generally, normalization 
methods are designed for a label-free experiment.  NSAF is the most widely used 
normalization method.  It considers spectral balancing as well as protein length 
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effect on probability of peptide assignment.  NSAF assumes that long proteins 
have a better chance of having identified peptides associated with it than short 
proteins.  Distributed NSAF (dNSAF) for i-th protein is calculated as described 
below: 
𝑑𝑁𝑆𝐴𝐹! =    𝑑𝑆𝐴𝐹!𝑑𝑆𝐴𝐹!!!!!   𝑤ℎ𝑒𝑟𝑒,𝑑𝑆𝐴𝐹! =   𝑢𝑆𝐶! +
𝑢𝑆𝐶!𝑢𝑆𝐶!!!!! ×𝑠𝑆𝐶!𝐿𝑒𝑛𝑔𝑡ℎ!  
Where, N = the number of total identified proteins, uSC is SC of a unique 
peptide, sSC is SC of a shared peptide, Length is the protein length and M is the 
number of unique proteins.  The sum of dNSAF within an MS run is 1, so the 
dNSAF number is very small.  This small number of dNSAF is often logged to 
make it easy to analyze. 
 In addition to NSAF, there are a few normalization methods including total 
PSM normalization, exponentially modified protein abundance index (emPAI), 
and quantile normalization.  Normalization by total sum of PSM is also widely 
used in label free metaproteomics studies [95] and is calculated as described 
below: 
𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑  𝑆𝐶! =    𝑆𝐶!!!!!!!!! 𝑀𝑆𝐶!!!!! ×𝑆𝐶! 
Where, N = the number proteins and M = the number MS runs.  The total sum 
normalization assumes that all the MS runs should have same amount of PSMs 
theoretically.  This makes MS runs have same total PSM.  However, the total 
sum normalization tends to amplify a small sum of PSM too much.  A small sum 
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of PSM runs generally has a small number of proteins, so the total sum 
normalization method can make false positives by distorting the data.  To 
complement this disadvantage of total sum normalization, average normalization 
can be used as described below: 
𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑  𝑆𝐶! =    𝑆𝐶!
!!!!𝑁!!!! 𝑀𝑆𝐶!!!!!𝑁 ×𝑆𝐶! 
Where, N = the number proteins and M = the number MS runs. 
 Normalization using emPAI method is used in MASCOT searches [96].  
emPAI is also designed for label-free proteomics and considers the number of 
experimentally observed peptides and observable peptides calculated as 
described below: 
𝑒𝑚𝑃𝐴𝐼 = 10 !!"#$%&$'!!"#$%&'"($ − 1 
Where, Nobserved = the number of experimentally observed peptides and Nobservable 
= the number of theoretically observable peptides.  Nobservable  is calculated by in 
silico protein digestion considering the digestion enzyme, allowed miss-
cleavages, and the mass range of the instrument.  Even though emPAI normalize 
SC based on the potential number of peptide identifications, it does not correct 
systemic errors between different MS runs. 
 Quantile normalization is a technique for making two distributions identical 
in rank statistics.  Quantile normalization considers the rank of SC within an MS 
run and makes the same rank proteins have the same SC across MS runs.  
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Since quantile normalization makes MS runs and SC have the same rank, it can 
make the data to lose variation within replicates, which is important to ANOVA. 
Statistical analysis in proteomics is not really any different from other 
large-scale biology data analysis.  Student’s t test, ANOVA, and quasi-Poisson 
modeling are used for statistical comparisons between different experimental 
groups.  Student’s t test and ANOVA requires a normal distribution assumption, 
but typical SC distributions from MS runs do not follow a normal distribution (Fig. 
14).  In Figure 14, the empirical estimation (red line) is not similar to normal-fitted 
line (blue line).  The left half of normal line is missing because negative values 
are not in SC.  Therefore, other distributions besides a normal distribution are 
required for proteomics data analysis. However, the different distributions are not 
tested in proteomics data analysis.  Recently Li et al [97] tested the quasi 
likelihood Poisson modeling (quasi-Poisson).  They compared the quasi-Poisson 
model to many methods including Fisher’s exact test, Wilcoxon rank test, and 
Student’s t test for processing LC-MS/MS data.  They concluded that quasi-
Poisson could be applied to proteomics data like other methods. 
Because Student’s t test is not appropriate for multiple comparisons, 
ANOVA is the analysis of choice for large biology data sets.  Whenever a t test is 
conducted, there is a chance of Type I error, which is typically 5%.  If we a run t 
test three times, the potential for a Type I error increases up to 15% [98].  If we 
conducted t test over 1,000 proteins collected from LC-MS/MS runs, the 
accumulated Type I error approaches 100%, which makes this analysis 
unreliable because it contains too many false positives.  
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Figure 14 Comparison of the distributions fitted to spectral counts in label-
free metaproteomics data.  Blue line is a normal distribution fitted to spectral 
counts and the red line is an empirically fitted line. 
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However, ANOVA can limits Type I errors even when it is repeatedly applied to a 
data set. The difference between ANOVA and a t test is based on what these 
analysis tools test.  Student’s t test compares the mean of each sample, while 
ANOVA analyzes the variance within groups and between groups.  Therefore, t 
test is not the appropriate statistical method for proteomics as well as other large 
biology data analysis. 
Quantitative and functional analysis pipeline for metaproteomics 
 Even though there is a growing sense that metaproteomics studies are 
important, very few bioinformatic analysis pipelines are publicly available.  
GalaxyP (https://usegalaxyp.org/) is a proteomics application of the Galaxy 
platform [99].  Galaxy platform is a scientific workflow and data analysis pipeline 
for computational biology for wet-lab biologists who have limited programming 
skills.  Galaxy is written in Python and JavaScript and provides a simple three-
column interface (Fig. 15). Galaxy is easy to install and free so any user can use 
it.  Adding bioinformatics tools to Galaxy is possible.  However many Galaxy 
servers already have many publicly available tools 
(https://wiki.galaxyproject.org/PublicGalaxyServers).  Current GalaxyP provides 
X!Tandem and Protein Prophet as well as data management.  However, GalaxyP 
may not be appropriate for metaproteomics because X!Tandem is not run in a 
parallel environment and Protein Prophet is not the best tool for handling 
redundant peptides.  Also GalaxyP does not have functional analysis modules, 
which is limiting. 
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Figure 15 The interface of GalaxyP.  Its three-column interface consists of 
available tools, main screen for analysis for results and parameter input and 
status of analysis steps from left to right.  This illustration is screen-captured from 
http://www.usegalaxyp.org. 
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 MetaProteomeAnalyzer (MPA) [100] was recently published and is 
designed for metaproteomics (Fig. 16).  While GalaxyP has a web-interface and 
server-oriented pipeline, MPA is simply a client-server communication system.  In 
MPA the client-side uploads MS/MS experimental data and the server-side 
deposits and analyzes the uploaded data.  MPA focuses on data interpretation 
rather than parallelized MS/MS searches.  MPA employs four DB search engines 
(X!Tandem, OMSSA, Crux [101] and InsPecT [102]) and aggregates four DB 
searchs to increase PSMs.  MPA groups proteins into meta-proteins due to 
redundant peptides.  Based on meta-proteins, MPA provides functional analysis 
using the Kyoto encyclopedia of genes and genomes (KEGG) pathways [103], 
enzyme commission (EC) [104] and National Center for Biotechnology 
Information (NCBI) Taxonomy [105].  MPA generates visualized reports drawing 
figures and produces analysis reports.  MPA is the first analysis pipeline, 
equipped with a visual interface, but it does not provide multiprocessing and 
sequence-based functional analysis.  MPA’s functional analysis is based on the 
reference DB at the current time.  However, metagenome sequences, which are 
used for metaproteome DB construction, cannot be annotated and many of 
microbes within the reference DB are not well annotated.  Therefore, MPA’s 
functional analysis is very limited in its current form. 
An analysis pipeline for metaproteomics should have two important 
requirements.  First, simultaneously running MS/MS search engine is necessary 
(i.e., multi-processing on multiple computer cores).    
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Figure 16 A schematic diagram of workflow in MetaProteomeAnalyzer.  
Server side and client side communicate and the uploaded data is deposited in 
server SQL DB.  The illustration is adapted from Muth et al [100]. 
  
  55 
Since metaproteomics experiments generally have a highly complicated protein 
sequence DB, DB search take much longer than single species proteomics.  
Even though the search speed of MyriMatch is also dependent on protein DB 
size, it is designed for multi-threading on computer clusters.  Therefore, it can 
use multiple CPUs simultaneously for DB searches.  Secondly, an analysis 
pipeline for metaproteomics should provide functional analysis based on the 
protein sequences, not based on the reference DB only.  Human, mouse, 
Escherichia coli and yeast DB are manually curated with high quality annotation.  
However, most microbes in an environmental sample are unknown and do not 
have basic annotation.  Functional analysis based on the reference DB that is 
used in MPA is not very valuable in metaproteomics analysis.  Therefore, a 
metaproteomics pipeline should have at least these two required features.  
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CHAPTER II 
QUANTITATIVE AND FUNCTIONAL ANALYSIS PIPELINE FOR 
METAPROTEOMICS DATA 
 
Quantitative and functional analysis for metaproteomics (QFAM) 
 
Objectives of QFAM 
Quantitative and functional analysis pipeline for metaproteomics (QFAM) 
is an analysis pipeline for the metaproteome, which is highly complicated and 
large data.  The goal of QFAM is to offer fast and reliable functional analysis of 
metaproteomics data.  Since the metaproteome consists of a large proteomics 
database, QFAM enables multiprocessing where many jobs can be processed at 
the same time.  Also, QFAM provides sequence-based functional analysis 
because the metaproteome cannot distinguish proteins with similar sequences 
and less-annotated microbial proteins.  Lastly, QFAM produces reliable statistics 
including a significance test, an enrichment test, and the effect sizes in order to 
reduce potential false positives in the analysis.   
 
General information of QFAM 
  QFAM is installed on the Newton cluster at the University of Tennessee-
Knoxville.  The Newton cluster has 4,200 processor cores (400 nodes).  All 
nodes are connected via 1Gb Ethernet and Infiniband interconnected (up to 
40Gb/sec).  The operating system is Scientific Linux 6.5, which is Redhat 
Enterprise compatible, and sun grid engine (SGE), also known as N1 grid 
  57 
engine, controls batch-queue system.  Newton is designed for scientific high 
performance computing and is freely available to students and faculty of the 
University of Tennessee.  Generally Newton allows only a 24 hour run for single 
job, but QFAM is allowed to use 48 cores for unlimited time because the PSM 
search of the metaproteomics analysis sometimes takes more than two weeks in 
spite of using 48 CPUs, which is the maximum number allowed by the server 
administrators.   
QFAM is designed for label-free shotgun metaproteomics data obtained 
from microbial communities in environmental samples.  The pipeline consists of 
five modules: PSM search module, contrast file module, normalization module, 
statistical analysis module, and functional analysis module (Fig. 17).  The PSM 
search module employs MyriMatch and IDPicker for fast and exact peptide and 
protein identifications.  The PSM search module produces tab-delimited files 
containing protein ID, spectrum counts, and decoy-target information.  If running 
multiple MS runs, spectrum counts of multiple MS runs are summarized into one 
contrast file that has protein IDs in rows and spectrum counts in columns.  This 
output file is tab-delimited and can be opened in excel.  The module that makes 
the contrast output file also compares each of MS run by calculating the Pearson 
coefficient correlation (PCC) for technical replicate.  If the experimental datasets 
has many technical replicates and thus a need to pick high quality technical runs, 
the algorithm preferentially selects MS runs that have high PCC.   
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Figure 17 A schematic diagram of QFAM.  QFAM consists of seven modules 
and is designed to process metaproteome data rapidly to give functional reports 
to users. 
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This repeated selection process could improve statistical analysis using ANOVA.  
The next module is for normalization.  The module provides three options: total 
sum normalization, same average normalization, and NSAF.  The statistical 
analysis module is programmed by an R statistics script to apply the three 
methodologies: quasi-Poisson model with Cohen’s f, negative binomial model 
with Cohen’s w, and Normal ANOVA with Cohen’s f.  The next module applies 
functional analysis based on the NCBI Biosystems DB [106] and cluster of genes 
(COG) terms [107].  The last module draws charts/graphs for publication.  This 
module draws bar and line graphs using the  ‘ggplot2’ R package [108]. 
 QFAM is distinguished from other proteomics pipelines, such as MPA and 
GalaxyP, by its PSM search speed, quantitative analysis module (QAM) and 
functional analysis module (FAM).  QFAM controls the PSM search module using 
MyriMatch and IDPicker, which are able to do multithreading processing, which is 
absolutely necessary for large databases common to metaproteomics studes.  
QAM of QFAM uses the ‘selfea’ R package for discerning false positives 
efficiently.  Selfea tests the significance of FAM using NCBI BioSystems DB and 
COG terms.  FAM provides a COG enrichment and significance test, which are 
not incorporated in other pipelines. 
Module for LC-MS/MS data analysis 
 
Automated module for DB search and protein assembly 
PSM search speed is dependent on protein DB size because each PSM 
comparison checks the protein DB and this process is repeated for each MS/MS 
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spectra in a run.  Since metaproteomics has large protein DB (> 100 megabytes), 
the PSM search speed is much slower than single species proteomics studies.  
The slow search speed increases the total time of the PSM search.  This time-
consuming process is the first bottleneck of the analysis pipeline for 
metaproteomics.  To improve search speed and the overall process timing, a 
multiprocessing technique is needed.  Multiprocessing executes multiple 
processes within a single process, which means running multiple jobs 
simultaneously using multiple CPU resources.  Because the PSM search is an 
independent process, it is simple to parralize.  This means that it is possible to 
run each PSM searches individually on multiple CPUs.  Multiprocessing is 
applied using MyriMatch for QFAM. 
MyriMatch and IDPicker v3.0 are incorporated to QFAM for DB searches, 
post-processing, and protein assembly.  Gross et al [109] showed that using 
MyriMatch can efficiently reduce run times (Table 4).  We also tested MyriMatch 
in our Newton cluster where QFAM is installed and could confirm that MyriMatch 
can reduce PSM search times by using more CPUs (Table 5). 
 
Table 4 MyriMatch search time. This table was adapted from Gross et al [109] 
Protein Database 1 CPU 2 CPU 20 CPU 40 CPU 
SwissProt Human (20,348 proteins) 02:24:54 01:30:23 00:07:28 00:03:57 
IPI Human (87,925 proteins) 06:51:21 04:31:19 00:22:15 00:11:06 
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Table 5 MyriMatch run time on the Newton cluster.  We tested MyriMatch 
using a 500-megabyte protein DB containing 176,620 proteins to search 41,079 
peaks.  Increasing the number of CPU cores dramatically decreases running 
time. 
 1 CPU 2 CPUs 12 CPUs 48 CPUs 
Run time for single RAW file 49:03:45 40:53:07 08:27:34 02:51:06 
 
 
 
Since the PSM search process is the major bottleneck of LC-MS/MS data 
analysis, saving significant time in the search process is particularly important for 
metaproteomics studies.  IDPicker has three sub-modules: IDPQonvert, 
IDPAssemble and IDPQuery.  IDPQonvert creates idpDB from pepXML or 
mzIdentML files produced by MyriMatch as PSM search results.  IDPAssemble 
analyzes peptide-protein matches by using bipartite graphs and calculates 
spectrum counts following greedy algorithm.  IDQuery is a data-retrieving tool 
from the idpDB processed by IDPAssemble.  Total execution with five RAW data 
runs took almost ten and half hours when tested on a 500 megabytes protein DB 
(Table 6).   
 
 
Table 6 Run time of LC-MS/MS data analysis in the pipeline. 
 MyriMatch IDPQonvert IDPAssemble IDPQuery Total 
Run time 10:24:55 0:01:07 0:00:31 0:00:15 10:26:48 
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DTASelect generally takes more than a week to assemble peptides and calculate 
spectrum counts, while IDPicker only took two minutes to do the same job (Table 
6).  This enhanced speed is essential for processing large and complicated 
metaproteome data.  IDPicker’s MaxFDR is 0.05 as the default setting.  QFAM 
reports peptides and proteins at a 0.05 FDR level. 
This module for MyriMatch and IDPicker is fully automated.  Only one job 
submission to Newton is needed.  This job controller is programmed in Python 
2.7.6 and requires one configure file named as “BMI_pipeline.cfg”.  This 
configure file contains information on the data file path, program (MyriMatch and 
IDPicker) path, the number of CPUs for pipeline execution, and a job list file 
location.  The PSM search module produces a tab-delimited file that has the 
protein ID, spectrum counts from unique peptides, the number of unique 
peptides, DB source (i.e., target or decoy), protein length, percentage of protein 
sequence coverage, and spectrum counts. 
Making contrast file, comparing MS runs, and normalization 
Every metaproteomics experiment has more than two MS runs for 
comparison unless it is a test run.  Multiple MS runs are included in the 
experimental design for comparisons of the treatment and control groups.  
Multiple MS runs and technical or biological replicates are needed for each 
experiment.  Multiple MS runs are summarized into one data file (i.e., contrast 
file), usually in a tab- or comma-delimited file, and contain the MS run names in 
  63 
columns and protein IDs in rows.  QFAM provides a module for making a 
contrast file from multiple PSM search results.  Also, QFAM reports the protein 
FDR, the number of decoy protein identifications divided by the total number of 
proteins, and removes decoy protein identifications. 
 In addition to making a contrast file, QFAM calculates the Pearson 
correlation coefficient (PCC) of every possible pair in one contrast file.  By 
comparing PCC within replicates and between different groups, users can 
choose the more similar replicates and different MS runs from other experimental 
groups.  This module is necessary for the comparison of technical replicates and 
biological replicates in Chapter 4.  The PCC comparison module is programmed 
in R statistical programming script.   Also the PCC comparison can group MS 
runs that are very similar (PCC >= 0.90).  Generally technical replicates have 
much better PCC than biological replicates and other experimental groups.  
Picking MS runs for further analysis is not automated and requires user input. 
 The next module is normalization followed by contrast file creation and 
picking MS runs.  Normalization is necessary step for label-free proteomics data 
to standardize different MS runs for comparison.  Piehowski et al examined 
source of errors during proteomics data generation [25].  They considered four 
variance sources, protein extraction, digestion, instrument stability and 
instrument variance (Fig. 18).  Dissecting different parts from the same sample 
made different protein extraction replicates.  Protein digestion, instrument 
stability and instrument variance were measured by repeating experiments at 
different stages.    
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Figure 18 Boxplots showing the distribution of Pearson correlation 
coefficients among the different of replicates during the different stages of 
the proteomics analysis.  This illustration was adapted from Piehowski et al 
[25]. 
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Interestingly, MS instrument related variances were negligible when compared to 
protein extraction and digestion (i.e., average PCC: 0.99 for instrument variance 
and 0.97 for instrument stability).  Despite of using the same patient’s sample, 
protein extraction variability was much higher than others (i.e., average PCC: 
0.86).  Normalization is used mainly for sample variation rather than instrument 
variability.  Our module for normalization provides total sum normalization and 
average normalization.  Since QFAM employs IDPicker, which uses greedy 
algorithms for assigning redundant peptide matches, spectral balancing is not 
included in the pipeline as IDPicker already accomplishes it. 
Even though normalization is employed to correct potential systematic 
errors, sometimes normalization can make serious changes in a dataset.  This 
means that normalization can make unwanted differences between experimental 
groups.  When we standardize our data, we should be aware of this potential 
data distortion.  Interestingly, normalization can have a huge impact on data 
analysis, but only a few papers discuss data normalization in proteomics.  As 
with any step of computational analyses the user should check the results to be 
sure that obvious errors have not been introduced into the dataset by an 
automated bioinformatics process. 
Module for quantitative and functional analysis 
Quantitative analysis module (QAM) 
 QFAM’s quantitative analysis module (QAM) is a major improvement 
compared to other proteomics analysis pipelines, in our opinion.  QFAM uses 
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‘selfea’ R package as the core statistics calculator.  Selfea will be explained in 
Chapter 3 in greater detail.  The analysis module has several R and Python 
scripts to execute ‘selfea’ simultaneously using multiple cores.  As with any 
analysis on a metaproteome, the running time for the statistics computation takes 
a relatively long time.  It took more than 12 hours to calculate the statistics of 55k 
proteins with single core.  However 1 hour was enough to finish the computation 
via the parallel-running module.   
The QAM has four steps.  First, the normalized expression profile is 
divided into small pieces.  Users can decide the size of data pieces.  Python 
script for the fragmentation produces job files for parallel execution as well as 
reduced data chunks.  Job files have information for module loading, change 
directory and R script execution.  R script is prepared for statistical calculation 
using ‘selfea’ package.  Next, job files are submitted to SGE of the Newton 
cluster.  All the submitted jobs are executed on computing cores that is dedicated 
only for computation, not for systems administration or control.  After all the jobs 
are completed, a Python script for gathering the results of the executed jobs is 
carried out.  All the separately calculated statistics results are collected and 
compiled.  P-values, calculated from three models (i.e., quasi-Poisson model, 
negative binomial model and Normal ANOVA model) are adjusted by user-
selected methods including Benjamini and Hochberg correction (FDR) [110].  At 
the same time, insignificant proteins are filtered out and a protein scatter plot 
drawn. 
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QFAM provides six statistics for every protein: Cohen’s w, Cohen’s f, 
maximum fold change and adjusted p-values from quasi-Poisson model, 
negative binomial model, and normal ANOVA model (Table 7).  Cohen’s w and f 
measure effect sizes (ES) by comparing how many of the detected proteins exist 
in the different experimental groups. The measurement of the ES is important to 
maintain the statistical power in the resultant signature.  Maximum fold change is 
the biggest fold change among all the possible pairs in the experimental groups.  
Selfea provides three probability models as well as various ES calculations.  Li et 
al [97] use the quasi-Poisson model for label-free proteomics data analysis.  The 
negative binomial model is similar to quasi-Poisson and is used for analysis of 
count-type data, such as spectrum counts of label-free proteomics and the 
number of reads in RNA sequencing (RNA-Seq) data.   
Selfea calculates the ES threshold according to the statistical power 
where the default is 90% ~ 0.90, but the user can change this.  By combining 
selected methods, such as quasi-Poisson and Cohen’s f, significant proteins are 
selected at the designated statistical power.  Statistical power is the probability 
correctly of rejecting the null hypothesis when it is false.  Hence, it is directly 
related to reliable protein selection.  Selfea enhances the statistical power by 
removing underpowered hypotheses tests using Cohen’s ES.  The higher the 
Cohen’s ES is, the stronger the statistical power, which generates higher quality 
data.  Making a higher statistical power can reduce the number of false positives 
in the final output dataset.  
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Table 7 An example result of the QAM.  “Cohen’s w“: Calculated Cohen’s w for 
expression profile of a protein, “Cohen’s f“: Calculated Cohen’s f for expression 
profile of a protein, “Max_FC”: maximum fold change, “QP_Pval_adjusted”: 
adjusted p-value from quasi-Poisson model, “NB_Pval_adjusted”: adjusted p-
value from negative binomial model and “Normal_Pval_adjusted”: adjusted p-
value from Normal ANOVA model. 
Protein Cohen’
s w 
Cohen’
s f 
Max_ FC QP_Pval_a
djusted 
NB_Pval_a
djusted 
Normal_Pv
al_adjusted 
SERPI
NA1 
0.4988 1.7646 3.1710 3.9790E-04 4.9878E-05 3.0741E-04 
UBC 0.8655 0.7157 7.4570 1.3285E-01 5.2853E-02 4.3099E-01 
IGLL5 1.2780 1.0265 96.4830 2.4177E-03 5.1797E-07 7.6510E-02 
FCGBP 0.9688 4.9266 266.0565 2.9330E-11 0.0000E+00 1.8945E-10 
CELA3
A 
0.4067 1.5158 6.8717 4.7076E-04 1.7161E-05 1.8453E-03 
ACTB 0.6098 1.5480 5.0740 3.2750E-04 2.6138E-06 1.4676E-03 
ACTG1 0.6098 1.5480 5.0740 3.2750E-04 2.6138E-06 1.4676E-03 
UBB 0.8595 0.7446 7.4849 1.1914E-01 4.8966E-02 3.6476E-01 
DMBT1 1.5035 3.7198 296.4068 3.4727E-09 1.9259E-12 1.2735E-08 
IGJ 1.0418 1.3838 Inf 4.1234E-05 2.7157E-11 4.9763E-03 
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However, many biological experiments may have limited statistical power 
due to limited budgets and time.  Selfea can complement low statistical power 
experiment by increasing ES.  For example, significance is usually determined 
based on p-value that is calculated from a Student’s t-test.  P-value can indicate 
statistical significance at high statistical power.  Therefore, Cohen’s ES is 
required to complement the p-value’s weakened selection power.  By applying 
Cohen’s d statistics into a Student’s t-test at higher than 90% statistical power in 
concert with a p-value significance test, there is increased confidence in those 
values. Selfea provides probability-based thresholds and ES thresholds at the 
same time for reliable selection. 
Finally, the QAM module supplies a protein scatter plot showing how 
significant proteins were selected from the total proteins (Fig. 19). In this example 
the red dots are insignificant proteins, while blue dots are significant. The 
horizontal line shows the p-value threshold, while vertical line indicates the ES 
threshold. 
Functional analysis module (FAM) 
Since metaproteome experiments generally have a large number of 
undistinguishable proteins, functional analysis improve the metaproteome’s 
output rather than focusing on individual proteins.  For this QFAM provides the 
FAM module.  This consists of two modules: biosystems and COG analysis.  
Both modules use two statistical tests: the enrichment test and significance test.   
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Figure 19 Protein scatter plot for the quasi-Poisson model and Cohen’s f 
combination.  Selfea provides a protein scatter plot for explaining how 
significant proteins were distinguished.  Horizontal black line is false discovery 
rate (FDR) = 0.05, user-defined p-value threshold, and vertical black line is 
Cohen’s f at 80% statistical power, which is typically the recommended power for 
reliable feature selection.  Red dots are insignificant proteins, while blue dots are 
significant.  
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The enrichment test measures how significantly specific functional terms are 
enriched from total proteins.  The significance test examines how the different 
terms are detected between independent experimental groups.  These two 
statistical methods can report differential and abundant functions in these 
microbial communities. 
Of the many functional analysis tools, FAM could be categorized as a 
second-generation functional class-scoring module (FCS).  Khatri et al [111] 
grouped pathway analysis tools into three categories: over-representation 
analysis (ORA), FCS, and pathway topology (PT) (Fig. 20).  FCS tools utilize 
expression profiles for finding significant functions, which is similar to FAM’s 
significance test using selfea.  The first generation ORA relied on pre-selected 
features such as differentially expressed genes or proteins.  FAM’s enrichment 
test is close to the ORA method.  Therefore, FAM functions by using two kinds of 
analytical methodologies, ORA and FCS.  The enrichment and significance test 
are used to identify important and differential functions.  FAM does not consider 
network topology or different weights that are important issues in TP. 
BioSystems analysis of FAM 
The application of FAM to biosystems uses KEGG, BioCyc [112], 
Reactome [113], National Cancer Institute (NCI) pathway interaction database 
(PID) [114] and GO [115] to analyze the pathways based on the proteomics data.   
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Figure 20 Overview of existing pathway analysis methods using gene 
expression data as an example. 
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These are functional annotations of biosystems, such as biological pathways and 
disease, which can involve any components of the cell (i.e., genes, proteins, 
metabolites and drugs).  Of these programs, KEGG and GO are most widely 
used.  BioCyc, Reactome and NCI PID have their additional advantages, such as 
pathway integration in BioCyc, reaction-focused responses in Reactome and PID 
for pathway interactions. 
FAM consists of an enrichment test and annotation pipeline, downloads of 
source files, parsing and updating reference files for FAM analysis.  This helps to 
maintain up-to-date information (Fig. 21).  FAM annotation pipeline downloads 
and parses NCBI Entrez Gene [116], RefSeq [117]  and BioSystems through file 
transfer protocol (FTP).  Then, FAM parses the downloaded files and updates 
flat-files for NCBI BioSystems analysis.  This process is automated and can be 
run regularly to keep up-to-date status. 
Next, FAM executes enrichment tests for the different pathways.  Proteins 
in the user’s expression profile will have NCBI RefSeq, Entrez Gene or UniProt 
IDs because FAM’s annotated reference files are based on NCBI GenBank and 
UniProt’s SwissProt and TrEBML IDs.  These IDs are transformed to an Entrez 
Gene ID that is directly connected to NCBI BioSystems IDs.  After 
transformation, a Python script collects all the BioSystem terms found in the 
Gene IDs of the query expression profile.  The number of proteins is counted for 
every BioSystem term.   
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Figure 21 A diagram of the biosystems analysis of FAM.  FAM has two parts, 
a script updating reference file and enrichment test.  QAM is incorporated into 
FAM for significance tests.  The user receives results from the enrichment and 
significance tests. 
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Table 8 An example of a contingency table for a pathway ID using the 
enrichment test of FAM. The numbers listed are the numbers of proteins in 
each category. 
 Expression profile data BioSystems DB 
Matched 19 37 
Unmatched 52,934 978,925 
Total 52,953 978,962 
 
 
Then, an enrichment test makes contingency tables using the number of found 
pathway proteins, the total number of proteins in the expression profile, and the 
total number of proteins in the BioSystems DB (Table. 8).   With the constructed 
contingency table, Fisher’s exact test is calculated using NumPy [118] and SciPy 
[119] packages.  The acquired p-values for every spotted pathway ID are 
adjusted according to the FDR.  The FDR was calculated using the Benjamini-
Hochberg method for controlling of false positives caused by repeated 
hypotheses tests.  This method is different from the one was used in PSM 
identification.   
 The significance test is conducted by calling QAM subsequent to the 
enrichment test.  FAM produces an expression profile for all the detected 
pathways during the enrichment test.  A pathway expression profile is 
constructed by transferring spectrum counts of identified proteins to the different 
pathways.  
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QAM is executed in concert with FAM to compute p-values and Cohen’s ES for 
the pathway expression profile.  The significance test identifies the different 
pathways, while the enrichment test how quantifies how many proteins are 
discovered.  Hence, those two tests are mutually combined to report pathways 
that should have the most significance in a biological context.  Basically, 
significant pathways are identified that have p-values less than 0.05 for both of 
tests and a Cohen’s ES larger than 90% statistical power (Table 9).  There are 
options for significance test methods, which selfea provides, such as quasi-
Poisson model and Cohen’s f and negative binomial model and Cohen’s w. 
COG analysis of FAM 
COG analysis is a better approach to interpret the characteristics of the 
microbial community than pathway analysis.  COG is not dependent on database 
annotation so it has better coverage than pathway annotations.  Model 
organisms, such as human, mouse, yeast and Escherichia coli, have very good 
annotation because of they have been investigated for a very long time.  
However, since almost all the microbes are not cultivable in laboratories, most 
microbes encountered in environmental proteomics studies have limited or no 
annotation available.  Hence, there are limited annotations of microorganisms in 
reference databases, such as NCBI Gene and BioSystems, compared to the 
model organisms mentioned above.  Many annotations of microbial proteins are 
inferred by sequence alignment, but this has limited usefulness.   
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Table 9 Example result of FAM.  FAM provides three statistics: adjusted p-
value of enrichment test, significance test, and effect size.  The table represents 
filtered pathways from a whole FAM analysis result using KEGG pathway p-value 
adjustment method for FDR, significance test method using quasi-Poisson and 
Cohen’s f, enrichment test p-value < 0.05, significance test p-value < 0.05 and 
80% statistical power.  “Enrich FDR” is the FDR of the Fisher’s exact test,  
“Source ID” uses the original DB ID in Biosystems (KEGG ID in this table), “# of 
prot” is the number of proteins and “Quasi-Poisson FDR” is the FDR calculated 
by quasi-Poisson model. 
BS ID Description Enrich 
FDR 
Source 
ID 
# of 
prot 
Cohen’
s f 
Quasi-
Poisson 
FDR 
287 Glycolysis / 
Gluconeogenesis 
2.49E-12 ko00010 38 2.5236 4.24E-07 
296 Fatty acid 
degradation 
1.65E-06 ko00071 22 2.6618 4.81E-10 
817567 Carbon metabolism 8.94E-11 ko01200 44 2.6143 2.41E-07 
795174 Biosynthesis of 
amino acids 
3.57E-09 ko01230 34 2.5554 6.84E-07 
478 Focal adhesion 3.03E-06 ko04510 52 2.5316 1.81E-07 
498 Olfactory 
transduction 
2.39E-06 ko04740 11 1.6099 1.25E-04 
169295 Pancreatic secretion 3.01E-10 ko04972 41 4.2238 9.48E-10 
171868 Protein digestion 
and absorption 
1.61E-09 ko04974 38 2.9432 2.82E-07 
516 Pathogenic 
Escherichia coli 
infection 
8.45E-08 ko05130 27 1.6479 1.07E-04 
167191 Amoebiasis 4.87E-08 ko05146 39 2.2770 1.16E-06 
662842 Viral carcinogenesis 6.77E-09 ko05203 59 1.5133 2.16E-04 
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Table 9 continued. 
BS ID Description Enrich 
FDR 
Source 
ID 
# of 
prot 
Cohen’
s f 
Quasi-
Poisson 
FDR 
468194 Glycolysis (Embden-
Meyerhof pathway), 
glucose => pyruvate 
4.87E-07 M00001 18 2.4862 6.24E-07 
468195 Glycolysis, core 
module involving 
three-carbon 
compounds 
9.19E-06 M00002 12 2.3486 1.03E-06 
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Table 10 Comparison of the number annotated proteins between KEGG and 
COG.  The total number of identified microbial proteins is 5,354. 
 KEGG Pathway COG 
The number of proteins annotated 2,254 (42.1%) 4,905 (91.6%) 
 
 
For example, the coverage of KEGG and COG is different for the microbial 
proteins discussed in application study in Chapter 4 (Table 10). 
There are two reasons why COG has better coverage than pathways.  
First, sequence comparisons are not an efficient way to annotate pathways, while 
COG was originally based on sequence comparisons.  Although there are shared 
pathways in different species, many microbes have different pathways adapted 
for survival in diverse environments.  Therefore, sequence comparisons for 
pathway annotation is restricted to universally shared pathways.  However, 
proteins can functions in ways that are not covered by the pathways analysis.  
This limits the usefulness of using this pathway analysis.  The pathways are 
manually generated by reading manuscripts and organizing the accumulated 
research findings into the determined pathways.  Theoretically, all the proteins 
should be involved in at least one pathway, but often it takes multiple studies to 
uncover even single pathways.  Unfortunately, most microbes are not well 
studied at this point. This limits pathway annotation to the many microbial 
proteins observed in metaproteomics studies. 
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COG assignment is built on protein sequences that are available in 
metaproteomics.  COG terms are annotated to proteins through comparing query 
protein sequences with protein sequences in the COG DB.  Each COG has 
protein paralogs from at least three lineages, so species information and 
sequence similarity are required to decide the COG assignment.  COG is widely 
used to find microbial orthologous proteins, but NCBI stopped updating it after 
2005.  From 2010 NCBI released an updated COG DB by expanding species 
coverage and introducing new a COG assignment algorithm (COG software) 
[120].  Until the new COGnitor, a tool for COG allocation, came out, to find a 
similar COG ID one would run the data through RPS-BLAST [121] or PSI-BLAST 
[122] at certain E-value level, such as 0.00000001. COG requires at least three 
proteins from different lineages and needs to have enough similarity to other 
members of COGs, not to only one member.  However, the simple method using 
RPS-BLAST and PSI-BLAST were widely accepted because they were easy to 
use and the original COG assignment algorithm, SymBet, was not.  SymBet was 
complicated and slow to run on a local desktop.   
The newly released COGSoftware employs the EdgeSearch algorithm that 
is faster and less complex than SymBet.  This enables the new COGnitor to 
assign COG IDs to proteins in our dataset and avoids violating COG construction 
rules.  COG analysis of FAM employs COGSoftware for COG allocation.  
COGSoftware goes through two steps to assign COG to new proteins.  Prior to 
COG assignment, COGSoftware requires PSI-BLAST results to be compared to 
the query protein sequences run against COG DB.  With these multiple sequence 
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alignments, the COGSoftware finds the best COG terms related to the query 
proteins.   
FAM controls the COGSoftware and distributes the PSI-BLAST jobs to 48 
CPUs for increased speed (Fig. 22).  Sequence comparisons using PSI-BLAST 
take most of time of COG analysis.  Basically, PSI-BLAST execution time 
depends on BLAST DB size and query protein size.  In the FAM module, the size 
of the BLAST DB and the query protein FASTA file are large because FAM 
requires a whole protein for PSM searches of LC-MS/MS data.  In 
metaproteomics, the DB is several hundred megabytes.  To run PSI-BLAST 
simultaneously FAM divides the large protein DB into small chunks and runs PSI-
BLAST simultaneously.  In spite of parallel operations, if the protein DB is large 
PSI-BLAST sometimes takes up to several days because of the limited number 
of available CPUs (e.g., 12 hours for the human fecal proteome study in Chapter 
4).  
The next step of COG analysis is the enrichment test (Fig. 22).  This 
enrichment test is similar to the BioSystems analysis.  However, COG 
identification of the whole protein DB is limited or not provided by publicly 
available databases, while BioSystems access this information from NCBI 
BioSystems.  Therefore, FAM identifies all the possible COGs in the whole 
metaproteomics protein DB despite of long PSI-BLAST running time (Fig. 22).  
Because the enrichment test measures how significantly proteins in the 
expression profile are enriched from the total DB, FAM needs COG identification 
of the whole protein pool. 
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Figure 22 COG analysis of FAM.  COG analysis runs PSI-BLAST and the 
COGSoftware to identify COG IDs of the query proteins.  With the identified COG 
IDs, enrichment and significance tests are conducted by the R and Python scripts 
of FAM.  Orange color box: input files; blue oval shape: python and R scripts; 
green box: COGSoftware and PSI-BLAST; purple box: distributed jobs; and light 
purple box: output files. 
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FAM makes a contingency table for every COG (Table 11) and calculates a p-
value using Fisher’s exact test.  
The COG enrichment and significance tests are combined to provide 
significant and differentially enriched COG terms.  All the p-values are adjusted 
by user-selected method, such as FDR, following the enrichment test.  Three 
statistics, adjusted p-values from two statistics tests, and Cohen’s effect size are 
integrated and finally significant COGs are reported as described in table 12.  
COG analysis of FAM enables us to obtain differentially and abundantly 
expressed proteins.  The same analysis used for COG and BioSystems is 
repeated for assigning the COG functional categories to provide a wider view of 
the functional features of the microbial community.  Because the COG analysis 
tools do not provide enrichment and significance tests at the same time, FAM is 
unique tool among functional analysis software.   
Other modules of QFAM 
QFAM has other modules besides the PSM search, QAM, and FAM.  
First, it has a module for metagenome proteins, translated proteins from 
metagenome sequences.  Metagenomes have a wide variety of un-annotated 
sequences.  Thus, metagenome sequences are not characterized even though 
those are differentially detected in metaproteomics studies.  The metagenome 
can be functionally analyzed by COG identification in QFAM.  However, 
annotation is required for BioSystems analysis of FAM.   Therefore, QFAM has a 
module for protein annotation of metagenomes via sequence comparison.  
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Table 11 A contingency table for one COG ID from the enrichment test in 
FAM.  For every COG term, FAM counts the number of matched and unmatched 
proteins in the expression profile data and entire metaproteomics DB.  With these 
counts FAM generates contingency table.  P-value is calculated using Fisher’s 
exact test on the contingency table.   
 Expression profile data Entire proteins in 
metaproteomics DB 
Matched 34 77 
Unmatched 48,934 263,921 
Total 48,968 263,998 
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Table 12 An example COG analysis in FAM.  Same thresholds applied in table 
9 were used for this table.  “Enrichment FDR”: FDR of Fisher’s exact test;  
“Source ID”: Original DB ID in Biosystems (KEGG ID in this table); “Func cat.”: 
COG broad functional category; “# of prot”: the number of proteins; and “Quasi-
Poisson FDR”: FDR calculated by quasi-Poisson model. 
COG ID Description Enrichme
nt FDR 
Func
cat. 
# of 
prot 
Cohen’
s f 
Quasi-
Poisson 
FDR 
COG00542 ATPases with 
chaperone activity; 
ATP-binding 
subunit 
2.33E-13 O 36 3.1885 4.27E-07 
COG00050 GTPases - 
translation 
elongation factors 
5.32E-12 J 26 1.5264 8.32E-05 
COG00480 Translation 
elongation factors 
(GTPases) 
5.32E-12 J 32 2.5506 9.50E-07 
COG00055 F0F1-type ATP 
synthase; beta 
subunit 
1.42E-11 C 24 2.7013 1.14E-06 
COG00465 ATP-dependent Zn 
proteases 
8.86E-11 O 27 3.3691 5.58E-08 
COG00653 Preprotein 
translocase subunit 
SecA (ATPase; 
RNA helicase) 
1.99E-10 U 23 1.4936 2.55E-04 
COG00086 DNA-directed RNA 
polymerase; beta' 
subunit/160 kD 
subunit 
1.99E-10 K 22 1.5654 1.30E-04 
COG00048 Ribosomal protein 
S12 
1.99E-10 J 21 1.6682 1.27E-04 
COG00100 Ribosomal protein 
S11 
1.99E-10 J 21 2.0664 4.58E-06 
COG00085 DNA-directed RNA 
polymerase; beta 
subunit/140 kD 
subunit 
2.75E-10 K 22 1.9143 4.63E-06 
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Table 12 continued 
COG ID Description Enrichme
nt FDR 
Func
cat. 
# of 
prot 
Cohen’
s f 
Quasi-
Poisson 
FDR 
COG00459 Chaperonin GroEL 
(HSP60 family) 
2.75E-10 O 22 2.9585 7.46E-08 
COG00052 Ribosomal protein 
S2 
7.43E-10 J 20 1.5196 7.50E-05 
COG00185 Ribosomal protein 
S19 
7.43E-10 J 20 1.6309 6.39E-04 
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This module uses BLAST for sequence comparison with UniProt, which has an 
extensive protein sequence pool collected over the years. The most similar 
UniProt ID is assigned to a metagenome protein if their alignment does not have 
open gaps and shows more than 95% sequence similarity.  Sequence similarity 
is calculated as described below: 
𝑆𝑖𝑚𝑖𝑙𝑎𝑟𝑖𝑡𝑦 = 𝐴𝑙𝑖𝑔𝑛𝑒𝑑  𝑙𝑒𝑛𝑔𝑡ℎ𝑃𝑟𝑜𝑡𝑒𝑖𝑛  𝑙𝑒𝑛𝑔𝑡ℎ ×𝑃𝑒𝑟𝑐𝑒𝑛𝑡  𝑖𝑑𝑒𝑛𝑡𝑖𝑡𝑦 
Where the aligned length and percent identity of the BLAST result and protein 
length is the number of amino acid residues.  Because generally the 
metaproteme DB has a lot of metagenome proteins, running of the BLAST 
assignments is divided into multi-cores and merged after all the jobs are 
completed.  With this annotation, we can apply the reference DB-based analysis 
to metagenome proteins. 
QFAM provides an R library for drawing graphs including bar- and line-
graphs and heat-maps using ‘ggplot2’ package.  Because most biologically 
meaningful images are manually drawn, QFAM does not provide an automated 
module for making figures.  However, if manually curated information is provided, 
QFAM can produce publication quality figures.  Bar- and line-graphs showing 
expression profiles of significantly differential proteins across different 
experimental groups can be generated (Fig. 23).  Line graphs can show 
expression profiles of multiple proteins over different samples.  Proteins are 
colored differently to make clear distinctions between identified proteins.  
  
  88 
 
 
Figure 23 Examples of bar- and line-graph generated by QFAM.  QFAM 
provides R library for drawing A) line graph and B) bar graph from analysis result 
of QFAM. 
  
A) 
B) 
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QFAM’s bar graph for showing multiple proteins, pathways, or COGs in different 
experimental groups.  Significance can be marked with red asterisks and error 
bars can be added to show data variation.   
QFAM’s R library Drawing heat maps are provided by (Fig. 24).  Heat map 
figures are widely used in Omics based studies to display expression profile of 
many proteins or genes.  Although heat-map can show global trends in whole 
dataset, it is not able to exhibit detail information.  Heat map graphs are often 
combined with hierarchical clustering to group similarly expressed proteins.  
QFAM provides protein and experiment group clustering.  Coloring of expression 
is standardized spectral counts calculated by (spectral counts – mean) / standard 
deviation.  Colored bars located at upper side of heat-map can display 
experimental groups.  Color-key is also provided by QFAM. 
Conclusion 
 
 We developed QFAM for quantitative and functional analysis of 
metaproteome data.  Since metaproteome data is highly complicated and less 
annotated, analysis pipeline should be able to run its processes in parallel 
computing environment and functionally interpret metaprotome proteins from 
limited annotated metagenomes.  In terms of these requirements, QFAM is 
excellent pipeline for metaproteome data analysis.  QFAM can run MyriMatch 
and IDPicker with 48 CPUs and automatically control all the processes of PSM 
search.  MPA is another pipeline for metaproteome, but it doesn’t provide 
multithreading and multiprocessing execution of PSM search steps. 
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Figure 24 Example heat-map drew by QFAM’s R library.  Heat-map, colored 
by steel blue and white, can display global trend of protein expression.  
Hierarchical clustering for proteins and for experimental groups are available in 
QFAM’s R library.  In this example, only proteins are clustered to show how 
protein expressions are changed in different groups (color bars of upper side of 
heat-map).  Heat-map’s cells are standardized spectral counts by mean and 
variance. 
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Therefore, QFAM has an important advantage to MPA in terms of PSM search 
speed.  Furthermore, QFAM is simple to install and optimize on any Linux 
cluster. 
 In addition to fast search speed, QFAM has QAM module for reliable 
feature selection.  QAM employs selfea R package for finding of differentially 
expressed proteins.  Selfea provides three widely used probability models, quasi-
Poisson, negative binomial and normal distribution, with Cohen’s effect-sizes, 
such as Cohen’s f and w.  Combination of p-values and effect-sizes is able to 
produce reproducible research findings.  Detail explanation about selfea is in 
chapter 3.  
QFAM services functional analysis module, FAM, for metaproteome data 
interpretation.  FAM has two parts, BioSystems and COG analysis.  BioSystems 
is based on reference databases of NCB, while COG is derived from sequence 
comparisons.  BioSystems analysis is more appropriate for well-annotated 
organisms, such as human, mouse and yeast, while COG is the best analysis 
approach to metagenome proteins that takes biggest portion of metaproteome 
data.  Through COG analysis and BioSystems analysis, FAM can cover from 
well-known species to undiscovered species.  Since metaproteome has mixed 
proteome with deeply studied organisms and potential microbes that have never 
been observed to date, FAM is appropriate analysis pipeline for metaproteomics. 
FAM provides two statistical tests, enrichment test and significance test, 
for every functional term including pathways and COGs.  Enrichment test 
measures how many proteins are enriched from total proteins, while significance 
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test is for getting differentially detected terms over different experiment groups.  
Both of two tests can be mutually analyzed to provide differentially and 
meaningfully enriched characteristics of microbial communities.  This FAM’s 
approach is unique in many of published functional analysis tools because FAM 
integrates enrichment test and significance test together. 
  
  93 
CHAPTER III 
Selfea: R package for reliable feature selection 
 
All of the data presented below has been adapted from the following submitted 
journal article: 
 
Lang Ho Lee, Nathan VerBerkmoes and Arnold Saxton “Using Cohen’s Effect 
Sizes for Reliable Feature Selection of Quantitative MS-based Proteomics Data”. 
Nature Methods (In review). 
 
Introduction 
In data analysis from biological studies it’s often a struggle to obtain 
reproducible confident results.  Most scientific discoveries, in the biological 
sciences, are statistically supported by p-value that is not always reliable 
evidence unless statistical power is high enough (≥90%) [123].  However, many 
of biology experiments are not conducted with parameters that have enough 
statistical power due to limited budget and time.  Button et al showed that 42 of 
49 neurological studies, published in 2011, have less than 90% power that is 
typically recommended level for reliable hypothesis tests [123,124] (Fig. 25).  
Since p-value is fickle at insufficient power, it is often accompanied by effect size 
(ES), such as fold change (FC), in biological studies, to increase result 
confidence[125,126].  ES can show the magnitude of difference between 
experiment groups, while p-value assesses if an effect exists[125].  Combination 
of ES and significance filter can improve reproducibility[126].  FC is, however, not 
sufficient to supplement p-value. 
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Figure 25 Median power of studies included in neuroscience meta-
analyses.  This figure shows a histogram of median statistical power of 
neuroscience papers published in 2011.  If this figure was based on minimum 
power as we used, the power of papers should be far more below than 80%.  
This illustration was borrowed from Button et al [124].  N: the number of papers, 
Power(%): median statistical power 
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FC is easy to calculate and a ratio for relative comparison, familiar to 
biological research, but it has obvious limits.  First, FC threshold is rooted on 
empirical evidence of biologists.  FC is traditionally accepted because it means 
observable changes that are clear to the naked eye.  However, this visible 
difference doesn’t always mean significant effect, considering signal intensity and 
variation within replicates.  The same FC threshold is generally applied to various 
data regardless of dataset’s characteristics, such as variance and sample size.  
Furthermore, since FC is a relative ratio, it cannot distinguish absolute 
quantitative difference, which is main purpose of ES[125].  For instance, in label-
free proteomics experiment, if expression level of proteinA has an observed 1 
spectrum count (SC) in control and 2 SC in test group, FC of proteinA is 2.  It is 
still same 2-FC, however, to another proteinB whose expression level is 1,000 
SC in control and 2,000 SC in test group.  Difference in the two groups for 
proteinA is 1 SC while for proteinB is 1,000 SC.  We may not be sure whether the 
1 SC difference of proteinA is true or from systematic-error because protein 
detection and quantitation are limited by the sensitivity of the instrumentation 
making the measurement (low spectral count proteins in label free proteomics is 
always suspect).  As was confirmed in microarray[127], FC is no-good at 
handling low expression level features (genes or proteins) that are prevalent in 
biological data. 
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Methods 
Label free LC-MS/MS Proteomics Data 
Gregori data were obtained from ‘msmsTests’ R package[126,128].  Fecal 
proteome data were generated in a study of chapter 4, human fecal proteome 
study, via label free shotgun proteomics.  The detail information of data 
generation is in method part of chapter 4. 
Calculation of Cohen’s effect sizes and statistics 
All the statistical analysis, used in this study, was done with R 3.1.3.  
Cohen’s effect sizes, fold change and p-values were obtained by ‘selfea’ R 
package we developed.  Selfea is available at http://cran.r-
project.org/web/packages/selfea/.  Selfea calculates Cohen’s f as described 
below: 
𝑓 =    𝑝! 𝜇! − 𝜇 !!!!! 𝑀𝑆𝐸  
Where pi = N/ni, k = the number of groups, ni = the number of observation in 
group i, N = total number of observations, µi = mean of group i, µ = grand mean 
over all the observations, and MSE = mean square error[129,130].  Cohen’s w is 
calculated in selfea as described below: 
𝑤 =    (𝑝0! − 𝑝1!)!𝑝0!!!!!  
Where m = the number of cells, p0i = cell probability in i-th cell under null 
hypothesis, and p1i = cell probability in i-th cell under alternative hypothesis.  We 
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used ‘ES.w1’ function of ‘pwr’ package[131] for Cohen’s w calculation because 
we compare goodness of fit of two NB models[129,130,132].  Selfea calculates 
minimum Cohen’s f using ‘pwr.anova.test’ function of pwr pacage with 
parameters (k = the number of groups, n = the common sample size in each 
group, sig.level = p-value threshold defined by an user (0.05 by default) and 
power = statistical power defined by an user (0.90 by default)).  Cohen’s w is 
calculated in selfea through ‘pwr.chisq.test’ function of pwr package with 
parameters (N = the total sample size, df = the degree of freedom, sig.level = p-
value threshold defined by an user (0.05 by default) and power = statistical power 
defined by an user (0.90 by default)).  Selfea calculates p-values from quasi-
Poisson, negative binomial and Normal distribution.  Since generalized linear 
model of basic R does not provide negative binomial distribution, ‘glm.nb’ 
function of MASS package[133] was used for making a negative binomial linear 
model.  Generated linear models for quasi-Poisson, negative binomial and 
Normal distribution were compared against null linear model using ‘anova’ 
function.  One-way ANOVA F-test is used to compare linear models based on 
quasi-Poisson and Normal distribution, while chi square likelihood ratio test is 
used for a negative binomial linear model.  Since one-way ANOVA F-test is used 
for quasi-Poisson and Normal distribution linear models, Cohen’s f is coupled.  
Negative binomial linear model is paired to Cohen’s w due to chi-square 
likelihood ratio test.  All the p-values were adjusted by FDR[110].  Fold change 
between experiment groups was calculated by selfea.  Selfea returns maximum 
fold change among all the possible pairs as representative fold change.  
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Minimum statistical power is reported as representative statistical power in selfea 
package. 
Benchmark data test and fecal proteome data test 
We employed the benchmark data generated by Gregori et al[126] and 
fecal proteome data in order to test Cohen’s effect sizes.  The dataset, termed 
here as fecal proteomes, have 29 2D-LC-MS/MS runs from 11 fecal samples 
from healthy adult volunteers (unpublished).  Selfea was used to find differently 
expressed proteins in 11 fecal samples.  Gregori data consist of 19 label-free 
liquid chromatography-tandem mass spectrometry runs and have 4 groups that 
have a fixed loading amount of standard yeast lysates (500 ng) with different 
amounts of 48 human proteins (100, 200, 400 and 600 fmol).  Differentially 
expressed proteins over 4 groups were found by using selfea.  As is assumed by 
Gregori et al[128], we considered human proteins as true positives and yeast 
proteins as false positives.  Using selfea, we got differentially expressed proteins 
of Gregori data and fecal proteome data through six methods; quasi-Poisson 
(FDR < 0.05) and Cohen’s f (Power > 0.90), quasi-Poisson (FDR < 0.05) and 2 
fold change, negative binomial (FDR < 0.05) and Cohen’s w (Power > 0.90), 
negative binomial (FDR < 0.05) and 2 fold change, Normal ANOVA (FDR < 0.05) 
and Cohen’s f (Power > 0.90), and Normal ANOVA (FDR < 0.05) and 2 fold 
change.  With the significant proteins, we counted human proteins as true 
positives and yeast proteins as false positives.  Percentage of false positives in a 
signature is the number of false positives divided by the total number of proteins 
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in a signature.  In addition to NB, QP and NOR model, we calculated p-values 
using QProt to check if Cohen’s ES can be successfully combined with other type 
method.  QProt was downloaded from http://sourceforge.net/projects/qprot and 
installed on the Newton computational cluster at the University of Tennessee.  
Since QProt provides only two-sample test, we tested all the possible pairs of 
experiments of Gregori data.  After collection of all the FDR-adjusted p-values 
from six two-sample tests, we picked minimum FDR as representative FDR.  
Input parameter of QProt was nburnin=2,000, niter=10,000, and normalized=1.  
Bar plots were drawn by Microsoft Excel.  Scatter plots were drawn by ‘ggplots2’ 
package[108]. 
Monte Carlo simulation 
We used ‘rpois’ function of R to generate random data based on Poisson 
distribution with mean expression level of each groups in Gregori data.  Since 
Gregori data has four groups, we separately generated random data for each of 
four groups (λ = mean spectral counts within groups).  From the randomly 
generated data, p-values, fold change and Cohen’s effect sizes were computed 
by selfea.  Six methods, used for the benchmark data test, were examined.  We 
calculated minimum statistical power and counted human proteins as true 
positives and yeast proteins as false positives in significant proteins.  FP rate is 
the number of false positives divided by the total number of yeast proteins in a 
random data.  This simulation was repeated 1,000 times.   Box-plots were drawn 
by ‘ggplot2’ package[108]. 
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User guide for selfea package 
R document of selfea is available at CRAN, R package repository, and its 
web addressed is http://cran.r-project.org/web/packages/selfea/selfea.pdf.  This 
R document provides detail information about every function and data as well as 
examples. 
Algorithm 
 To overcome limitations of FC, we developed an alternative approach 
based on Cohen’s ES.  Cohen’s ES are designed to measure difference between 
groups and there are specific types for different hypothesis test methods, such as 
Cohen’s d for Student’s t-test[134].  Cohen’s ES is, moreover, a parameter for 
statistical power calculation of a hypothesis test[134,135].  The higher Cohen’s 
ES is, the better statistical power is.   Statistical power is the probability of 
correctly rejecting the null-hypothesis when it is false.  Therefore, higher 
statistical power can improve reliability of quantitative biological studies.  We can 
obtain higher statistical power by increasing threshold of Cohen’s ES filter. 
First, our approach calculates Cohen’s f and w for each comparison 
between experiment groups for every individual feature[129,135].  Cohen’s f is 
for one-way ANOVA F-test using quasi-Poisson (QP) or Normal distribution 
(Normal).  Cohen’s w is linked to the Chi-square likelihood-ratio test (LR-test) for 
comparing goodness of fit of two generalized linear models based on negative 
binomial distribution (NB).  Those three, QP, Normal and NB, are widely used 
distributions for treatment comparisons in biological data.   
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Next, the minimum Cohen’s f and Cohen’s w are calculated for desired 
statistical power, typically 90%, and alpha, typically 0.05, by using power analysis 
function[129,131].  Features having Cohen’s f or w below the obtained minimum 
are filtered out.  This gives a statistical basis to determine ES threshold by 
considering sample size, significance and statistical power.  In addition to the 
statistical benefits, our approach can maintain the level of statistical power by 
filtering out low-powered hypotheses tests.   
We incorporated these concepts in an R package named ‘selfea’, freely 
available on CRAN. To test if its performance was significantly better than 
traditional FC approach, we employed benchmark data, generated by Gregori et 
al[126], because it has clear true positive (TP) and false positive (FP) 
identifications.  Gregori data consist of 19 label-free liquid chromatography-
tandem mass spectrometry (LC-MS/MS) runs and have 4 groups that have a 
fixed loading amount of standard yeast lysates (500 ng) with different amounts of 
39 purified standard human proteins (100, 200, 400 and 600 fmol).  Theoretically, 
the human proteins should show significant quantitative differences over the 4 
groups while yeast proteins should not.  As is assumed by Gregori et al[128], we 
counted human proteins as TP and yeast proteins as FP in signatures of Gregori 
data.  At FDR[110]-adjusted p-value (FDR) < 0.05, we compared Cohen’s ES (> 
0.90 power ) to 2-FC (> 2-fold change) (Fig. 26).  We chose 90% power for ES 
threshold because it is the level p-value requires for being reliable evidence[123]. 
We picked maximum FC as representative FC and minimum statistical power as 
representative statistical power.    
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Figure 26 Testing result with Gregori data and fecal proteome data.  A) 
Statistical power, B) the number of true positives (human proteins) and C) the 
number of false positives (yeast proteins) in significant protein list of Gregori data 
benchmark test for 6 method sets, QP_F, QP_FC, NB_W, NB_FC, NOR_F and 
NOR_FC described in table 13.  FDR thresholds for QP, NB and NOR are 0.05 
and Cohen’s ES (f and w) threshold is 90% statistical power.  Scatter plot of 39 
human (red) and 646 yeat (blue) proteins comparing D) Cohen’s w and FC, E) 
Cohen’s f and FC, F) QP model and Cohen’s f, G) NB model and Cohen’s w and 
H) NOR model and Cohen’s f. 
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Figure 26 continued.  
A) B) 
C) D) 
E) 
F) 
G) H) 
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Benchmark test 
Tests using Gregori data 
We compared 2-FC and Cohen’s ES for three models (QP, NB and NOR) 
using the benchmark data (Table 13).  The benchmark data test showed that our 
approach has significantly better statistical power than 2-FC, 0.90 for Cohen’s ES 
vs. 0.08~0.59 for 2-FC (Fig. 26A).  Cohen’s ES has similar number of true 
positives (TP) (Fig. 26B), while it has a lower number of false positives (FP) (Fig. 
26C).  This means that Cohen’s ES lost fewer of TP while filtering out many more 
FP than 2-FC. 
Protein scatter plots show that Cohen’s ES filters out FP efficiently.  
Cohen’s w (Fig. 26D) and Cohen’s f (Fig. 26E) could remove more FP (blue dots) 
while excluding less number of TP (red dots).  Especially, Cohen’s f has superior 
selection power than Cohen’s w and 2-FC (Fig. 26E).  Also, Cohen’s f showed 
that it could complement p-value by efficiently removing FP (Fig. 26F and 26H), 
while 2-FC removed a smaller number of FP (Fig. 27A-C).  Relatively low 
performance of Cohen’s w and NB (Fig. 26G) is speculated that these are not fit 
to the benchmark data.  Nevertheless, Cohen’s w showed better selection power 
than 2-FC (Fig. 26A-C). 
Tests using fecal proteome data 
We also compared the statistical methods with a more complex and real 
human dataset that is noisier than the well-organized benchmark data.   
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Table 13 Six methods used for comparing Cohen’s ES and FC.  Three 
probability models, widely used in biological data analysis, were employed for 
comparison of Cohen’s ES with FC.   
 Quasi-Poisson 
model (QP) 
(< 0.05 FDR) 
Negative binomial 
model (NB) 
(< 0.05 FDR) 
Normal ANOVA 
model (NOR) 
(< 0.05 FDR) 
FC2  
(> 2-fold change) 
QP_FC2 NB_FC2 NOR_FC2 
Cohen’s f 
(> 90% power) 
QP_F - NOR_F 
Cohen’s w 
(>90% power) 
- NB_W - 
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Figure 27 Protein scatter plots comparing three models and FC.  False 
positive yeast proteins (blue color cross) and true positive human proteins (red 
color dot) were distributed on the plain of A) FDR-adjusted p-value of QP model 
and FC, B) FDR-adjusted p-value of NB model and FC and C) FDR-adjusted p-
value of Normal model and FC.  Vertical line is 2-FC and horizontal line is 0.05 
FDR.  Red-colored left-bottom section, divided by vertical and horizontal lines, is 
filtered by 2-FC after probability filter (FDR < 0.05).  Little or none of FPs (blue 
dots) is removed by 2-FC. 
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Figure 27 continued. 
  
A) 
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Figure 27 continued. 
  
B) 
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Figure 27 continued. 
 
  
C) 
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The dataset, termed here as fecal proteomes, have 29 2D-LC-MS/MS runs from 
11 fecal samples from healthy adult volunteers (chapter 4).  The fecal proteome 
is extremely complex having proteins coming from both human and bacterial 
origin, over a wide dynamic range, and high variability between individuals.  
Since we can’t know TP and FP of fecal proteomes, we compared statistical 
power between Cohen’s ES and 2-FC (Fig. 27).  Similar to Gregori data, Cohen’s 
ES had higher statistical power than 2-FC (0.90 for Cohen’s ES vs. 0.16 ~ 0.70 
for 2-FC). 
Monte Carlo simulation 
After the verifications of our method using the benchmark and actual 
experiment data, we explored our method via the Monte Carlo simulation (MC). 
We generated random data based on Poisson distribution with mean expression 
level of each groups in Gregori data.  Then, we calculated statistics and counted 
TP and FP.  These simulations were repeated 1,000 times in order to investigate 
how much our approach is effective.  The simulation results are summarized and 
illustrated in Fig. 2.  We could confirm that Cohen’s ES have better power (0.90 
for Cohen’s ES vs. 0.06~0.55 for 2-FC) (Fig. 28A), reduced FP greatly (29~32 for 
Cohen’s ES vs. 70~114 for 2-FC) (Fig. 28B) and lost fewer TP (20 for Cohen’s 
ES vs. 27~32 for 2-FC) (Fig. 28C) when compared with 2-FC.  FP rate is the 
probability of falsely rejecting the null hypothesis and is calculated by FP divided 
by total number of yeast proteins in Gregori data.   
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Figure 28 Boxplots of 1,000 times Monte Carlo simulation of Gregori data.  
A) Statistical power, B) the number of false positives (yeast proteins), C) the 
number of true positives (human proteins) and D) FP Rate, FP/(FP+TN), of 1,000 
times Monte Carlo simulation, based on Gregori data, for 6 method sets, QP_F, 
QP_FC, NB_W, NB_FC, NOR_F and NOR_FC described in table 13.  FDR 
thresholds for QP, NB and NOR are 0.05 and Cohen’s ES (f and w) threshold is 
90% statistical power.  TN: True Negative (The number of total yeast proteins in 
Gregori data – FP). 
  
C) 
A) B) 
D) 
  112 
Cohen’s ES has a smaller FP rate than 2-FC (< 5% of Cohen’s ES vs. > 11% of 
2-FC), which means that our method is better at discerning FP than 2-FC (Fig. 
28D).  Similar to Gregori data, Cohen’s ES had higher statistical power than 2-FC 
(0.90 for Cohen’s ES vs. 0.16 ~ 0.70 for 2-FC). 
Monte Carlo simulation 
After the verifications of our method using the benchmark and actual 
experiment data, we explored our method via the Monte Carlo simulation (MC). 
We generated random data based on Poisson distribution with mean expression 
level of each groups in Gregori data.  Then, we calculated statistics and counted 
TP and FP.  These simulations were repeated 1,000 times in order to investigate 
how much our approach is effective.  The simulation results are summarized and 
illustrated in Fig. 2.  We could confirm that Cohen’s ES have better power (0.90 
for Cohen’s ES vs. 0.06~0.55 for 2-FC) (Fig. 28A), reduced FP greatly (29~32 for 
Cohen’s ES vs. 70~114 for 2-FC) (Fig. 28B) and lost fewer TP (20 for Cohen’s 
ES vs. 27~32 for 2-FC) (Fig. 28C) when compared with 2-FC.  FP rate is the 
probability of falsely rejecting the null hypothesis and is calculated by FP divided 
by total number of yeast proteins in Gregori data.  Cohen’s ES has a smaller FP 
rate than 2-FC (< 5% of Cohen’s ES vs. > 11% of 2-FC), which means that our 
method is better at discerning FP than 2-FC (Fig. 28D).  
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Conclusion 
P-values should not be the only piece of information used to discern 
reproducible findings in biological studies. Although effect size filters can 
complement p-value information, fold-change, widely used effect size in 
biological data analysis, is not sufficient.  We suggest using Cohen’s effect sizes 
at a desired statistical power.  The benchmark test and MC simulation show that 
our method can reduce a number of FP while losing relatively small number of 
TP.  This drop of FP is meaningful because many published research findings 
are concerned by potential false positives due to misused statistical approaches 
including low statistical power[124,136].  In addition to QP, NB and NOR, 
Cohen’s ES can be associated with another type of probability-based method, 
such as QProt[137], and showed good selection power when compared to 2-FC 
(Fig. 27).  We believe that Cohen’s ES can help biologists to report reproducible 
discoveries.  Even though selfea was tested only for label-free proteomics data, 
we believe that it can be applied to other type of biological data, such as RNA 
sequencing.    
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CHAPTER IV 
APPLICATION CASE 1 – HUMAN FECAL PROTEOME STUDY 
 
Introduction 
Microbes inhabit every part of human body including the skin, the gut, 
mouth and the nose.  Sometimes they cause illness, but most of the time, 
microorganisms commensally live with their human host organs.  The number of 
microbes in symbiosis with human is estimated to 100 trillion, while we have 10 
trillion cells, thus outnumbering human cells by 10 to 1. The microbes are not just 
living in human body, but they are interacting and playing a vital role in human 
health and diet [138].  In recent years the human gut microbiome, all the 
microbes living in human gastrointestinal tracts, has become an area of heavy in-
depth research by a large number of labs across the planet.  Many of research 
groups applied a wide range of analytical technologies for understanding 
microbiome’s role in human health and how they interact with human host cells 
[139,140].  Also, gut microbiota are known to be associated with disease states, 
such as inflammatory bowl disease [140] and type-2 diabetes [141].  Since 
microbiome has unique microbial communities related to human health, the 
microbiome is an important target for metaproteomics [142].   
Typically, metaproteome studies of gut microbiota have focused on fecal 
samples because feces are considered a direct proxy for the gastrointestinal 
tract.  Furthermore, fecal material has a large amount of microbial proteins, 
convenience of sample collection interplay between the immune response of 
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human intestinal cells and microbiome [143].  Also, feces have abundant host 
proteins, so it enables us to explore biomarkers of disease and interactions 
between microbes and human cells.  Therefore, fecal metaproteomics has a 
great potential for disease diagnostics, studying host-microbes interaction and 
microbial community cohabiting in gastrointestinal tracts.   
Fecal metaproteomics has several unresolved problems that must be 
overcome before it can really be used in biomarker studies, disease state 
prediction, etc.  First, we don’t know the overall diversity of microbes inhabiting 
the fecal material.  In other words, species composition of microbiome is not 
uncovered.  This is important issue to PSM search.  However, many studies have 
resolved this uncertainty by employing metagenome sequence directly from fecal 
material [142-144].  Another challenge is variation of individual microbiomes.  
Naturally, people have different microbiome due to diets, origin, drugs and 
genetic backgrounds.  Probably, personal microbiome may be the most varying 
organ in entire human body, if the microbiome is considered as a 13th organ.  We 
are not sure if there is normal microbiome shared by all the people.  This large 
variation of the microbiome may make effective metaproteomics difficult.   
The potential high variation of fecal proteomes will make the statistical 
analysis of resultant datasets difficult.  Indeed, sample size is very limited for 
many biological studies due to finite budget and time; hence low statistical power 
is ineluctable destiny of biology researches conducted by small labs including 
fecal metaproteomics studies.  At low-powered studies, high variance within 
biological replicates, caused by dissimilar microbiomes corresponding to different 
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environmental factors, impedes obtaining reproducible results via comparison 
between different individuals, disease states or diets.  Thus the chance of false 
positive findings may be relatively high in fecal metaproteomics.  This application 
study shows if there is large variation within fecal proteomes from healthy 
volunteers and how QFAM can be employed to analyze such a dataset. 
Methods 
Sample preparation and LC-MS/MS experiment 
Proteins from all fecal samples were extracted by the direct cell lysis 
method (Fig. 29).  Direct cell lysis method is preferred to collect host proteins, 
while indirect method is better for microbial proteins.  Proteins of all the samples 
were digested by trypsin and analyzed via two-dimensional (2D) nano-LC MS/MS 
system with a split-phase column (SCX-RP) Velos Orbitrap Pro (Thermo Fisher 
Scientific) for feces and LTQ-Velos (Thermo-Fisher) for PBMC with 22 hour runs 
per sample as shown in Figure 29.  The Orbitrap settings were as follows: 30K 
resolution on full scans in Orbitrap, data-dependent MS/MS in LTQ (Top 10 
peaks were chosen), two micro-scans for both full and MS/MS scans, centroid 
data for all scans.   
PSM search and protein identification 
All MS/MS spectra were searched against our customized sequence 
database.  
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Figure 29 Experiment workflow of fecal metaproteome data generation.  
This illustration was adapted from Xiong et al [143]. 
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Our database consists of human protein sequences, microbial proteins isolated 
from human gut and common contaminants (i.e., trypsin and keratin; 36 protein 
sequences).  We collected ~36,000 human protein sequences from NCBI RefSeq 
DB and microbial proteins databases from JGI IMG human microbiome project 
(http://img.jgi.doe.gov/) as is described in our previous paper [95].  For PBMC 
samples, we used human protein sequences only for the MS/MS search while 
microbiome proteins were included in the DB used for MS/MS search of fecal 
samples.  All MS/MS individual runs were searched with the SEQUEST (v.27) 
algorithm [68] against our customized FASTA sequence database.  Search 
parameters were followed to our prior study (<4 miscleavages, 3 Da mass 
tolerance window around the precursor ion mass and 0.5 Da for fragment ion 
masses).  All SEQUEST output files were gathered and filtered using DTASelect 
(1.9) [86] at ≥ 2 peptides per protein and the following widely accepted 
parameters for all the MS runs: XCorr of at least 1.8, 2.5, 3.5 for +1, +2, and +3 
charge states, respectively and a minimum deltCN for 0.08.  All the peptide 
spectrum matches (PSM) that could not satisfy a post-database search filter, -
10≤ ppm ≤10, were excluded out to remove false positives as described in 
previous study [95].  In this study, only human proteins were analyzed, but we 
included microbial proteins in the FASTA database to remove false positives.  
We calculated spectral counts of human proteins via DTASelect.  We removed 
redundant protein sequences in the result proteome using NCBI Entrez Gene 
[116] so that one gene symbol have one sequence.  Spectral counts (SC) were 
normalized by scaling factor αi for i-th protein described as below: 
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Where N = the number MS runs, n = the number of proteins, SC is spectral 
counts of i-th protein in j-th MS run. 
Statistical analyses 
 All the statistical analysis including hierarchical clustering were done by R 
version 3.1.0 and Python 2.7.3 in-house scripts.  We used vegan, cluster, psych 
and gclus library of R to calculate distances between MS runs and draw 
dendrogram.  To maximize clustering efficiency we calculated Cophenetic 
correlation coefficient and Gower similarity coefficient of several distance 
methods, such as single linkage, complete linkage, Unweighted pair-group 
method using arithmetic averages (UPGMA) and Ward’s minimum variance 
matrixes.  UPGMA matrix shows highest Cophenetic correlation coefficient 
(93.3%), so we used UPGMA for hierarchical clustering.  Pearson correlation 
coefficients (PCC) between 29 MS runs were calculated by in-house R scripts.  
Shapiro-Wilk normality test was used to test our dataset if it is following Normality 
using shapiro.test function of R. 
The proteomics results were also analyzed by using ‘selfea’ R package, 
described in chapter 3, providing quasi-Poisson Generalized Linear Modeling 
(QP) and Cohen’s f [145].  We applied QP model to find significantly varied 
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proteins in 11 fecal proteomes.  Poisson distribution is usually assumed to 
analyze frequency-based data like spectral counts [97].  However, Poisson 
distribution assumes that its parameter λ = E(X) = Var(X).  Because of the 
assumption, Poisson distribution cannot bear over-dispersion.  Quasi maximum 
likelihood approach can alleviate Poisson test’s less flexibility by employing 
variance function based on given data [97].  Our QP model is Spectral count ~ 
Fecal sample.  P-value was calculated by QP model and adjusted by Benjamini-
Hochberg method (FDR) [110].  Cohen’s f was used as effect size filter.  Cohen’s 
f is ES linked with ANOVA F-test, which was used for QP model comparison.  
Important advantage of using Cohen’s f is that we can filter out underpowered 
hypotheses tests.  P-value cannot play its statistical evidence role at low 
statistical power (< 90%)[123,124].  Selfea provides minimum Cohen’s f at 90% 
statistical power and reliable results using ES filter and FDR filter.  Cohen’s f is 
calculated as described below: 
𝑓 =    𝑝! 𝜇! − 𝜇 !!!!! 𝑀𝑆𝐸  
Where, pi = N/ni, k = the number of groups, ni = the number of observation in 
group i, N = total number of observations, µi = mean of group i, µ = grand mean 
over all the observations, and MSE = mean square error.  The minimum Cohen’s 
f at 90% statistical power was 1.3769 given sample size and p-value 0.05 
threshold.  We accepted proteins that have bigger Cohen’s f than 1.3769 and 
less than 0.05 FDR for further analysis. 
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Functional analysis of fecal proteome was done by enrichment test and 
significance test.  These analyses were done by in-house Python and R script.  
We annotated the dataset with GO terms [115] for human proteins and Cluster of 
orthologous genes (COG) terms [146] for microbial proteins.  GO terms were 
downloaded from NCBI BioSystems database [106] via FTP.  COG terms were 
assigned to fecal microbial proteins by using COGSoftware [120].  We followed 
steps recommended by COGSoftware to identify COG terms.  With COG and GO 
terms, we conducted enrichment test using Fisher’s exact test and significance 
test using selfea.  Same filtering threshold, FDR < 0.05 and Cohen’s f > 1.3769, 
were applied to find significant GO and COG terms. 
 
Results 
Data generation from 11 fecal and 5 PBMC samples 
The 11 healthy volunteer fecal samples metaproteomic datasets were 
generated by nano 2D-LC-MS/MS on an OrbiVelos Pro (Thermo-Fisher).  Of 
these 11 samples four were duplicated and others were triplicated, for a total of 
29 MS run..  The datasets were searched against human NCBI RefSeq and 21 
microbes isolates from human gut, downloaded from JGI IMG 
(http://img.jgi.doe.gov/), by using SEQUEST/DTASelect.  From these 29 MS 
runs, we were able to identify 7,455 proteins, 2,102 human proteins and 5,353 
microbiome proteins, after excluding out of redundant sequences using NCBI 
Entrez Gene DB (Table 14).  
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Table 14 Comparison of MS runs of fecal sample and PBMC.  The number of 
identified proteins was counted for fecal human, microbiome and PBMC human 
data.  Unshared proteins were uniquely identified in only one sample. 
 Feces PBMC 
 Human Microbiome Human 
Total number of proteins 2,102 5,353 2,556 
The number of MS Runs 29 29 5 
Average number of proteins 
detected/MS run 
501 1,688 1,278 
Average number of unshared 
proteins 
115 213 158 
% of unshared proteins 22.88% 12.61% 12.37% 
 
 
These redundant protein sequences have same spectral counts (SC) due to 
short and redundant trypsin-digested peptides.  SC of 7,455 proteins were 
normalized by scaled factor (αi) that is average number of total SC per run (N) 
divided by sum of SC of run i (ni) as is used in our previous study of Crohn 
disease [95].  This normalization makes 29 MS runs to have same total number 
of PSMs. 
We also collected five peripheral blood mononuclear cell (PBMC) 
samples.  PBMC is any blood cell that has a round nucleus, such as lymphocyte, 
a monocyte or a macrophage.  We applied same pre-processing steps to five 
PBMC runs such as, normalization by total spectral counts and reduction of 
redundant protein sequences by NCBI Gene ID.  Finally, 2,556 human proteins 
are identified from five PBMC replicates (Table 14).  In terms of the number of 
identified human proteins, PBMC has two times more proteins per MS run than 
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feces, 501 in feces vs. 1,278 in PBMC, (Table 14).  Unshared proteins are 
uniquely identified in only one sample.  Percentage of unshared human proteins 
in fecal samples is almost two times that of fecal microbiome and PBMC human 
proteins (Table 14).  More than 20% of human fecal proteins are uniquely 
identified from 11 healthy volunteers, which means that on average one fifth of 
human fecal proteins are not shared. 
Comparison of 29 fecal and 5 PBMC MS runs 
All the fecal samples were collected from healthy volunteers who do not 
have any of gastrointestinal disorders or other known disease states.  To 
understand how their fecal proteomes are different, we first compared 29 MS 
runs in a broad sense using hierarchical clustering method (Fig. 30).  Unweighted 
pair-group method using arithmetic averages (UPGMA) was used to calculate 
distance between MS runs because its Gower similarity coefficient is lower than 
other metrics, such as complete, average and single linkage metrics.  The 
dendrogram of figure 30 shows that technical replicates of 11 fecal samples are 
clustered together (Fig. 30), which means technical replicates are not biased nor 
highly varied neither.  Pearson correlation coefficients (PCC) between technical 
replicates confirm their similarity ranged from 0.75 to 0.98, which means closely 
correlated data (Fig. 31A). 
In contrast to technical replicates’ high similarity, all the individual donors 
of fecal proteomes are dissimilar with each other.   
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Figure 30 Hierarchical clustering of 29 MS runs of 11 fecal samples.  
Technical replicates are closely clustered together, which means small variance 
within technical replicates.  
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Figure 31 Correlation coefficients between fecal and PBMC MS runs.  
Pearson correlation coefficients between A) technological replicates of fecal 
samples, B) biological replicates of PBMC samples and C) biological replicates of 
fecal samples.   
  
B) A) 
C) 
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In addition to hierarchical clustering result, we could confirm this dissimilarity 
from comparing PCC between biological replicate MS runs.  PCC between 
biological replicates of feces are ranged from 0.15 to 0.81 (Fig. 31C).  A 
difference between maximum and minimum PCC is 0.23 in technical replicates, 
but 0.66 in biological replicates.  Moreover, minimum PCC in technical and in 
biological replicates ws much different, 0.77 for technical replicates and 0.10 for 
biological replicates.  Also, average PCC of biological replicates is 0.50 that is 
much lower than one of technical replicates (0.91).  PCC in the biological 
replicates is relatively low and widely ranged.  This shows the diversity between 
individual fecal proteomes.   The highest PCC of biological replicates, 0.81, is 
similar to the lowest PCC of technical replicates, 0.77, showing dissimilarity of 
biological replicates and high similarity of technical replicates. 
Comparing PCC of biological replicates between feces and PBMC 
proteome confirms that the heterogeneity of fecal proteome is especially high. 
PCCs between PBMC biological replicates are ranged from 0.62 to 0.95 (Fig. 
31B).  This range is much narrower and relatively higher than the fecal proteome 
(PCC: 0.15~0.81).  The difference between minimum and maximum of PCC in 
PBMC is 0.33 that is half of the fecal proteome, 0.66.  Also, minimum PCC of the 
fecal proteome, 0.15, is one fourth to one of PBMC, 0.62.  All in all, we could see 
high variability in individual human fecal proteomes when compared to PBMC. 
In addition to PCC comparisons, frequency of protein identifications within 
11 fecal samples shows non-uniformity in protein identifications (Table 15).  We 
counted how many times proteins were identified in 11 fecal samples.  
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Table 15 Protein identification frequency in fecal and PBMC proteomes.   
Protein 
Frequency 
Fecal Human PBMC Human Fecal Microbiome 
# of 
proteins 
% of 
frequency 
# of 
proteins 
% of 
frequency 
# of 
proteins 
% of 
frequency 
1 1,261 59.99% 947 37.05% 2,342 43.75% 
2 287 13.65% 540 21.13% 738 13.79% 
3 116 5.52% 342 13.38% 479 8.95% 
4 86 4.09% 299 11.70% 315 5.88% 
5 64 3.04% 428 16.74% 233 4.35% 
6 32 1.52% - - 226 4.22% 
7 30 1.43% - - 175 3.27% 
8 32 1.52% - - 158 2.95% 
9 37 1.76% - - 140 2.62% 
10 54 2.57% - - 236 4.41% 
11 103 4.90% - - 311 5.81% 
Total 2,102 100.00% 2556 100.00% 5,353 100.00% 
 
 
Surprisingly, of overall 7,455 proteins, the number of proteins with frequency 1 is 
3,603, which means that almost half of total proteins are not redundantly 
detected in 11 healthy volunteers (Table 15).  This percentage of unshared 
proteins is increased up to 60% in human proteins (Table 15).  This 60% is much 
higher than one of PBMC, 37%.  As protein frequency is increased, the number 
of proteins is drastically decreased in fecal samples, 60% to around 1%, when 
compared to PBMC samples, 37% to about 12% (Table 15).  It is significant that 
almost 74% of human fecal proteins were discovered just once or twice in 11 
fecal samples (Table 15).  PCC comparison and identification frequency of fecal 
proteins shows its seriously high dissimilarity. 
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Human proteins in 11 fecal proteomes 
Even though many of human fecal proteins are low abundant and 
unshared, about one hundred proteins were repeatedly and abundantly identified 
in 11 healthy volunteers (Table 15).  Many of these high-spectral-count proteins 
are related to digestion, such as chymotrypsin like elastases (CELA3A and 
CELA3B), alpha-amylases (AMY1A, 1B, 1C and 2A), trypsins (PRSS1 and 
PRSS2) and chymotrypsinogen B (CTRB1 and CTRB2) (Table 16).  Also, 
immune response related proteins are frequently spotted such as, IgG Fc binding 
protein, DBMT1 that is related to innate immunity [147,148], SERPINA3 that is 
related to inflammation [149] and PIGR that is polymeric immunoglobulin 
receptor precursor (Table 16).  Polyubiquitin-C (UBC) is also in top-25 list and is 
related to innate immunity according to Gene Ontology DB (GO) [115].  
Polyubiquitin B, isoform of UBC, is also discovered in all the fecal samples.  
Various myosin isotypes were found in fecal proteomes, such as myosin type 1, 
2, 4, 6 and 8 (Table 16).  Interestingly, transthyretin precursor (TTR) is copiously 
identified in 11 fecal samples. TTR is thyroid hormone-binding protein and is 
considered that it transports thyroxine from the bloodstream to the brain.  TTR is 
found in various tissues including colon muscle according to Proteomics DB [31].   
We searched top 25 abundant proteins of table 16 using Human Proteome 
Map (Fig. 32A) [150] and Proteomics DB (Fig. 32B) [31] to know where these 
came from.  Human Proteome Map is a database that has proteins profiled from 
17 adult tissues, 6 primary hematopoietic cells and 7 fetal tissues.   
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Table 16 Top 25 abundant human proteins in 11 fecal samples.  “ * ”: 
Immune response related proteins,  “Frequency”: Identification frequency in 11 
fecal samples of healthy volunteers and  “Sum of SC”: total count of SC from 29 
MS runs. 
Rank Gene Symbol Description Frequency Sum of 
SC 
1 CELA3A Chymotrypsin-like elastase 
family member 3A preproprotein 
11 7,562.19 
2 *FCGBP IgGFc-binding protein precursor 11 5,582.98 
3 *DMBT1 Deleted in malignant brain 
tumors 1 protein isoform c 
precursor 
11 4,793.61 
4 SERPINA1 Alpha-1-antitrypsin precursor 11 4,089.48 
5 AMY2A Pancreatic alpha-amylase 
precursor 
9 3,367.48 
6 AMY1A Alpha-amylase 1 precursor 9 3,225.87 
7 AMY1B Alpha-amylase 1 precursor 9 3,225.87 
8 AMY1C Alpha-amylase 1 precursor 9 3,225.87 
9 CELA3B Chymotrypsin-like elastase 
family member 3B preproprotein 
11 3,176.00 
10 AMY2B Alpha-amylase 2B precursor 9 3,015.61 
11 MYH2 Myosin-2 11 2,067.20 
12 MYH1 Myosin-1 11 1,984.50 
13 TTR Transthyretin precursor 10 1,860.49 
14 PRSS1 Trypsin-1 preproprotein 11 1,654.03 
15 MYH4 Myosin-4 11 1,577.53 
16 MYH8 Myosin-8 11 1,572.74 
17 UBC Polyubiquitin-C 11 1,568.63 
18 PRSS2 Trypsin-2 preproprotein 11 1,178.51 
19 MYH6 Myosin-6 11 1,134.14 
20 MYH7 Myosin-7 11 1,126.16 
21 CTRB2 Chymotrypsinogen B2 precursor 10 1,041.42 
22 CTRB1 Chymotrypsinogen B precursor 10 997.56 
23 *PIGR Polymeric immunoglobulin 
receptor precursor 
10 950.77 
24 *IGLL5 Immunoglobulin lambda-like 
polypeptide 5 
11 938.32 
25 *SERPINA3 Alpha-1-antichymotrypsin 
precursor [Homo sapiens] 
11 935.14 
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Figure 32 Expression location of top 25 abundant human fecal proteins. 
Origin of fecal proteins were estimated by two databases, A) Proteomics DB and 
B) Human Proteome Map. 
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Figure 32 continued. 
A) 
  132 
 
 
 
 
 
Figure 32 continued. 
 
  
B) 
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Proteomics DB is developed by Technische Universität München (TUM) and 
dedicated to deposit and share proteomics data to the scientific community.  We 
compared our top-25 list to Proteomics DB through its provided analysis tool.  
The most frequently matched tissue in Proteomics DB is colon (22 proteins) and 
pancreas (19 proteins) (Fig. 32A), whereas is adult pancreas (16 proteins) and 
adult gallbladder (14 proteins) in Human Proteome Map  (Fig. 32B).   
All those tissues, frequently matched in both of Proteomics DB and 
Human Proteome Map are related with digestion.  MYH1, MYH7 and MYH8 are 
not detected in colon tissue of Proteomics DB, but these are previously identified 
in esophagus among digestion related tissues.  Therefore, we guess that MYH1, 
MYH7 and MYH8 come from esophagus unlike other isotypes of myosins.  Many 
tissues involved in the digestion are found in the search result of Proteomics DB, 
such as colon muscle, saliva, salivary gland, rectum, pancreatic juice, pancreas, 
oral epithelium, esophagus and colon (Fig. 32B).  Besides tissues on the 
digestion tract, immune response related cells are spotted in the result of 
Proteomics DB and Human Proteome Map (Fig. 32).  Some of proteins in the 
top-25 list are reported that these are expressed in Natural killer cell, monocyte, 
helper T-cell, cytotoxic T-cell and B-lymphocyte according to previous studies of 
Proteomics DB (Fig. 32B).  Human Proteome Map also shows similar result 
including B cells, CD4+ T cells, CD8+ T cells, NK cells and Monocytes (Fig. 32A).   
On top of proteins related with digestion, proteins associated with immune 
response were also repeatedly identified in the 11 fecal samples.  We expected 
that feces have abundant immune proteins because of innate and adaptive 
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immune responses against microbiome, pathogens or vaccines.  Immune 
proteins were recognized by combining several annotation resources that are 
WikiGO [12], Immunome [151,152], Innate DB [153], 19 immune response GO 
terms [154] and immune response keyword search against protein description, 
such as immunoglobulin and IgA that were missed by other methods.  Of 2,102 
total human fecal proteins, 214 immune response proteins were discovered. We 
recognized frequently and abundantly identified 25 immune proteins in table 17.  
IgGFc-binding protein precursor (FCGBP) is the most abundant protein in table 
17.  FCGBP is not directly related to immune response, but it is interacting with 
FC portion of IgG and indirectly involved in the mucosal immunity by making gel-
like mucosa [155].  FCGBP also interacts with Mucin-2 (MUC2) [156] and is 
expressed at colon, colon epithelium, colon muscle and gut according to 
Proteomics DB (Fig. 32B).  Some of inflammatory proteins, such as S100-A8, 
S100-A9, lactotransferrin (LTF) and Keratin type II cytoskeletal 1 (KRT1) were 
copiously detected in the fecal proteomes.  LTF is antimicrobial protein by 
removing essential substrate required for bacterial growth and stimulateTLR4 
signaling pathway [157,158].  KRT1 is also reported that it is involved in the 
inflammatory network in a skin by interacting with interleukin-18 [159].  S100A8 
binds to S100A9 in order to be heterodimer named as Calprotectin that is 
secreted by Neutrophils and acts as important pre-inflammatory mediator in 
acute and chronic inflammation [160].  IGLL5 and IGJ are immunoglobulin 
subtypes, detected in the fecal proteome.  IGLL5’s function is not clarified while 
IGJ is known to interact with IGA and IGM to form polymers.   
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Table 17 Top 25 abundant immune response proteins in 11 fecal samples.  
Frequency is identification frequency in 11 fecal samples of healthy volunteers.  
“Sum of SC” is total count of SC from 29 MS runs.  “Freq.” is identification 
frequency in 11 fecal samples.  “Sources” is immune protein annotation source. 
Gene 
Symbol 
Description Freq. Sum of 
SC 
Sources 
FCGBP IgGFc-binding protein 
precursor 
11 5,582.98 Keyword 
DMBT1 Deleted in malignant brain 
tumors 1 protein isoform c 
precursor 
11 4,793.61 WikiGO, GO term, 
Innate DB 
IGLL5 Immunoglobulin lambda-
like polypeptide 5 
11 950.77 Keyword 
SERPINA3 Alpha-1-antichymotrypsin 
precursor 
11 938.32 WikiGO 
PIGR Polymeric immunoglobulin 
receptor precursor 
10 935.14 WikiGO, Keyword 
IGJ Immunoglobulin J chain 10 729.67 WikiGO, GO term, 
Immunome, 
Keyword 
S100A9 Protein S100-A9 11 636.55 WikiGO, GO term, 
Innate DB 
CEACAM5 Carcinoembryonic 
antigen-related cell 
adhesion molecule 5 
preproprotein 
11 414.82 WikiGO, 
Immunome 
GP2 Pancreatic secretory 
granule membrane major 
glycoprotein GP2 isoform 
4 
10 414.06 GO term, Innate 
DB 
CEACAM1 Carcinoembryonic 
antigen-related cell 
adhesion molecule 1 
isoform 2 precursor 
11 395.66 WikiGO, Innate 
DB, Immunome 
LGALS3BP Galectin-3-binding protein 11 369.90 WikiGO 
DEFA1 Neutrophil defensin 1 
preproprotein 
11 293.57 WikiGO, GO term, 
Innate DB, 
Immunome 
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Table 17 continued. 
 
Gene 
Symbol 
Description Freq. Sum of 
SC 
Sources 
DEFA3 Neutrophil defensin 3 
preproprotein 
11 273.66 WikiGO, GO term, 
Innate DB, 
Immunome 
LTF Lactotransferrin isoform 1 
precursor 
7 227.05 WikiGO, GO term, 
Immunome 
MPO Myeloperoxidase 10 224.96 WikiGO, GO term, 
Immunome 
LYZ Lysozyme C precursor 9 214.56 WikiGO, 
Immunome 
KRT1 Keratin, type II 
cytoskeletal 1 
8 196.43 WikiGO, GO term 
ALB Serum albumin 
preproprotein 
8 187.45 WikiGO 
S100A8 Protein S100-A8 8 172.26 WikiGO, GO term, 
Innate DB, 
Immunome 
CEACAM6 Carcinoembryonic 
antigen-related cell 
adhesion molecule 6 
precursor 
10 167.92 WikiGO, 
Immunome 
DPP4 Dipeptidyl peptidase 4 6 150.79 WikiGO, GO term, 
Immunome 
ANXA2 Annexin A2 isoform 1 9 142.79 Innate DB 
ANPEP Aminopeptidase N 
precursor 
10 137.01 WikiGO, 
Immunome 
DEFA5 Defensin-5 preproprotein 5 108.09 WikiGO, GO term, 
Innate DB, 
Immunome 
CTSG Cathepsin G preproprotein 8 101.60 WikiGO, GO term, 
Innate DB, 
Immunome 
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Even though IGA and IGM were not found in 11 fecal proteomes, we can 
speculate that there are IGA or IGM from IGJ identification.  CEACAM5, 
CEACAM1 and CEACAM6 are another immunoglobulin superfamily called as 
CEA family.  They are glycoprotein and their function is not clearly known, but 
CEACAM5 is reported that it is located on the cell surface and stimulates 
intracellular signaling by binding to adhesins of Escherichia coli [161]. 
Quasi-Poisson model construction using QFAM 
After we confirmed variation of the fecal proteome by PCC and protein 
frequency, we constructed a linear regression model of the fecal proteins in order 
to find proteins significantly varied in 11 fecal proteomes.  Since protein spectral 
counts of our proteome dataset deviate from Normality (Shapiro-Wilks normality 
test p-value = 2.2E-16) and are frequency-based data, we employed Poisson 
distribution via Generlized Linear Model (GLM) for hypothesis tests.  Poisson 
distribution is usually assumed to analyze frequency-based data like spectral 
counts and shows better or equal performance for label-free proteomics data 
than other methods, such as Fisher’s exact test, G-test, student’s t-test 
[97,137,162].  However, Poisson distribution has less-flexibility to over-dispersion 
in terms of empirical fitting because of its assumption that its parameter λ = E(X) 
= Var(X).  GLM can handle non-normal response variables and Quasi maximum 
likelihood (QP) approach can alleviate Poisson test’s less flexibility by employing 
variance function based on given data [97].  We used F-test to calculate p-values 
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that were adjusted by False Discovery Rate (FDR) method to correct multiple 
hypothesis testing [110]. 
In addition to QP model, we also calculated fold changes (FC) from all the 
possible pairs of 11 fecal samples and picked maximum-FC as representative FC 
of a protein because hypotheses test and fold change filtering can give us better 
selection power [126].  Interestingly, maximum-FC of all the 7,455 fecal proteins 
is over 2-fold change.  Since many of fecal proteins are sparsely identified, many 
of proteins have infinite FC even though these are identified in only one fecal 
sample at low level of SC.  Thus, we utilized another type of effect size, Cohen’s 
f [145], to figure out how much different is reliable when considering sample size, 
significance threshold (FDR < 0.05) and desired statistical power (power > 90%).  
Statistical power is a probability rejecting correctly null hypothesis when it is 
false.  The certain level of power (90%) is required to correctly find significant 
proteins [123].  Cohen’s f is designed for ANOVA’s F-test and was used to keep 
our model to have enough statistical power, 90%, given samples size and 
significance level.  Minimum Cohen’s f for effect size filter was obtained by power 
analysis.  The minimum Cohen’s f for effect size filter is 1.3769 for 29 samples of 
11 healthy volunteers for 90% power and 0.05 significance level.  By combining 
QP and effect size filter, of total 7,455 fecal proteins, 1,610 proteins were 
categorized as differentially identified fecal proteins from 11 fecal proteomes (Fig. 
33).  Of significant 1,610 proteins, 355 proteins are from human and 1,255 
proteins are from microbiome.   
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Figure 33 Protein scatter plot of human fecal proteome comparison.  Blue 
dots are significantly categorized proteins, while red dots are proteins that could 
not passed two thresholds, FDR < 0.05 and Cohen’s f > 1.3769. 
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More than 20% of total fecal proteins are significantly varied at 5% false 
positive level and 90% statistical power.  This is not comparison between control 
and treatment group, but examining changes within biological replicates of 
healthy normal volunteers.  Studies using fecal samples should consider high 
within-group variance.  High variance within replicates affects on comparison 
between different experiment groups.  To analyze highly varied data like fecal 
proteomes, many biological and technical replicates are required.  Otherwise, 
strict threshold should be applied and reliable statistical methodology is required. 
Functional analysis using QFAM 
We analyzed fecal proteins in terms of functional terms, such as gene 
ontology (GO) [115] enrichment test for human proteins and cluster of ortholog 
groups (COG) [146] analysis for microbiome proteins, so that we understand 
metabolic functions of identified human fecal proteins.  GO and COG terms are 
widely used to get to know functional features of proteomics data [163,164].   
COG and GO terms were enriched over all the human fecal proteins by 
using Fisher’s exact test.  P-values of the enriched COG and GO terms were 
adjusted by FDR.  Also, significance test was conducted by employing QP model 
and transferring SC of member proteins to COG and GO terms.  Significantly 
enriched and varied COG and GO terms have less than 0.05 p-value (Fisher’s 
exact test FDR < 0.05 and QP FDR < 0.05) and more than 1.3769 Cohen’s f 
(statistical power > 90%). 
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Table 18 Significantly varied GO terms in human fecal proteins. “GO ID”: 
Gene ontology ID obtained from BioSystems DB, “FDR”: FDR-adjusted 
enrichment test, “Enrich. FDR”:  FDR of enrichment test, “# of prots”: the number 
of member proteins and “QP FDR”: FDR calculated by QP model. 
GO ID Description Enrich. 
FDR 
# of  
prot 
Cohen’
s f 
QP  
FDR 
GO:0070062 Extracellular exosome 3.91E-98 691 4.4624 3.29E-10 
GO:0065010 Extracellular membrane-
bounded organelle 
3.91E-98 691 4.4624 3.29E-10 
GO:1903561 Extracellular vesicle 1.17E-97 691 4.4624 3.29E-10 
GO:0043230 Extracellular organelle 1.17E-97 691 4.4624 3.29E-10 
GO:0031988 Membrane-bounded 
vesicle 
2.12E-87 765 4.7401 1.66E-10 
GO:0031982 Vesicle 7.12E-84 770 4.7451 1.61E-10 
GO:0044421 Extracellular region part 2.02E-76 771 5.0905 3.40E-11 
GO:0005576 Extracellular region 3.67E-55 804 5.2393 1.67E-11 
GO:0007586 Digestion 7.80E-07 39 3.8928 3.28E-11 
GO:0002385 Mucosal immune 
response 
7.08E-05 17 2.0228 1.94E-05 
GO:0050832 Defense response to 
fungus 
1.18E-03 13 4.1696 1.17E-08 
GO:0009620 Response to fungus 8.80E-03 14 4.1802 1.03E-08 
GO:0042742 Defense response to 
bacterium 
3.15E-02 38 3.4573 4.33E-09 
GO:0001906 Cell killing 3.39E-02 15 4.5767 2.52E-11 
GO:0005856 Cytoskeleton 2.14E-40 418 4.2486 1.08E-09 
GO:0071822 Protein complex subunit 
organization 
8.08E-42 356 1.6116 1.44E-04 
GO:0006936 Muscle contraction 1.91E-12 70 3.4826 2.61E-08 
GO:0004022 Alcohol dehydrogenase 
(NAD) activity 
4.42E-02 5 2.4551 1.16E-11 
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The result of GO term analysis includes interesting GO terms.  
Extracellular location related GO cellular component terms, extracellular 
vesicular exosome (GO:0070062), extracellular vesicle (GO:1903561), 
extracellular membrane-bounded organelle (GO:0065010), vesicle 
(GO:0031982), extracellular organelle (GO:0043230), extracellular region 
(GO:0005576) and extracellular region part (GO:0044421), were understandably 
enriched (Enrichment FDR <1.07E-55) from the significant human proteins 
(Table 18).  This shows that many of the significant human fecal proteins are 
secreted into extracellular regions and excreted into feces.   
Besides of extracellular location GO terms, digestion (GO:0007586) and 
mucosal immune response (GO:0002385) were enriched (Table 18).  Mucosal 
immune response GO term was enriched from RYR1, TPM4, VCL, FLII, myosin 
proteins and actin proteins (FDR = 7.08E-05).  In addition to mucosal immunity, 
immune defense-related GO terms were enriched (FDR < 0.05), such as defense 
response to fungus (GO:0050832), response to fungus (GO:0009620), defense 
response to bacterium (GO:0042742) and cell killing (GO:0001906) (Table 18).  
Digestion related proteins, such as AMY2B, CTRB1, CTRB2 and CELA2A, are 
abundantly identified in the fecal proteomes (Table 17) and also included in the 
355 significant protein list.  Digestion proteins are required to obtain nutrition and 
energy for everybody, but abundance of those proteins is very dissimilar.  For 
example, average spectral counts of digestion related proteins, assigned to 
digestion (GO:0007586), is 24.2904 in 174c while it is 289.1341 in 196N.  The 
fold change between 174c and 196N is more than 10.  Since cytoskeleton 
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proteins including keratins, tubulins, actins and myosins are significantly and 
differentially detected in the fecal proteomes, cytoskeleton (GO:0005856), protein 
complex subunit organization (GO:0071822) and muscle contraction 
(GO:0006936) are enriched with remarkable FDR (FDR < 1.91E-12) (Table 18). 
We guess that these cytoskeletal proteins are excreted from the dead 
intestinal cells and immune cells, and their amount is different from person to 
person.  Interestingly, alcohol dehydrogenase (GO: 0004022) was also 
differentially detected over healthy volunteers (Table 17).  Its QP model FDR 
(1.16E-11) and Cohen’s f (2.4551) shows how it was variously expressed from 
person to person.   
Functional features of microbial proteins were analyzed by employing 
COG terms.  We tested COG terms by enrichment test using Fisher’s exact test 
and quantitative QP model with conferred SC from member protein to COG 
terms.   Lots of ribosome related COG terms were frequently found in the COG 
analysis result, such as ribosomal protein L1 (COG00081), S2 (COG00052), S10 
(COG0051), S11 (COG00100), L11 (COG0080), S12 (COG00048) and S19 
(COG00185) at enrichment FDR < 2.95E-09 and QP FDR < 0.0007 (Table 19).  
Since ribosome is the most abundant protein in microorganism cells, many 
ribosome-related COGs were detected in the COG analysis.  Different ribosome 
complex may mean different biomass of microbiome rather than expression level 
of ribosomal proteins.  Energy-required (ATP or GTP) enzyme activity COG 
terms were also frequently enriched besides ribosomes (Table 19).   
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Table 19 Significant COG terms in microbial fecal proteins.  “COG ID”: COG 
term ID assigned by COGSoftware, “FDR”: FDR-adjusted enrichment test, 
“Enrich. FDR”:  FDR of enrichment test, “# of prots”: the number of member 
proteins and “QP FDR”: FDR calculated by QP model. 
COG ID Description Enrich. 
FDR 
# of 
prots 
Cohen’
s f 
QP FDR 
COG00542 ATPases with 
chaperone activity; ATP-
binding subunit 
2.33E-13 36 3.1885 4.27E-07 
COG00480 Translation elongation 
factors (GTPases) 
5.32E-12 32 2.5506 9.50E-07 
COG00050 GTPases - translation 
elongation factors 
5.32E-12 26 1.5264 8.32E-05 
COG00055 F0F1-type ATP 
synthase; beta subunit 
1.42E-11 24 2.7013 1.14E-06 
COG00465 ATP-dependent Zn 
proteases 
8.86E-11 27 3.3691 5.58E-08 
COG00100 Ribosomal protein S11 1.99E-10 21 2.0664 4.58E-06 
COG00048 Ribosomal protein S12 1.99E-10 21 1.6682 0.000127
452 
COG00086 DNA-directed RNA 
polymerase; beta' 
subunit/160 kD subunit 
1.99E-10 22 1.5654 0.000129
515 
COG00653 Preprotein translocase 
subunit SecA (ATPase; 
RNA helicase) 
1.99E-10 23 1.4936 0.000254
607 
COG00459 Chaperonin GroEL 
(HSP60 family) 
2.75E-10 22 2.9585 7.46E-08 
COG00085 DNA-directed RNA 
polymerase; beta 
subunit/140 kD subunit 
2.75E-10 22 1.9143 4.63E-06 
COG01592 Rubrerythrin 7.43E-10 21 2.2773 1.10E-06 
COG00057 Glyceraldehyde-3-
phosphate 
dehydrogenase/erythros
e-4-phosphate 
dehydrogenase 
7.43E-10 23 1.9770 1.11E-05 
COG01629 Outer membrane 
receptor proteins; mostly 
Fe transport 
7.43E-10 45 2.0563 2.90E-05 
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Table 19 continued. 
COG ID Description Enrich. 
FDR 
# of 
prots 
Cohen’
s f 
QP FDR 
COG00052 Ribosomal protein S2 7.43E-10 20 1.5196 7.50E-05 
COG00185 Ribosomal protein S19 7.43E-10 20 1.6309 0.000638
967 
COG00443 Molecular chaperone 8.88E-10 25 2.6864 7.01E-07 
COG00080 Ribosomal protein L11 1.12E-09 20 2.0750 3.51E-06 
COG00051 Ribosomal protein S10 1.12E-09 20 1.7237 4.86E-05 
COG01454 Alcohol dehydrogenase; 
class IV 
9.98E-06 21 1.9329 7.50E-05 
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ATPases with chaperone activity; ATP-binding subunit (COG00542), 
F0F1-type ATP synthase; beta subunit (COG00055), ATP-dependent Zn 
proteases (COG00465), Preprotein translocase subunit SecA (ATPase; RNA 
helicase) (COG00653), GTPases - translation elongation factors (COG00050) 
and Translation elongation factors (GTPases) (COG00480) were enriched at 
enrichment FDR < 1.99E-10 and QP FDR < 0.0003.  Interestingly, alcohol 
dehydrogenate COG term (COG01454) was significantly and differentially 
enriched like GO analysis of human proteins at enrichment FDR = 9.98E-06 and 
QP FDR = 7.50E-05. 
COG’s broad functional terms were analyzed likewise to GO and COG 
terms (Table 20).  We applied same thresholds (enrichment FDR < 0.05, QP, 
FDR < 0.05 and Cohen’s f < 1.3769).  As is confirmed by COG term analysis, 
translation, ribosomal structure and biogenesis (J) were significantly and 
differentially enriched (enrichment FDR: 7.00E-258 and QP FDR = 1.48E-10) 
(Fig. 34) (Table 20).  Also, energy production and conversion (C), carbohydrate 
transport and metabolism (G), inorganic ion transport and metabolism (P), and 
amino acid transport and metabolism (E) were detected (Fig. 34) (Table 20).  
These are partially related to digestion and energy generation.  These COG 
functions may be varied in different microbiome.  Interestingly, cell motility and 
defense mechanisms (V) were found in the COG broad functional analysis result 
(enrichment FDR = 1.19E-07 and QP FDR = 2.95E-05) (Fig. 34) (Table 20).  
Microbiome is speculated that they may move to find nutrients and defend 
themselves from host immune system.    
  147 
Table 20 Significant COG functional terms in microbial fecal proteins.  “ID”: 
COG functional term ID, FDR: FDR-adjusted enrichment test and # of prots: the 
number of member proteins. 
ID Description Enrich. 
FDR 
# of 
prots 
Cohen’
s f 
QP FDR 
J Translation; ribosomal 
structure and biogenesis 
7.00E-258 1,060 4.1810 1.48E-10 
S Function unknown 1.44E-39 159 2.3167 3.51E-06 
X Not predicted 2.42E-37 205 2.3234 7.05E-07 
C Energy production and 
conversion 
1.47E-34 476 2.2074 1.46E-06 
G Carbohydrate transport and 
metabolism 
1.39E-31 626 3.1924 3.15E-09 
O Posttranslational modification; 
protein turnover; chaperones 
1.88E-27 319 4.5972 1.48E-10 
R General function prediction 
only 
1.10E-19 313 1.7545 3.43E-05 
K Transcription 6.68E-17 214 2.1878 2.77E-07 
L Replication; recombination 
and repair 
2.51E-16 229 1.8058 2.76E-06 
T Signal transduction 
mechanisms 
1.39E-09 94 1.5192 3.12E-04 
V Defense mechanisms 1.19E-07 70 2.1949 2.95E-05 
M Cell wall/membrane/envelope 
biogenesis 
1.26E-05 226 3.7150 8.49E-09 
E Amino acid transport and 
metabolism 
1.60E-05 471 2.2311 7.57E-07 
N Cell motility 5.57E-04 37 1.5247 9.60E-05 
P Inorganic ion transport and 
metabolism 
3.44E-03 162 2.1932 1.45E-06 
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Figure 34 Line plot showing expression profile of 15 COG functions.  
Spectrum counts of member proteins were transferred to COG broad functional 
terms.  COG function name for corresponding symbol is in “ID” column of table 
19.  This plot was drown by line plot module of QFAM. 
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Figure 34 continued.  
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These functions also were dissimilar in different people, which mean that 
microbiome may be facing in different environment (human gut).  Table 20 has 
statistics of significant COG broad functional terms whose expression profiles are 
described in figure 34.  Figure 34 was produced by plot library of QFAM. 
Conclusion 
 
We could identify 2,102 fecal human proteins and 5,453 microbial proteins 
from feces of 11 healthy volunteers and confirmed their heterogeneity.  This 
number of human fecal proteins is larger than previous studies, 234 proteins from 
three samples in Lichtman et al [17] and 446 proteins from two samples in our 
previous study [148].  We identified 501 proteins per a MS run that is larger 
number than total number of proteins from two or three samples in the previous 
studies.  We confirmed that host proteins in feces are diverse in human as is 
shown in mice feces by Lichtman et al [17].  Host fecal protein’s variance was 
disclosed by PCC (Fig. 31) and identification frequency (Table 15) comparisons 
with technical replicates and five PBMC proteomes.  Figure 31 shows that fecal 
proteins are not uniformly identified in individual fecal samples.  The QP model 
also reveals that expression levels of fecal proteomes are various.  We could find 
1,610 proteins that are differentially and significantly detected in 11 fecal 
proteomes via QP model and effect size filter.  We utilized Cohen’s f to enhance 
statistical power of our QP model.  Functional enrichment analyses over the 
1,610 significant proteins show that human significant proteins are generally 
located extracellular regions and are related with digestion, cytoskeleton and 
  151 
protein metabolisms, and microbial significant proteins are related with 
translation, energy generation and protein metabolisms. 
 Many immune response proteins were also identified in our fecal 
proteome. Identification of immune response proteins in fecal proteomes is a 
natural outcome because the gastrointestinal tract is a direct interface of 
interaction between host immune system and microbiome including commensal 
flora and enteric pathogens.  We found 214 immune proteins out of 11 fecal 
proteomes.  Almost 40 immune proteins were detected in more than half of fecal 
samples (> 5 samples), while others are less-frequently identified.  Toll-like 
receptor family protein (TLR) plays a key role in the innate immunity, so we 
expected TLR proteins in many fecal samples. However, only TLR6 was weakly 
identified in one fecal sample.  TLR6 has a fundamental role in pathogen 
recognition and induction of innate immune response.  We speculate that rare 
identification of TLRs is because of their low expression level in cells.  We also 
expected to see immunoglobulins for innate immunity, such as IGA, IGD, IGE, 
IGG and IGM, but none of these are in our fecal proteomes.  In place of above 
five immunoglobulins, IGJ are strongly and frequently identified.  IGJ is involved 
in polymer form of IGA and IGM, so IGJ can be an indirect clue of existence of 
IGA and IGM.  IGJ is also identified in previous studies, but TLR6 is found only in 
our study. 
Human fecal proteins that were identified by previous studies were 
confirmed in our study.  We could confirm that 196 proteins of 234 in Lichtman et 
al [17] and 243 proteins of 446 in our previous study were identified in our study.  
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The number of fecal proteins commonly identified in three studies including our 
fecal proteomes is 101.  Of the commonly identified 101 proteins, 24 proteins 
were immune response proteins including IGJ and DMBT1.  Digestion related 
proteins, such as, AMY2A and PRSS1, are also commonly found.  Many of the 
simultaneously found proteins are detected with high SC in our study.  Top 25 
abundant fecal proteins in table 16 are found in at least one of previous studies.  
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CHAPTER V 
APPLICATION CASE 2 – HUMAN DIET PROTEOME STUDY 
 
Introduction 
 What we are eating undoubtedly has a great impact on the relative 
abundance and the types of our microbiome living in gastrointestinal tract [165].  
For example, western diets, low in carbohydrates and high in simple sugar and 
fat, are associated with the decrease of Bacteriodetes in North Americans 
[166,167].  This change in gut microbiome is generally detected in feces [168].  
For instance, certain type of bacteria are increased or decreased by short-term 
dietary changes, such as resistant starch (RS) diets and antibiotics, in the 
collected fecal samples.  Antibiotics, effective against autochthonous species 
members, such as Helicobacter pylori and Lactobacillus Reuteri, create 
significant decrease of these microbes detected in the feces [168].  The microbial 
pattern changed by different RS amount in diets is likely associated with how 
long the changed diet is taken and its specific nutritional contents, such as more 
refined RS [169-171].   
 RS is one of starch or derivatives of starch and is not fully digested by 
human small intestine, while sugars and most starches are rapidly digested and 
absorbed as glucose.  This undigested RS, dietary fiber, is diet-derived energy-
source of microbiome living mostly in large intestine.  Several scientific reports 
showed that high RS diet could result in abundance of specific bacteria in 
microbiome, such as Ruminococcus bromii, Eubacterium rectale, and 
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Bifidobacterium adolescentis [165,171-173].  These changes in microbiome are 
probably caused by substrate-specific preference of different microbes that can 
uptake and degrade RS efficiently.  Generally, people inhabiting different places 
have dissimilar microbiome, but children in European Union and Burkina Faso 
showed similar response to high fiber diets, which Bacteroidetes and Firmicutes 
ratio are changed by different amount of dietary RS [174].  Potential increase of 
short chain fatty acid and butyrate-producing microbes and decrease of disease-
causing bacteria enable us to associate RS diet with human health. 
 While the influence of resistant starch on the gut microbial community has 
been demonstrated, the precise functional and quantitative relationship between 
the gut microbiome and RS amount remains unclear.  This chapter focuses on 
the metaproteomics apart of the integrative “omics” study including 
metagenomics, metabolomics and metaproteomics.  Two different diets 
containing high and low amounts of RS were treated to 8 patients in crossover 
time course design.  Feces after having specific diets were sampled and 
analyzed by 2D LC-MS/MS and QFAM. 
Methods 
Generation of Metaproteome data 
The diet study design is summarized in Figure 35.  Briefly, 8 patients who 
were insulin resistant (HOMA-IR > 50th percentile for sex), overweight or obese 
(BMI between 27 and 35 kg/m2), and met other eligibility criteria were enrolled in 
the study.  
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Figure 35 Experiment design of diet proteome study.  Low RS has 2g 
amylose and High RS has 38g amylose.  Every diet is treated for two weeks.  
Total 8 patients had different diets, as is scheduled in cross over design. 
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All subjects were otherwise healthy and not taking any antibiotics, lipid-
reducing or blood-thinning medications, or hormones.  The study protocols were 
approved by the Human Subjects Committee of both Children’s Hospital Oakland 
Research Institute and Lawrence Berkeley National Laboratory.  Written informed 
consent was obtained from each subject.  Study participants were randomly 
assigned to a sequence of the two experimental diets: a low resistant starch 
(LRS) diet containing 2 grams of resistant starch and a high resistant starch 
(HRS) diet containing 38 grams of resistant starch. Each diet period was 2 weeks 
with 2 weeks baseline washout diet between diet periods (Fig. 35).  In both diets, 
type 2 RS, a granular form of high amylose cornstarch, was used. Melojel of 
Ingredion Inc. was used for LRS diets, while Hi-maize 260 RS was used for the 
HRS diets.  Following the initial baseline diet and each diet period, fecal samples 
were collected.  
Sample preparation and LC-MS/MS experiment 
Proteins of all fecal samples were extracted by indirect cell lysis method 
(Fig. 29) preferred for collection of microbial proteins.  Proteins of all the samples 
were digested by trypsin and analyzed via 2D LC MS/MS with C18-SCX 
(Phenomonex) self-packed nano back column (3 cm C18, 3 cm SCX, 150 µm 
i.d.) that serves as the first dimension of the 2D-LC system to capture peptides 
and wash away salts and a QExactive MS (Thermo Fisher). QExactive settings 
were as follows: the normalized collision energy for HCD was 28 eV, a full scan 
resolution of 70,000K from 400-1600 m/z, a HCD MS/MS resolution of 17,500 
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with an isolation width of 3 m/z, and the dynamic exclusion was set at 15 
seconds. Peptides were not excluded based on charge state and 1 microscan for 
both full and MS/MS scans were acquired.  All MS and MS/MS data were 
acquired in profile mode.   
Quantitation and normalization of metaproteome data 
All MS/MS spectra were searched against our customized sequence 
database.  The database consists of human protein sequences, translated meta-
genome sequences, proteins of 34 human-gut-isolated microbial species, and 
common contaminants (i.e., trypsin and keratin; 36 protein sequences).  We 
collected human protein sequences from NCBI RefSeq and microbial proteins 
from JGI human microbiome project (IMG-HMP) as is described in our previous 
paper [95].  All MS/MS individual runs were searched with the SEQUEST (v.27) 
algorithm against our customized FASTA sequence database.  Search 
parameters were followed to our prior study [95] (<4 miss-cleavages, 3 Da mass 
tolerance window around the precursor ion mass and 0.5 Da for fragment ion 
masses).  All SEQUEST output files were gathered and filtered using DTASelect 
(1.9) at ≥ 2 peptides per protein and the following widely accepted parameters for 
all the MS runs: XCorr of at least 1.8, 2.5, 3.5 for +1, +2, and +3 charge states, 
respectively and a minimum deltCN for 0.08.  All the peptide spectrum matches 
(PSM) that could not satisfy a post-database search filter, -10 ≤ ppm ≤ 10, were 
excluded out to remove false positives as described in our previous study [95].  
Finally 57,397 proteins were quantitatively identified (human: 1,103 and 
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microbes: 56,294).  Spectrum counts (SC) of protein is normalized as described 
below [95]:  
𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑  𝑆𝐶! =    𝑆𝐶!!!!!!!!! 𝑀𝑆𝐶!!!!! ×𝑆𝐶! 
Where, N = the number proteins and M = the number MS runs. 
Quantitative analysis of metaproteome data 
All the statistical analyses were fulfilled by using R 3.1.3 and Python 2.7.6.  
Since people have different gut microbiome and different genetic background, 
fecal proteomes are heterogeneous from person to person.  Chapter 4 study 
showed that human fecal proteome is highly varied.  Hence, we considered that 
personal variation is important to interpret our proteomics data in terms of diet 
type.  Generalized Linear Mixed Model (GLMM) is the expanded model of 
generalized linear model (GLM) and able to include random effects in addition to 
the usual fixed effects.  We set personal variation as random effect to explain 
different people’s different fecal proteomes.  Our model for the proteome analysis 
is SC ~ µ + Diet type + (1|Person).  Negative binomial distribution (NB) was 
employed as null distribution in GLMM instead of Normal distribution because 
spectral count is frequency-based data and NB distribution is generally used for 
count-type data analysis, such as read numbers of RNA sequencing.  The 
constructed GLMM NB model was compared to null model through chi-square 
likelihood ratio test (LR test).  All the P-values were adjusted by FDR in order to 
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reduce multiple comparison effect.  Cut-off FDR is 0.0001.  We used ‘lmerTest’ 
package to construct GLMM NB model [175]. 
On top of GLMM NB model, effect size (ES) filter was applied to enhance 
reproducibility.  Combining p-value and ES filter can enhance reproducibility of 
proteomics data analysis [128].  As is showed in chapter 3, fold change is widely 
used ES, but Cohen’s ES is better ES in terms of statistical power and selection 
power filtering false positives.  We used ‘selfea’ R package, described in chapter 
3, to calculate Cohen’s w that is designed for chi-square test that was used for 
GLMM NB model comparison.  Since a number of microbial proteins were 
significantly detected, we used very strict statistical filters (FDR-adjusted p-value 
(FDR) < 0.0001) to make the expected number of false positives is smaller than 
1.  When p-value threshold is 0.0001, minimum Cohen’s w for our data was 
1.0258 corresponding to 80% statistical power that is recommended level for 
reliable hypothesis test.  Statistical power is the probability of correctly rejecting 
null hypothesis when it is false, so it is directly related statistics with reproducible 
result.  The expected number of false positives is 0.7 at 0.0001 FDR and 80% 
power.  The number of significantly detected human proteins is 94, while the 
number of microbial proteins is 7,018. 
Functional analysis of metaproteome data 
Metaproteome data was functionally analyzed by using COG for microbial 
proteins and KEGG pathway terms. COG and COG functional terms were 
examined by using COG-analysis pipeline of FAM.  To assign COG ID to 
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microbial proteins, we used COG-software by following steps suggested by 
Kristensen et al [120].  For proteins, COG-software could not assign, PSI-BLAST 
search against COG sequences was used with cut off E-value 0.00000001.  We 
could assign COG ID to 54,290 microbial proteins.  To quantitatively analyze 
COG IDs, we transferred SC of member proteins, allocated to at least one COG 
ID, to COG ID.  Same assignment was done to 25 broad COG functional terms.  
We applied GLMM NB model and Cohen’s w to get significant COG terms and 
their broad functional terms.  For COG analysis, 0.0001 FDR thresholds and 
1.0258 Cohen’s w were applied. We could examine significantly changed 400 
COG terms and 4 COG functional terms across different diet types.  Since many 
of significant COG terms were supported by only 1 or 2 member proteins, we 
filtered out COGs by the number of member proteins (member > 2).  This rule 
was applied to COG functional terms.  After filtering by minimum member 
proteins, remaining COGs were 166 terms and 2 functional terms.  For COG 
functions, we applied 0.001 FDR of GLMM-NB model and 0.9051 Cohen’s w (the 
number of expected false positive is 0.02).   
FAM was used to analyze KEGG pathway for human proteins in diet 
metaproteome.  SC transfer to KEGG pathways was done like COG analysis.  
Enrichment test was carried out by QAM module.  FDR threshold for the 
enrichment test was 0.05.  To quantitatively analyze KEGG pathways, we applied 
GLMM NB model and Cohen’s w, 0.05 FDR thresholds and 0.6336 Cohen’s w, 
so that the number of expected false positives is 1.  We could identify 20 
significant KEGG pathways. 
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Identification of translated-metagenome sequences 
 Undefined translated-metagenome sequences (metagenome proteins) 
were defined by BLAST search pipeline of QFAM against whole UniProt DB 
downloaded in Dec. 2014.  BLAST search, using BLAST 2.2.24, was fulfilled in 
Newton cluster of the University of Tennessee (https://newton.utk.edu/).  We 
divided 48,284 metagenome proteins into 48 groups and had run 48 BLAST jobs 
simultaneously onto 48 cores of Newton cluster.  Sequence similarity was 
calculated for every alignment as described below: 
𝑆𝑖𝑚𝑖𝑙𝑎𝑟𝑖𝑡𝑦 = 𝐴𝑙𝑖𝑔𝑛𝑒𝑑  𝑙𝑒𝑛𝑔𝑡ℎ𝑃𝑟𝑜𝑡𝑒𝑖𝑛  𝑙𝑒𝑛𝑔𝑡ℎ ×𝑃𝑒𝑟𝑐𝑒𝑛𝑡  𝑖𝑑𝑒𝑛𝑡𝑖𝑡𝑦 
Where aligned length is value of ‘alignment length’ of BLAST result, protein 
length is the number of amino acid of a protein and percent identity is ‘% identity’ 
of BLAST result.  We assigned single UniProt ID to a metagenome protein by 
95% sequence similarity without gap opens.  At 95% similarity level, 38,543 
metagenome proteins were successfully determined. 
  Results 
Generation of diet metaproteome data 
 From 24 MS runs (8 patients * 3 diets), 57,398 proteins were determined.  
Of 57,398 proteins, 56,295 were from microbiome and 1,103 were host human 
proteins.  This identification bias is caused by indirect protein extraction method 
(Fig. 29).  Since we collected microbial pellets and removed supernatant, human 
proteins, floating in supernatant, were efficiently removed.  Filtering out of host 
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proteins are required to get more microbial proteins from fecal samples.  This diet 
proteome study targets understanding of changes in microbiome communities, 
so half number of human proteins was identified when compared to human fecal 
proteome study of chapter 4.    
Much larger number of microbial proteins was detected in this study than 
human fecal proteome study (56k of diet proteome vs. 5k of human fecal 
proteome).  This abundant microbial protein examination is due to two reasons.  
First, it is employing indirect protein collection method as is described in chapter 
4.  Another factor is the metagenome sequencing.  As is explained in chapter 4, 
species composition of human feces is not known and is various from person to 
person.  In this study, metagenome sequencing was employed and added to 
PSM search, while it wasn’t in human fecal proteome study.  Since metagenome 
is not annotated, metagenome characterization is required.  Nevertheless, 
microbial protein identification is dramatically increased by metagenome 
sequences and indirect method.  The number of metagenome proteins, 
translated metagenome coding genes, is 48,376 of 56,295 total microbial 
proteins.  This is 86% of total microbial protein identifications, which means 
showing huge contribution of metagenome proteins to increase of microbial 
proteins. 
 Some species had significant changes in terms of the number of identified 
proteins (Table 21).   The number of metagenome proteins was increased by RS 
amount (26,075 in LRS and 28,776 in HRS).   
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Table 21 The number of identified proteins in different species and in 
different diets.  “SD” is standard deviation of numbers in three different diets. 
Species Baselin
e 
LRS HRS SD 
Aeromonas hydrophila hydrophila ATCC 
7966   
4 4 5 0.58 
Desulfovibrio sp. 3_1_syn3 13 13 11 1.15 
Escherichia coli CFT073   12 10 8 2.00 
Lactobacillus reuteri CF48-3A   6 2 4 2.00 
Enterococcus faecalis PC4.1   11 10 7 2.08 
Shigella flexneri 2a 2457T 11 10 7 2.08 
Methanobrevibacter smithii F1, DSM 2374   1 1 6 2.89 
Salmonella enterica enterica sv Typhi Ty2 13 8 8 2.89 
Blautia hydrogenotrophicus S5a33, DSM 
10507   
72 66 66 3.46 
Klebsiella sp. 1_1_55 20 9 15 5.51 
Streptococcus sp. 2_1_36FAA   21 14 8 6.51 
Coprococcus sp. HPP0048 75 61 74 7.81 
Anaerostipes sp. 3_2_56FAA 58 67 74 8.02 
Ruminococcus lactaris ATCC 29176   87 103 89 8.72 
Prevotella melaninogenica D18 64 82 71 9.07 
Clostridium sp. 7_2_43FAA 45 31 50 9.85 
Dorea formicigenerans ATCC 27755   93 104 84 10.02 
Coprococcus comes   77 81 98 11.15 
Lachnospiraceae bacterium 6_1_63FAA 90 89 115 14.73 
Alistipes putredinis DSM 17216   130 157 161 16.86 
Dialister invisus DSM 15470   23 47 57 17.47 
Roseburia intestinalis L1-82   104 145 111 21.93 
Akkermansia muciniphila ATCC BAA-835   14 11 58 26.31 
Eubacterium rectale ATCC 33656   263 311 325 32.52 
Bifidobacterium adolescentis ATCC 15703 41 38 102 36.12 
Ruminococcaceae bacterium D16 75 147 126 37.03 
Bacteroides uniformis CL03T00C23 393 314 367 40.26 
Bifidobacterium adolescentis L2-32 44 38 111 40.53 
Bacteroides uniformis CL03T12C37 392 312 366 40.81 
Prevotella copri CB7, DSM 18205   529 633 523 61.85 
Homo sapiens 893 723 760 89.40 
Faecalibacterium prausnitzii A2-165   226 361 454 114.64 
Bacteroides vulgatus ATCC 8482   777 571 785 121.31 
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Table 21 continued 
Species Baseline LRS HRS SD 
Bacteroides sp. 1_1_6 774 389 320 244.64 
Bacteroides sp. D2 885 379 409 283.88 
Metagenome 23,359 26,075 28,766 2,703.51 
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As is reported previously [174], Bacteriodes showed changes by RS amount 
(Table 20).  Bacteriodes vulgatus ATCC 8482 had 571 proteins in low RS, 
however its number of proteins is increased in high RS up to 785 (Table 21).  
Interestingly, all the Bacteriodes species, Bacteriodes sp. D2, Bacteriodes sp. 
1_1_6 and Bacteriodes vulgatus ATCC 8482, were remarkably decreased in low 
RS when compared to baseline diet (Table 21).  These changes are relatively 
large, considering changes in other species.  The number of human proteins is 
not quite changed by different diets  (Table 21).  Abundance of many species in 
fecal samples was not much changed except Bacteroides and Metagenome 
(Table 21).   
Construction of generalized linear mixed model 
 Generalized linear mixed model (GLMM) was constructed for comparing 
proteomes between different diets.  This model considers that SC can be varied 
by diet type in different patients.  We assumed that eight patients could have 
different fecal proteome profiles, even though they are basically same biological 
replicates that have same disease and healthy background.  GLMM has patients 
as random effect and diet type as fixed effect.  Negative binomial distribution 
(NB) was employed as null distribution in GLMM instead of Normal distribution 
because spectral count is frequency-based data and NB distribution is generally 
used for count-type data analysis, such as read numbers of RNA sequencing.  
NB is widely used distribution in RNA sequencing data comparison [176,177], 
while has not been used in proteomics data analysis.  NB is robust to over-
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dispersion when compared to Poisson that is also basically designed distribution 
for count type data.  Additionally, NB is uniquely determined by two parameters, 
mean and variance.  However, the number of replicates in biological studies is 
often not enough to estimate mean and variance reliably.  Therefore, tools based 
on NB for RNA sequencing data comparison, such as DESeq[177] and 
edgeR[176], have their own variance functions adjusted for RNA sequencing 
data.  The constructed GLMM-NB model was compared to null model through 
chi-square likelihood ratio test (LR test).  All the p-values were adjusted by FDR 
in order to reduce multiple comparison effect.  On top of GLMM-NB model, 
Cohen’s w was applied because GLMM model used NB distribution. 
Using GLMM-NB and Cohen’s w we found 7,113 significant proteins, 94 from 
human and 7,018 from microbiome and metagenome, that are differently 
detected in different diet types.  These significant proteins were picked by 0.0001 
FDR and 1.0258 Cohen’s w threshold (Fig. 36).  We increased p-value threshold 
to reduce the number of expected false positives.  The expected false positive in 
our results is less than 1.  Protein scatter plot in figure 36 shows how many 
proteins we filtered out from total proteins.  Since fecal proteomes are highly 
varied by patients as is shown in chapter 4, we applied rigorous thresholds to 
exclude out potential false positives.  Cohen’s w was calculated by selfea R 
package used in chapter 3 and 4.  
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Figure 36 Protein scatter plot of diet proteome comparison.  Green dots 
mean insignificant microbial proteins, and red dots are insignificant human 
proteins.  Significant proteins are colored as purple (significant microbial) and 
blue (significant human).  Since we used rigorous thresholds to make the 
expected number of false positive below 1, almost all the visible spots were 
excluded by two lines (FDR threshold (= 0.0001) horizontal line and Cohen’s w (= 
1.0258) vertical line).   
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Functional analysis using FAM 
 Functional analysis of diet proteomes was conducted by using FAM.  For 
this study, we used KEGG pathway analysis for human proteins and COG terms 
for microbial proteins.  Even though relatively small number of human proteins 
was identified in the diet proteome, we analyzed their functional characteristics.  
Since we are interested in microbial changes caused by different RS amount, 
COG analysis of QFAM helped us to get insights about changes in microbiome. 
 First, we analyzed human proteins in the diet proteome using KEGG 
pathways.  FAM was employed to get reliable results using enrichment test and 
significance test.  Enrichment test was carried out via Fisher’s exact test.  For 
quantitative comparison GLMM NB model and Cohen’s w were applied.  Also, 
SC transferring from member proteins to KEGG pathways was done for human 
proteins of diet metaproteome.  We downloaded up-to-date NCBI BioSystems 
DB at the moment of analysis.  All the p-values from two tests were adjusted by 
FDR.  FDR thresholds of two tests were 0.05 and minimum Cohen’s w was 
0.6336 for 80% statistical power that is generally recommended level.   
With these probability and ES filters, we could get 20 significant KEGG 
pathways (Fig. 37).  HIF-1 signaling pathway, biosynthesis of amino acids, 
galactose metabolism, central carbon metabolism in cancer, proteasome and 
immunoproteasome were enriched almost only in LRS.  In other diets, HRS and 
baseline, these were not expressed.  Since proteasome and immunoproteasome 
are related to defense against microbial proteins, we speculate that innate 
immune system was turned on against increased species in LRS diets.   
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Figure 37 Stacked bar graphs of accumulated spectral counts of 20 
significant KEGG pathways.  Y-axis is KEGG pathway and X-axis is 
percentage of accumulated spectral counts of 2A (baseline), HRS and LRS 
samples.  Blue-colored bar is sum of spectral counts in baseline diet.  Red-
colored bar means expression level (sum of spectral counts) in HRS.  Green bars 
are from sum of expression level in LRS. 
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Interestingly, digestion-related pathways were enriched in both of LRS and HRS, 
such as glycolysis, fructose and mannose metabolism, carbon metabolism, 
pentose phosphate pathway and glucogenesis.  This may be human body 
response to get nutrients from changed diets (baseline to LRS or HRS).  Insulin 
signaling pathway and starch and sucrose metabolism were enriched in HRS.  
These means that uptake of glucose was not efficient in HRS because high 
amount of RS in HRS cannot be digested and absorbed by small intestine.  
Therefore, these were expressed higher than other diet types. 
 COG analysis was achieved by employing FAM.  For this study we 
employed FAM’s quantitative test only because of time.  Since diet 
metaproteomics used metagenome, more than several million sequences are in 
protein DB.  To conduct the enrichment test, we have to run PSI-BLAST of more 
than million sequences, which means that it takes too much long time about a 
month in Newton.  This is critical disadvantage of QFAM.  QFAM analyzes highly 
complicated and very large metaproteomics data, so it requires high level of 
computing power.  Unfortunately, Newton could not afford to run this type of big 
data in a reasonable time.  Therefore, we used arbitrary threshold instead of the 
enrichment test.   
 We transferred SC of member proteins to COG terms and constructed 
GLMM NB model for COG terms.  Also, Cohen’s w for COG terms was computed 
for quantitative analysis using QAM.  P-values were adjusted by FDR.  FDR 
threshold of GLMM NB model was 0.001 and minimum Cohen’s w for 80% 
statistical power was 0.9051.  On top of GLMM NB model, we applied arbitrary 
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threshold for COG terms by the number of member proteins (> 2).  With these 
thresholds, we could have 166 significant COG terms (Table 22).  Also, heat-map 
of significant 166 COGs was drawn by using QFAM’s R graphic library (Fig. 38).  
Energy generation and digestion related COG terms were enriched in baseline 
diet, such as COG03808, COG01775 and COG01748 (Table 22 and Fig. 38).  
Also, ribosomal COGs were significantly enriched, such as COG00261 and 
COG00238 (Table 22).   We speculate hat microbiome is growing with baseline 
diet, considering significantly enriched translation and DNA replication COG 
terms (Table 22). 
 COG terms analysis in LRS and HRS diets give us insight speculating 
changes caused by RS addition.  In LRS diet, microbes in human gastrointestinal 
track are not quite different from baseline.  Energy generation (COG00716, 
COG01013, COG01951, COG00554 and COG01805) is activated and digesting 
nutrients, such as amino acids, carbohydrates, lipid metabolism, are turned on 
similarly to baseline (Table 22 and Fig. 38).  However, microbes seem to adapt 
changed nutrients by expressing appropriate proteins and post-translational 
modifications (COG00060, COG00254, COG00124, COG00621, COG00525 and 
COG01438 for transcription and translation and COG00760, COG00484, 
COG00691, COG01066 and COG00740 for post-translational modifications).  
Interestingly, cell motility COG terms are started being expressed from LRS diets 
(COG01360 and COG01749), which mean that microbes were moving to 
somewhere (Table 22).  Also, cell wall biogenesis is differentially enriched in LRS 
when compared to baseline (Table 22 and Fig. 38).  
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Table 22 166 significant COG terms in different diets.  COG Func: COG 
broad function single digit symbol.  Related diets (Rel. Diets) are categorized by 
expression level in three diets (Base: Baseline, LRS: low RS and HRS: high RS). 
COG ID # of 
Prot 
Description COG 
Func 
Rel.
Diets 
COG03808 158 Inorganic pyrophosphatase C Base 
COG01748 13 Saccharopine dehydrogenase and related 
proteins 
E Base 
COG01775 12 Benzoyl-CoA reductase/2-hydroxyglutaryl-
CoA dehydratase subunit; 
BcrC/BadD/HgdB 
E Base 
COG00040 7 ATP phosphoribosyltransferase E Base 
COG00006 4 Xaa-Pro aminopeptidase E Base 
COG01027 3 Aspartate ammonia-lyase E Base 
COG00176 9 Transaldolase G Base 
COG02160 8 L-arabinose isomerase G Base 
COG03693 5 Beta-1;4-xylanase G Base 
COG01830 4 DhnA-type fructose-1;6-bisphosphate 
aldolase and related enzymes 
G Base 
COG02893 4 Phosphotransferase system; 
mannose/fructose-specific component IIA 
G Base 
COG01482 3 Phosphomannose isomerase G Base 
COG03345 3 Alpha-galactosidase G Base 
COG02022 3 Uncharacterized enzyme of thiazole 
biosynthesis 
H Base 
COG00447 3 Dihydroxynaphthoic acid synthase H Base 
COG01260 4 Myo-inositol-1-phosphate synthase I Base 
COG01022 3 Long-chain acyl-CoA synthetases (AMP-
forming) 
I Base 
COG02030 3 Acyl dehydratase I Base 
COG00261 35 Ribosomal protein L21 J Base 
COG00238 25 Ribosomal protein S18 J Base 
COG00188 21 Type IIA topoisomerase (DNA gyrase/topo 
II; topoisomerase IV); A subunit 
L Base 
COG01918 21 Fe2+ transport system protein A P Base 
COG00523 21 Putative GTPases (G3E family) R Base 
COG02406 10 Protein distantly related to bacterial ferritins R Base 
COG03937 5 Uncharacterized conserved protein S Base 
COG01217 25 Predicted membrane GTPase involved in 
stress response 
T Base 
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Table 22 continued. 
COG ID # of 
Prot 
Description COG 
Func 
Rel. 
Diets 
COG01702 6 Phosphate starvation-inducible protein 
PhoH; predicted ATPase 
T Base 
COG03706 5 Response regulator containing a CheY-like 
receiver domain and a GGDEF domain 
T Base 
COG00317 9 Guanosine polyphosphate 
pyrophosphohydrolases/synthetases 
TK Base 
COG00342 28 Preprotein translocase subunit SecD U LRS 
COG00716 51 Flavodoxins C LRS 
COG01013 20 Pyruvate:ferredoxin oxidoreductase and 
related 2-oxoacid:ferredoxin 
oxidoreductases; beta subunit 
C LRS 
COG01951 5 Tartrate dehydratase alpha 
subunit/Fumarate hydratase class I; N-
terminal domain 
C LRS 
COG00554 3 Glycerol kinase C LRS 
COG01805 3 Na+-transporting NADH:ubiquinone 
oxidoreductase; subunit NqrB 
C LRS 
COG00347 31 Nitrogen regulatory protein PII E LRS 
COG00436 10 Aspartate/tyrosine/aromatic 
aminotransferase 
E LRS 
COG00076 3 Glutamate decarboxylase and related PLP-
dependent proteins 
E LRS 
COG00175 4 3’-phosphoadenosine 5’-phosphosulfate 
sulfotransferase (PAPS reductase)/FAD 
synthetase and related enzymes 
EH LRS 
COG00444 4 ABC-type dipeptide/oligopeptide/nickel 
transport system; ATPase component 
EP LRS 
COG01102 3 Cytidylate kinase F LRS 
COG00395 10 ABC-type sugar transport system; 
permease component 
G LRS 
COG03534 5 Alpha-L-arabinofuranosidase G LRS 
COG02376 4 Dihydroxyacetone kinase G LRS 
COG01440 4 Phosphotransferase system cellobiose-
specific component IIB 
G LRS 
COG03669 4 Alpha-L-fucosidase G LRS 
COG01904 4 Glucuronate isomerase G LRS 
COG03717 3 5-keto 4-deoxyuronate isomerase G LRS 
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Table 22 continued. 
COG ID # of 
Prot 
Description COG 
Func 
Rel. 
Diets 
COG00413 12 Ketopantoate hydroxymethyltransferase H LRS 
COG01429 7 Cobalamin biosynthesis protein CobN and 
related Mg-chelatases 
H LRS 
COG00452 4 Phosphopantothenoylcysteine 
synthetase/decarboxylase 
H LRS 
COG00161 4 Adenosylmethionine-8-amino-7-
oxononanoate aminotransferase 
H LRS 
COG00007 3 Uroporphyrinogen-III methylase H LRS 
COG00214 3 Pyridoxine biosynthesis enzyme H LRS 
COG01024 15 Enoyl-CoA hydratase/carnithine racemase I LRS 
COG02185 13 Methylmalonyl-CoA mutase; C-terminal 
domain/subunit (cobalamin-binding) 
I LRS 
COG01788 6 Acyl CoA:acetate/3-ketoacid CoA 
transferase; alpha subunit 
I LRS 
COG00332 3 3-oxoacyl-[acyl-carrier-protein] synthase III I LRS 
COG00060 15 Isoleucyl-tRNA synthetase J LRS 
COG00254 7 Ribosomal protein L31 J LRS 
COG00124 5 Histidyl-tRNA synthetase J LRS 
COG00621 4 2-methylthioadenine synthetase J LRS 
COG00525 3 Valyl-tRNA synthetase J LRS 
COG01438 3 Arginine repressor K LRS 
COG02885 25 Outer membrane protein and related 
peptidoglycan-associated (lipo)proteins 
M LRS 
COG00860 3 N-acetylmuramoyl-L-alanine amidase M LRS 
COG00773 3 UDP-N-acetylmuramate-alanine ligase M LRS 
COG02089 3 Sialic acid synthase M LRS 
COG01360 12 Flagellar motor protein N LRS 
COG01749 9 Flagellar hook protein FlgE N LRS 
COG00760 5 Parvulin-like peptidyl-prolyl isomerase O LRS 
COG00484 4 DnaJ-class molecular chaperone with C-
terminal Zn finger domain 
O LRS 
COG00691 3 tmRNA-binding protein O LRS 
COG01066 3 Predicted ATP-dependent serine protease O LRS 
COG00740 7 Protease subunit of ATP-dependent Clp 
proteases 
OU LRS 
COG01116 5 ABC-type nitrate/sulfonate/bicarbonate 
transport system; ATPase component 
P LRS 
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Table 22 continued. 
COG ID # of 
Prot 
Description COG 
Func 
Rel.  
Diets 
COG01160 6 Predicted GTPases R LRS 
COG00312 6 Predicted Zn-dependent proteases and 
their inactivated homologs 
R LRS 
COG02872 3 Predicted metal-dependent hydrolases 
related to alanyl-tRNA synthetase HxxxH 
domain 
R LRS 
COG04716 26 Myosin-crossreactive antigen S LRS 
COG04198 19 Uncharacterized conserved protein S LRS 
COG04260 8 Putative virion core protein (lumpy skin 
disease virus) 
S LRS 
COG00393 6 Uncharacterized conserved protein S LRS 
COG04475 5 Uncharacterized protein conserved in 
bacteria 
S LRS 
COG02013 3 Uncharacterized conserved protein S LRS 
COG02197 3 Response regulator containing a CheY-
like receiver domain and an HTH DNA-
binding domain 
TK HRS 
COG00039 26 Malate/lactate dehydrogenases C HRS 
COG01456 8 CO dehydrogenase/acetyl-CoA synthase 
gamma subunit (corrinoid Fe-S protein) 
C HRS 
COG03426 7 Butyrate kinase C HRS 
COG00778 6 Nitroreductase C HRS 
COG03288 6 NAD/NADP transhydrogenase alpha 
subunit 
C HRS 
COG00479 6 Succinate dehydrogenase/fumarate 
reductase; Fe-S protein subunit 
C HRS 
COG00711 4 F0F1-type ATP synthase; subunit b C HRS 
COG00371 3 Glycerol dehydrogenase and related 
enzymes 
C HRS 
COG00031 20 Cysteine synthase E HRS 
COG03643 13 Glutamate formiminotransferase E HRS 
COG02873 13 O-acetylhomoserine sulfhydrylase E HRS 
COG00527 9 Aspartokinases E HRS 
COG00747 7 ABC-type dipeptide transport system; 
periplasmic component 
E HRS 
COG00140 6 Phosphoribosyl-ATP 
pyrophosphohydrolase 
E HRS 
COG01362 5 Aspartyl aminopeptidase E HRS 
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Table 22 continued. 
COG ID # of 
Prot 
Description COG 
Func 
Rel. 
Diets 
COG00410 4 ABC-type branched-chain amino acid 
transport systems; ATPase component 
E HRS 
COG00160 3 4-aminobutyrate aminotransferase and 
related aminotransferases 
E HRS 
COG00106 3 Phosphoribosylformimino-5-
aminoimidazole carboxamide 
ribonucleotide (ProFAR) isomerase 
E HRS 
COG00252 3 L-asparaginase/archaeal Glu-tRNAGln 
amidotransferase subunit D 
EJ HRS 
COG00145 3 N-methylhydantoinase A/acetone 
carboxylase; beta subunit 
EQ HRS 
COG03185 10 4-hydroxyphenylpyruvate dioxygenase 
and related hemolysins 
ER HRS 
COG00274 8 Deoxyribose-phosphate aldolase F HRS 
COG00504 8 CTP synthase (UTP-ammonia lyase) F HRS 
COG00035 7 Uracil phosphoribosyltransferase F HRS 
COG00027 6 Formate-dependent 
phosphoribosylglycinamide 
formyltransferase (GAR transformylase) 
F HRS 
COG03363 6 Archaeal IMP cyclohydrolase F HRS 
COG00150 5 Phosphoribosylaminoimidazole (AIR) 
synthetase 
F HRS 
COG00152 4 Phosphoribosylaminoimidazolesuccinocar
boxamide (SAICAR) synthase 
F HRS 
COG00167 4 Dihydroorotate dehydrogenase F HRS 
COG00284 3 Orotidine-5’-phosphate decarboxylase F HRS 
COG01109 14 Phosphomannomutase G HRS 
COG01080 12 Phosphoenolpyruvate-protein kinase (PTS 
system EI component in bacteria) 
G HRS 
COG02190 6 Phosphotransferase system IIA 
components 
G HRS 
COG03957 6 Phosphoketolase G HRS 
COG01820 5 N-acetylglucosamine-6-phosphate 
deacetylase 
G HRS 
COG01523 4 Type II secretory pathway; pullulanase 
PulA and related glycosidases 
G HRS 
COG00698 4 Ribose 5-phosphate isomerase RpiB G HRS 
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Table 22 continued. 
COG ID # of 
Prot 
Description COG 
Func 
Related 
Diets 
COG01638 4 TRAP-type C4-dicarboxylate transport 
system; periplasmic component 
G HRS 
COG00054 6 Riboflavin synthase beta-chain H HRS 
COG00511 5 Biotin carboxyl carrier protein I HRS 
COG00245 3 2C-methyl-D-erythritol 2;4-
cyclodiphosphate synthase 
I HRS 
COG00304 4 3-oxoacyl-(acyl-carrier-protein) synthase IQ HRS 
COG00233 17 Ribosome recycling factor J HRS 
COG01534 5 Predicted RNA-binding protein containing 
KH domain; possibly ribosomal protein 
J HRS 
COG00255 4 Ribosomal protein L29 J HRS 
COG01190 3 Lysyl-tRNA synthetase (class II) J HRS 
COG00568 28 DNA-directed RNA polymerase; sigma 
subunit (sigma70/sigma32) 
K HRS 
COG01158 18 Transcription termination factor K HRS 
COG00781 3 Transcription termination factor K HRS 
COG04775 7 Outer membrane protein/protective 
antigen OMA87 
M HRS 
COG04932 5 Predicted outer membrane protein M HRS 
COG00438 5 Glycosyltransferase M HRS 
COG01209 4 dTDP-glucose pyrophosphorylase M HRS 
COG00793 3 Periplasmic protease M HRS 
COG00643 19 Chemotaxis protein histidine kinase and 
related kinases 
NT HRS 
COG00840 9 Methyl-accepting chemotaxis protein NT HRS 
COG01450 4 Type II secretory pathway; component 
PulD 
NU HRS 
COG00576 5 Molecular chaperone GrpE (heat shock 
protein) 
O HRS 
COG02077 5 Peroxiredoxin O HRS 
COG00735 6 Fe2+/Zn2+ uptake regulation proteins P HRS 
COG01117 6 ABC-type phosphate transport system; 
ATPase component 
P HRS 
COG00004 4 Ammonia permease P HRS 
COG00226 4 ABC-type phosphate transport system; 
periplasmic component 
P HRS 
COG00704 3 Phosphate uptake regulator P HRS 
COG02368 3 Aromatic ring hydroxylase Q HRS 
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Table 22 continued. 
COG ID # of 
Prot 
Description COG 
Func 
Rel. 
Diets 
COG00714 17 MoxR-like ATPases R HRS 
COG01837 8 Predicted RNA-binding protein (contains 
KH domain) 
R HRS 
COG01461 8 Predicted kinase related to 
dihydroxyacetone kinase 
R HRS 
COG01878 4 Predicted metal-dependent hydrolase R HRS 
COG01159 3 GTPase R HRS 
COG04864 16 Uncharacterized protein conserved in 
bacteria 
S HRS 
COG02268 13 Uncharacterized protein conserved in 
bacteria 
S HRS 
COG00217 11 Uncharacterized conserved protein S HRS 
COG01624 6 Uncharacterized conserved protein S HRS 
COG01917 5 Uncharacterized conserved protein; 
contains double-stranded beta-helix 
domain 
S HRS 
COG01302 4 Uncharacterized protein conserved in 
bacteria 
S HRS 
COG02859 4 Uncharacterized protein conserved in 
bacteria 
S HRS 
COG04702 4 Uncharacterized conserved protein S HRS 
COG03976 3 Uncharacterized protein conserved in 
bacteria 
S HRS 
COG01875 6 Predicted ATPase related to phosphate 
starvation-inducible protein PhoH 
T HRS 
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Figure 38 Heat-map of significant 166 COG terms.  We standardized sum of 
transferred SC of each of COG terms.  Deeper steel-blue color means higher 
expression level in diet metaproteome.  COG terms are clustered by their 
expression pattern and broad functional term. 
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Figure 38 continued  
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In HRS, energy production and uptake of nutrients were similarly expressed to 
LRS and baseline.  However, cell wall and envelope biogenesis is turned on so 
that microbes may need to defense themselves from increase of competing or 
host immune system (COG04775, COG04932, COG00438, COG01209 and 
COG00793).  Likewise to LRS, microbes are trying to express and modify 
appropriate proteins in order to adapt to the changed environment, high amount 
of RS (COG00233, COG01534, COG00255 and COG01190 for translation, 
COG00568, COG01158 and COG00781 for transcription and COG00576 and 
COG02077 for post-translational modification).  Interestingly, HRS also has 
differentially enriched cell motility COG terms like LRS.  This may mean that 
microbes were moving toward new energy source (COG00643, COG00840 and 
COG01450).   
Conclusion 
 
We could identify 57,398 proteins from 24 MS runs (8 patients * 3 diets).  
Of 57,398 proteins, 56,295 were from microbiome and 1,103 were host human 
proteins.  This seriously unequal protein identification is caused by employing 
indirect methods and metagenome.  Those two could dramatically increase the 
number of identified microbial proteins that are main targets of this study.   
With this successful microbial protein identification, we constructed 
GLMM-NB model to compare diet metaproteomes.  Since the experiment design 
is based on cross over, we selected GLMM model by setting patients as random 
effect and diet types as fixed effect.  High variation of fecal proteome, even within 
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same group was also considered while making GLMM model.  NB is employed 
as null distribution of GLMM model because NB is effective to analyze count type 
data, such as spectrum counting of the diet metaproteome.  On top of GLMM NB 
model, Cohen’s w was combined to enhance statistical power of hypothesis 
tests.  This GLMM NB model and Cohen’s w could provide reliable statistical 
comparisons and were used for finding significantly changed proteins and 
functional analysis of the diet metaproteome.  We could find 7,113 significantly 
changed proteins (94 from human and 7,018 from microbiome and 
metagenome).  These significant proteins were picked by 0.0001 FDR and 
1.0258 Cohen’s w 
Functional analysis of the diet metaproteome provided understanding of 
systematic changes in human and microbial community.  KEGG pathway 
analysis showed that functional changes in host proteome are immune response 
and glucose uptake.  COG analysis illustrated that microbial community also had 
changes in energy generation, gene and protein expression and cell motility.  
Considering those alterations, we speculate that specific bacteria grow as RS 
amount in diet is increased because they can use RS as energy source in large 
intestine.  Then, population growth of specific bacteria stimulates human immune 
response including adaptive and innate immunities.  These changes in large 
intestine, enhanced host defense and nutrient change, result in expression of 
self-defense and cell motility of existing microbes in the microbiome. 
All in all, diet metaproteome is highly complicated and very large and 
complicated data set.  However, QFAM could appropriately analyze the 
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generated metaproteome and could give exciting insights about functional 
changes in human host and microbiome.  In spite of high variance within 
biological replicates, GLMM NB and Cohen’s w could rigorously compare and 
give interesting and reliable analysis results. 
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CHAPTER VI 
Conclusions 
 
Overview 
 The ability to analyze metaproteome datasets quantitatively and 
functionally, with reliability is an essential requirement in metaproteomics 
research.  Although metaproteomics has emerged as a promising technique for 
deep and wide characterization of the protein complement of microbial 
communities, bioinformatic analysis strategies for metaproteomics are currently 
inadequate.  In terms of processing speed and sequence-based functional 
analysis, required attributes for processing highly complicated and redundant 
number of metaproteome sequences, MPA and GalaxyP, mentioned in chapter 
1, are not optimal pipelines for metaproteomics.  In contrast to MPA and 
GalaxyP, QFAM enables multiprocessing up to 48 CPUs of Newton 
computational cluster and COG analysis for poorly annotated metagenome and 
microbial metaproteome sequences.  Moreover, QFAM utilize Cohen’s effect 
sizes to filter out low-powered hypothesis tests at desired statistical power level.  
This quantitative analysis module is applied for all the analysis steps in QFAM, 
such as QAM, FAM for BioSystems and FAM for COG analysis.  The details of f 
QFAM are explained in chapter 2.  Chapter 3 illustrated how ‘selfea’, utilized for 
quantitative analysis in QAM, could enhance reliability of hypothesis tests in 
quantitative proteomics data analysis.  Selfea can filter out hypothesis tests that 
have low statistical power in order to keep certain level of statistical power.  P-
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value cannot be reliable evidence at low statistical power.  In the benchmark data 
test, real noisy data test and Monte Carlo simulation test, selfea could filter out 
false positives efficiently, while losing few true positives at high statistical power.   
We also demonstrated that QFAM is useful to analyze metaproteome 
data.  Chapter 4 illustrated how QFAM is applied for human fecal metaproteome 
analysis.  This human fecal proteome study compared 29 MS runs from 11 
healthy volunteers.  Human fecal proteome is highly varying between healthy 
individuals.  Its variance within group was shown in figure 31 (0.75 to 0.98 PCC 
for technical replicates and 0.15 to 0.81 PCC for biological replicates). This 
variation was confirmed by 90% statistical power and 0.05 p-value of QFAM.  
From BioSystems of QFAM, we could reveal that digestion related proteins and 
immune response proteins are differently detected in human fecal proteomes 
(Table 18).  COG analysis showed that almost all the functions including energy 
generation and defense mechanism were variously enriched in microbial fecal 
proteomes (Table 20).   
Also, QFAM was employed to analyze diet metaproteome data described 
in chapter 5.  Fecal metaproteomes were collected from 8 patients at three 
different time points.  At each time points patients were treated by three different 
diets, baseline, low resistant starch (RS) (2 mg) and high RS diet (38 mg).  Since 
RS amount in diet is known to be associated with changes in microbiome, this 
study is designed to investigate quantitative and functional relationship between 
RS and the gut microbiome.   However, fecal proteomes are very dissimilar as 
was confirmed in chapter 4.  Hence, stringent thresholds were applied for 
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selection of significant features in order to make the expected number of false 
positives less than 1, and thus results more reliable.  QFAM analyzed diet 
proteomes by constructing GLMM NB model and employing Cohen’s w.  GLMM 
NB model could consider personal fecal proteome variation based on negative 
binomial distribution.  Proteins, KEGG pathways, COG terms were compared at 
80% statistical power and 0.0001 FDR-adjusted p-value.  QFAM’s functional and 
quantitative analysis revealed that glucose uptake, digestion related pathways 
and immune responses were differentially detected in human host proteomes 
(Fig. 37).  Through COG analysis, QFAM discovered differentially expressed 
microbial functions, such as cell wall construction, cell motility, energy generation 
and protein modification (Fig. 38).  Based on these findings using QFAM, we 
speculated that specific bacteria grow as RS amount in diet is increased because 
they can use RS as energy source in large intestine.  Then, population growth of 
specific bacteria stimulates human immune response including adaptive and 
innate immunities.  These changes in large intestine, enhanced host defense and 
nutrient change, result in expression of self-defense and cell motility of existing 
microbes in the microbiome.  From two application studies, we could confirm 
QFAM is practically useful to biologists by providing functional and quantitative 
analysis. 
Current status of QFAM and remaining challenges 
 QFAM can be employed to normal single species proteomics for 
quantitative and functional analysis.  Since quantitative comparison of proteomes 
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has been done by using Student’s t-test or ANOVA based on Normal distribution.  
However, spectral counting does not follow Normal distribution, so Student’s t-
test and Normal ANOVA are not recommended for proteomics data analysis (Fig. 
14).  Moreover, Student’s t-test has serious disadvantage in repeated tests using 
same dataset.  Type I error of Student’s t-test is linearly increased, while ANOVA 
can keep Type I error at certain level with multiple tests [98].  Even though QProt 
is developed to overcome error rate problem of Student’s t-test, it only enables 
two-sample comparison.  As was explained in chapter 3, p-value is only valid at 
high statistical power that is not achieved in most of biology studies due to limited 
money and time.  Therefore, using Cohen’s ES with p-value can be applied to 
general proteomics and other type of data besides metaproteomics. 
 Despite the availability of many functional analysis tools, FAM is unique 
due to employing two statistical tests, enrichment test and significance test.  
Enrichment test using Fisher’s exact test is widely accepted methodology to 
enrich functional terms from signatures.  However, enrichment test has not been 
combined with significance test, to date and to our knowledge.  Moreover, FAM’s 
significance test uses selfea providing reliable feature selection.  Therefore, FAM 
can be distinguished from many pre-existing tools by two tests.  Usefulness of 
these two tests was demonstrated by two application studies in chapter 4 and 5. 
 Even though QFAM can use 48 CPUs, maximum number of allowed 
CPUs in Newton cluster, for unlimited time in Newton cluster, it is not enough to 
analyze huge metaproteomics data.  For example, while searching PSMs of 
permafrost metaproteome, it took two weeks for one MS run using 48 CPUs.  
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Permafrost has 900 megabytes protein database.  Since MyriMatch is DB search 
engine, its search speed is more dependent on the size of DB.  Each MS/MS 
spectra is compared with every theoretically generated peptides of the DB after 
precursor mass filter.  Narrowing mass tolerance window and more precise 
parent mass measurement can reduce the number of comparisons for one 
MS/MS spectrum.  However, MS instrument with high mass accuracy and 
precision can be very expensive and narrowing mass tolerance window may 
result in missing true targets. 
De novo sequencing based search algorithm, such as MS-GF+, can 
reduce PSM search time.  Search speed of MS-GF+ is dependent on generation 
of possible de novo sequences rather then DB size.  Even though MS-GF+ has 
not been used for metaproteomics study, if it can complete PSM search even for 
1 gigabytes protein DB within reasonable time, it can replace DB search engine 
efficiently.  Moreover, MS-GF+ has reliable score system that is confirmed by 
several proteomics studies [178].  Therefore, we believe that MS-GF+ can be 
good replacement of widely used DB search engines, such as SEQUEST and 
Mascot for metaproteomics studies. 
The increase of the available CPUs is the best way to reduce PSM search 
with QFAM.  Although performance test of MyriMatch with 1,000 cores is not 
confirmed yet, MyriMatch is expected to get faster with larger number of CPUs as 
was tested up to 48 in Newton cluster (Table 4, 5 and 6).  QFAM has Python job 
controller and can run PSM search and analysis processes using multiple CPUs.  
Therefore, increasing the number of CPUs in either Newton or in sun grid engine 
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cluster doesn’t matter to QFAM.  QFAM’s current job controller is designed only 
for sun grid engine, thus if QFAM is installed to different batch-queuing system; it 
requires simple update to recognize new job processes. 
Increased number of computational cores can speed up COG analysis as 
well.  COG annotation is one of two most time consuming job in QFAM along 
with the PSM search.  In order to calculate enrichment test of COG terms, QFAM 
tries to annotate all the available protein sequences in protein DB.  In human 
fecal proteome study of chapter 4, the total number of proteins in DB was 
100,000.  However, the number of proteins in diet metaproteome DB was several 
millions.  This is why we couldn’t implement COG enrichment test for diet 
metaproteome study.  Another study, Permafrost metaproteome, had two times 
more number of proteins than diet proteome study.  Therefore, high 
computational power is necessary for QFAM to operate at optimal levels for all 
types of metaproteome studies.   
QFAM needs to have more options for protein identification.  Currently, 
QFAM has only one option, MyriMatch and IDPicker, for PSM search.  Even 
though MyriMatch and IDPicker are useful and accepted tools for protein 
identification, users need more options for protein identification.  Basically, 
different algorithms in PSM search generate different protein identification.  
These identifications can either be combined for greater proteome depth or take 
only those identifications that each algorithm finds for higher confidence.  Other 
PSM search engines are available, such as X!!Tandem [78] and wrapper for 
proteomics [79].  MS-GF+ would be good option for metaproteomics because it is 
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not dependent on DB size.  QFAM may need to provide various search engines, 
working with multiple CPUs, to users, such as X!!Tandem and MS-GF+ to 
complement MyriMatch/IDPicker. 
QFAM is hard to access by untrained end user because it does not have 
graphical user interface (GUI), while GalaxyP and MPA provides excellent GUI 
interface for easy use.  GUI should be able to communicate between user and 
analysis server including transferring large metaproteomics data to the server 
and receiving analysis results from the server.  However, file transfer is limited in 
Newton cluster for security purpose. Globus (https://www.globus.org/) or Dropbox 
(https://www.dropbox.com/) can be possible solution because these provide easy 
and fast data sharing.  Data transfer is recently getting easier by aforementioned 
tools. 
Metaproteomics is promising technique for discovering mechanisms of 
unknown microbial communities and is a rapidly growing field available to 
microbial ecologist.  However, metaproteomics data is large and highly 
complicated, so the current largest challenge and bottleneck is the bioinformatics 
data processing.  QFAM is developed to analyze this huge and intricate data 
quantitatively and functionally at enhanced speed and reliability.  Two application 
studies in chapter 4 and 5 prove usefulness of QFAM for metaproteome data 
analysis.  We believe that QFAM can be an excellent tool for metaproteome 
experts to improve their analyses of microbial communities. 
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